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PREFACE 
 
 
Mental health is an indivisible part of public health. This has been the uppermost idea of 
the process "Putting Mental Health on the European Agenda", which was started as 
early as 1995. The main objectives of this process have been to gain more value and 
visibility for mental health issues in the context of public health policy, and to integrate 
the promotion of mental health and prevention of mental health problems with general 
health promotion on the one hand, and with practical mental health work on the other. 
The European Commission, the European Parliament, the European Council of health 
ministers, and the EU Member States have backed up these efforts in various forms, 
including large-scale projects and conferences. This conference 'Mental Health in 
Europe, New Challenges, New Opportunities', held in Bilbao on 9-11 October, 2003, 
has been a logical continuation of this process. 
The European Union is expected to increase the membership by ten new Member States 
in 2004. This will bring new challenges, but also opportunities, related to mental health 
issues for the enlarged European Union. One major issue will be the new mental health 
threats encountered in the central and eastern European countries, many of them being 
in the accession process to the EU. 
Collaboration between the European Union and the World Health Organisation in the 
field of mental health started in 1999 with a conference on the topic "Balancing Mental 
Health Promotion and Mental Health Care". After that, the WHO has been a partner in 
organising several EU presidency conferences in this field. The WHO Regional Office 
for Europe has been a cosponsor for this conference. Therefore, this conference may 
also be seen as a step towards the WHO ministerial conference on mental health, which 
will be held in January 2005.  
Finally, one has to mention the crucial role of many other stakeholders in developing 
and implementing the European Mental Health Agenda. These include several European 
networks in the field of mental health, civil society organisations (NGOs), user and 
family organisations as well as research institutions and university departments. 
The overall goal of this conference was to analyse the challenges and opportunities for 
promoting mental health in Europe and for strengthening collaboration in the field by 
especially taking into consideration the forthcoming enlargement of the European 
Union.  
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CONFERENCE RECOMMENDATIONS 
 
 
1. Existing models of good practices in mental health promotion and prevention 
of mental ill-health shall be widely disseminated with a view to implementing 
them in all European countries and regions. 
2. Special attention shall be paid to programs enabling people to better cope with 
transitions during their life cycle; these interventions must start as early as 
possible and already during school age. 
3. In order to cope with the rapid changes in our societies it is essential to 
strengthen the sense of coherence concerning life-roles, participation, and 
common values, as well as to strengthen change management, credibility and 
trust in our societies.  
4. Efforts shall be taken to strengthen the participation of users and carers in 
mental health policy planning, as well as in the implementation of relevant 
activities covering promotion, prevention and care. 
5. A European resource centre is needed for the definition of, collection on a 
repeated basis, analysis, interpretation and dissemination of relevant and 
comparable data on mental health, including suicides.  
6. Mental health monitoring systems shall include relevant indicators on the 
economic and social burden of mental ill-health 
7. In health impact assessment, special attention shall be paid to the development 
of expertise and tools for mental health impact assessment. 
8. Special emphasis shall be devoted to assess the economic and social impact of 
mental health promotion and prevention activities concerning children and 
young people, as well as in the workplace.  
9. All countries shall have a comprehensive alcohol and drug policy, including a 
monitoring system on alcohol and drug consumption, on implementation of 
that policy, and on the harm produced by alcohol and drugs. Special attention 
shall be directed to particular groups such as adolescents, older people, 
prisoners, minorities, immigrates, recreational drug users, and drivers of 
motor vehicles. 
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CONCLUSIONS FROM THE CONFERENCE 
 
Edited by Ville Lehtinen, STAKES, Finland 
 
 
OBJECTIVES 
The specific objectives of the conference Mental Health in Europe, New Challenges, 
New Opportunities were to: 
• Build momentum: Take maximum advantage of previous and on-going mental 
health activities within the European Union supported by the European Commission 
through the Public Health Action Programme. 
• Develop four priority areas (conference themes): 1) The economic and social 
impact of mental health problems on the one hand, and of mental health 
promotion/prevention on the other; 2) The impact of transitions (both on a societal 
and individual level) on mental health; 3) Establishment of a supportive 
infrastructure, including relevant information systems, needed for the promotion of 
mental health and prevention of common mental disorders (depression and anxiety); 
and 4) The prevention of premature mortality, especially suicide, including the 
prevention of substance abuse problems. 
• Support collaboration: Establish contacts and collaboration to share experiences 
between the mental health organisations and networks within the European Union 
and those of countries in accession to ensure maximum dissemination of 
information between different cultural and societal environments. Continue and 
strengthen the fruitful collaboration between the EU and the WHO-Euro in the field 
of mental health. 
• Outline recommendations for future mental health policy within the European 
Union, especially in the context of the enlargement of the Union. 
PARTICIPANTS 
The conference was attended by 144 active registered participants from 14 EU Member 
States (all except Portugal), the three EEA countries, and the ten accession countries. In 
addition, the conference had participants from Bulgaria, Romania, Montenegro, Serbia, 
Switzerland and even as far away as Nigeria. The WHO Regional Office for Europe 
supported the participation of four people from Central and Eastern Europe. Participants 
represented the European Commission, the WHO Regional Office for Europe, several 
Health Ministries of the European countries, different European projects and networks, 
civil society organisations (NGOs) in the field of mental health, especially those of 
users and caregivers, as well as administrators, experts, researchers and professionals in 
the field of mental health promotion, and prevention and care of mental health 
problems. 
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CONFERENCE CONCLUSIONS 
Each of the four conference themes was covered by a key presentation, two responses 
and two parallel workshops. In addition a key-note speech about the health implications 
of the enlargement of the EU was given, and a round table discussion about user and 
carer participation was held. In the concluding session the first outline of these 
conclusions and recommendations were presented and discussed, and also some 
viewpoints about the future perspectives and needs of the accession countries were 
given. The conclusions which are presented in the following are based on the 
presentations, the workshop reports, and general discussion during the conference. It 
should be noted that the full workshop reports are also included in this Conference 
Report. The conference recommendations, which are presented in the beginning of the 
report, are derived from these conclusions. 
1.  Concerning the economic and social burden of mental disorders: 
It is essential to:  
• develop national policies and strategies on mental health which should be integrated 
and funded across a range of sectors and agencies; 
• give priority to promotion, prevention, and community services development, 
particularly for service reforms in the accession countries; 
• stimulate evaluation of the performance of systems for promotion, prevention, care 
and treatment.  
 
There is a special need to: 
 
encourage a focus on mental health promotion and prevention within employment and 
workplaces by: 
      - emphasising support for employment for people with severe mental illness; 
      - emphasising strategies and programmes aimed at gaining and sustaining work for 
people with common mental health problems 
 
encourage a focus on mental health in children by: 
      - implementing programs to support good parenting; 
      - providing home-based support for parents with mental health problems; 
      - encouraging schools to address mental health issues. 
2.  Concerning the impact of transitions on mental health: 
It is essential to take into consideration that: 
• people are often unable to follow the high-speed intensity and diversity of changes;  
thus, there is a great challenge for learning.  
• people may react to this stress with either hopefulness or pessimism, depending on 
the perception and interpretation of the situation; 
• life transitions can also enable the individual to find new ways of life and 
opportunities for personal growth by overcoming situations in which one feels one 
is stuck without being able to make changes; 
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• erosion of traditional support systems makes it necessary to build up compensating 
institutional provisions of help that are accessible, acceptable and problem-sensitive; 
effective means to cope with these challenges are available. 
• transitions effect social institutions either positively by managing the removal of 
structural barriers to mental health through effective initiatives, or negatively by 
conserving barriers for implementation of modern principles i.e. through strong 
traditions of a culture of dependency at all levels. 
3.  Concerning mental health promotion and prevention of mental health 
problems: 
For the implementation of the policy recommendations it is essential to: 
• agree on common definitions for mental health and mental health promotion; 
• identify responsible organisations working in promotion and prevention to be 
engaged in the implementation process of the mental health policy 
recommendations; 
• set priorities for the implementation process taking into account local and regional 
needs and circumstances.  
For mental health monitoring it is important to consider that: 
• one of the major challenges is the fact that necessary data on mental health 
indicators is often missing or at least noncomparable between countries and even 
within a country; 
• it is important to collect data on a repeated basis to be able to follow the trends; 
• two types of data are needed for monitoring purposes: routine statistics and data 
which need population health surveys; 
• there is need to build up a European-wide system of data collection and analysis.  
4.  Concerning the prevention of premature mortality and abuse problems: 
For the prevention of suicides and other premature mortality it is essential that:  
• each country includes in its national health plans the requirement to address the need 
for suicide preventive measures; 
• each country establishes its national suicide prevention strategy; 
• a European database will be established and maintained about good practices and 
methods in suicide prevention across all sectors of society and national borders. 
 
For prevention of abuse problems it is essential to recognise that: 
• drug addiction represents a priority per se both in EU and accession countries given 
the amount of health, economic and social problems connected to it; 
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• there is a need to promote cooperation and integration between different public, 
private and NGO actions, and to search for common goals for different stakeholders; 
• there is need to make available specific treatments to everyone who needs them by 
providing a comprehensive range of programs and interventions. 
5.  Concerning user and carer participation: 
• the main barriers are a lack of resources (like funding, information, collaboration, 
experience and organisational skills); 
• clear strengths can be identified as: 
     -  an understanding of what works 
     -  energy and commitment; 
• governments can support user/carer participation by funding, providing information, 
education, and affirmative actions; 
• professionals can support user/carer participation by giving them more time, 
interaction,  participation on an equal basis, trust, and listening.  
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OPENING ADDRESSES 
 
Gabriel Mª Inclán Iribar, Health Minister of Basque Government 
 
 
Opening of the Conference 
Good morning. First of all, I should like to welcome to the Basque Country all the 
professionals who have come to this Conference on Mental Health from a large number 
of European countries, some of which are current members of the European Union and 
others who are to join the EU next year. 
It was precisely the extension of the European Union that led us to organise this event 
among professionals involved in this field, in order to discuss the subject of how we are 
to face the challenge of improving mental health care in our respective systems, and 
particularly in those countries that are having to face the challenges involved in 
achieving better standards of mental health care after many years of isolation from the 
mainstream developments that have taken place in so-called Western Europe. Although 
we recognise that we can still learn a lot from all of you, we intend to offer an overview 
of how we in the Basque Country have developed over the last 20 years, when we 
started from a similar situation to that in which the countries I have just referred to find 
themselves today. 
Clearly, a Conference such as this one is not the product of improvisation, but the result 
of the cooperation we have developed over recent years with the European 
Commission's Directorate General for Public Health, STAKES (the Finnish National 
Research and Development Centre for Welfare and Health); and the Finnish 
government itself who, without doubt, have made exceptional contributions in 
introducing the subject of mental health onto the agenda of the European Union.  
I was saying that our intention with this Conference is to promote the protection of 
mental health with even greater determination, sharing our experience on how we have 
dealt with the impact of the transition with those countries that are to join the European 
Union in the near future.  
For example, in the Basque Country, we have experienced a similar transition to the one 
which some of these countries are undergoing at the present time, changing from a 
totalitarian system to a democracy, from imposed ideologies to freedom of expression. 
In our case, the change coincided with a serious economic crisis, with unemployment 
figures that reached 33% of the population in some areas, and so on. In short, a scenario 
in which mental health policies together with several social service and economic 
planning strategies played a decisive role in maintaining cohesion and bearing the costs 
of change. 
Therefore, in this short introduction I should like to give you a brief account of the 
developments we have seen in psychiatric care over the last 20 years, in keeping with 
the series of economic, social and political changes that have taken place in our society. 
Work on the planning of Psychiatric Care in the Autonomous Community of the Basque 
Country began in 1979 when the preliminary analyses were made of the status of 
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psychiatric care at that time. Some years after this, in July 1982, the Advisory 
Committee was created, which was responsible for drafting the first Psychiatric Care 
and Mental Health Plan of our community, which finally saw the light of day in 1983. 
Since then, we have seen major changes in the care applied in the field of psychiatry. 
Thanks to new therapeutic procedures, we have developed from the traditional model 
based on mental hospitals to multidisciplinary psychiatric practices, integrated in the 
community and with deep roots in medical practice. 
This has led to the development of psychiatric organisations away from hospitals, the 
integration of short-term psychiatric services such as general hospital units, and the 
progressive modifications of medium and long-term hospitals towards ambulatory 
support structures in the form of day hospitals and/or centres, and even assisted 
residential facilities.  
On the other hand, and in a parallel manner, the changes experienced by western 
societies over the recent years have led to the gradual incorporation of citizens in 
decision-making processes in different areas, including health. In this way, citizens have 
the right to give their appraisal of the treatment they receive, participate in therapeutic 
decisions, question our actions, and take part in other forums. Thus, in general, medical 
practice has seen changes in its operating procedures, from paternalistic models with 
unequal levels of information, to models of doctor-patient relationships with sufficient 
levels of autonomy and information, in which patients cease to be considered as mere 
receivers and submissive followers of the orders and recommendations of the "experts". 
All these changes have involved a parallel development of health service structures. 
Thus, today the human resources dedicated to psychiatric care in the Basque 
Autonomous Community represent a total of 2000 professionals, with ratios of 15.4 
doctors for every 100 000 inhabitants, or, in other words, a total of 6 500 inhabitants for 
each professional (psychiatrist or psychologist). Overall, approximately one person in 
every 1000 inhabitants in our community works in public organisations associated with 
psychiatric care, excluding the civil society organisations involved in this area. 
In spite of all the developments we have described here, there are still some aspects that 
need to be worked on, such as, for example, clarifying the role of long-term hospitals; 
improving rehabilitation resources; covering the residential and professional needs of 
patients more adequately; improving the integration between levels inside and outside 
hospitals, etc. 
It is for this reason that, having overcome the initial transition phase from the mental 
hospital model, the community model continues to be the programmatic basis of the 
mental health and psychiatric care model in the Basque Health Service/Osakidetza. 
We understand that during this stage such a model must maintain and promote: 
• Its definition as a specialised care structure, understood as a structure dedicated to 
the appraisal, diagnosis and treatment of the most complex cases, with the highest 
level of disability. To do this, it is necessary to identify priority groups of patients in 
order to provide them with direct services with a high technical level based on  
evidence; and offering, at the same time, inter-doctor consulting with primary care 
and other services that deal with the most frequent and mild disorders. 
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• The maintenance of care centres as part of the community, with adequately-
equipped multidisciplinary teams, forming an interdependent care structure which is 
accessible and includes the different psychiatric resources existing in a specific 
geographical area (network concept) defined in the Mental Health Care Map, and 
any others that might be developed. 
• The early diagnosis and treatment of psychiatric disorders preferably in primary care 
services (health centres). 
• Collaboration with other health and social services in the community, within the 
framework of the social-health space, in order to achieve in the mid-term an 
adequate integration of mentally-ill individuals in all aspects of daily life (education, 
employment, housing). 
• Actions designed to foster mental health in general and a reduction in the exposure 
to risk factors for mental disorders, encouraging educational activities to fight 
against the stigma associated with mental illness. 
• The integration of self-help associations, strengthening the responsibility of the 
patient, the family and the community in caring for their own health by means of 
appropriate educational programs. 
• The development of training and research as the means necessary to acquire new 
care techniques that allow the "advanced" nature of our network to be maintained. 
This conception of mental health gives you an idea of the importance we attach to 
psychiatric care in our community, and this is also shown by the fact that it is 
considered a priority area in the health plans drawn up by the Health Department of the 
Basque Government for the periods 1995-2001 and 2002-2010. During the latter period, 
actions in the field of mental health have established priorities in the area of care for 
infants and young persons; in the most prevalent mental disorders or those of major 
importance in the care of the adult population; in the care of drug addiction in general, 
and in the prevention of suicides; all this is done in accordance with the guidelines set 
out in the WHO document "Health for all in the 21st century". 
Moreover, in all these areas of activity, the importance of early diagnosis, prevention 
and health promotion work are mentioned expressly as a formula that needs to be 
approached with determination in our community. It is true that, although in some areas 
of mental health, such as drug addiction, a great deal of work has been done, and is 
being done, on prevention, in other areas work has focused especially on the 
development of rehabilitation and on providing patients with rapid access to medical 
care. This probably has a lot to do with the development from an institution model in 
which rehabilitation work was clearly seen to be an area for development. 
Now that these bases have been established, it seems logical to provide clear support for 
the central theme of this Conference, based on the promotion and prevention of mental 
disease.  
For all these reasons, our Department supported the idea of holding this Conference in 
Bilbao with great enthusiasm, as it will, without doubt, help us to exchange know-how 
and experiences in mental health plans and policies. Without more ado, I declare this 
conference to be officially inaugurated. 
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Horst Kloppenburg, Principal Administrator, European Commission 
 
The European Commission Perspective on Mental Health in Europe 
 
 
Ladies and gentlemen, I am very pleased on behalf of the European Commission to 
present some perspectives on mental health at this conference on new challenges and 
new opportunities in Bilbao. As you all know, the European Union has a relatively 
targeted mandate in public health. Pursuant to Article 152 of the Treaty, the European 
Union has to ensure a high level of human health protection by complementing national 
policies, with the aim of improving public health by preventing human illness and 
diseases. Thus, in the arena of mental health, the European Union has primarily 
concentrated on positive health promotion and on the prevention of mental health 
problems. It also has focused its activities to fighting the negative consequences of 
mental health problems such as social exclusion and stigma. 
We have, in particular, developed prevention and promotion strategies in relation to 
mental health within projects funded under the Community Action Programme on 
Health Promotion and the Health Monitoring Programme. Under the Health Monitoring 
Programme, European indicators for mental health have been set up with a view to 
mirroring the mental health status of all citizens and to determining specific responses 
to needs within the Member States. We, in cooperation with the Member States, 
candidate countries, and EEA countries, will seek to make these mental health 
indicators operational, and to initiate or to invite these countries to carry out concrete 
intervention measures in promoting mental health and well-being. At the same time, 
these indicators will provide a basis for fighting stigma and discrimination in relation to 
mental health problems. The Work Plan 2003 of the new Community Action 
Programme in Public Health, which has been implemented since the beginning of this 
year, foresees the creation of a working party on mental health for collecting the 
relevant data for the mental health indicators. These indicators will allow cross-border 
comparisons and might later initiate the establishment of European standards in the area 
of mental health in relation to health care and prevention of mental health problems. 
The most important message in mental health was incorporated within projects funded 
under the Health Promotion Programme, e.g. ‘there is no health without mental health’. 
This message was used within the Council Resolution on Promotion of Mental Health in 
1999. 
By accepting mental health problems in the same way as we accept physical health 
problems, we shall be able to avoid the stigma and social exclusion of sufferers from 
mental health problems and their carers. We have to overcome the fear that mental 
health problems automatically give rise to anti-social behaviour and attitudes or 
violence from which the general public has to be protected. In the past, the 
consequences of these unwarranted fears were often to detain or institutionalise those 
people suffering from mental health problems instead of treating them appropriately. 
We have to be aware that mental health problems very often lead to the socio-economic 
deprivation of sufferers from mental ill-health and also of those who are indirectly 
affected by these problems such as carers, families and friends. Deprivation in many 
cases is closely linked to inequalities in health, be it access to health services or to 
treatment of costly mental diseases. A pan-European project on tackling inequalities in 
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health, which was funded under the Health Promotion Programme, showed evidence 
that among the disabled population people suffering from mental health problems have 
the lowest participation rate in the labour market. Moreover, their unemployment rate is 
considerably higher than that of the rest of the population. Furthermore, evidence from 
recent studies shows that although life expectancy in general has increased from 75 to 
about 79 years, there are gaps in life expectancy between people at the top and at the 
bottom of the social hierarchy of typically between 5 to 10 years. As sufferers from 
mental health problems normally do not belong to the top of the social hierarchy, they 
face a reduced life expectancy in addition to their disease. 
These aspects have been discussed during the Greek presidential conference on mental 
health and stigma in March this year. The Council Conclusions, which are based on this 
conference, have given rise to new initiatives to fight stigma and social exclusion across 
the whole of Europe. To implement this aim, a closer cooperation of the Commission 
Services, in particular between DG SANCO and DG EMPLOYMENT is foreseen. 
In order to obtain more information on compulsory admission and involuntary treatment 
of mentally ill patients, we have funded a project to collect the relevant data on 
legislation and practices in all Member States. The focus of this project was to 
emphasise commonalties and differences between the Member States of the EU. 
Currently a follow-up project on forensic psychiatry is being carried out. 
Due to the fact that depression has the highest prevalence among mental health 
problems, Belgium had devoted its Presidency in 2001 to mental health promotion and 
prevention strategies for coping with depression and stress related problems in Europe. 
The Council Conclusions based on the mental health conference gave rise to a project 
on coping and prevention strategies in relation to anxiety, depression and stress-related 
problems during the life cycle. Specific attention was paid to critical periods of 
transition during the life cycle such as transition from education to working life, from 
working life to unemployment, and from working life to retirement. This project was 
funded under the Health Promotion Programme. The results shall be presented at this 
conference. 
The Commission intends to build up the public awareness of mental health problems by 
widely publishing the results of the mental health status of the European population, 
based on the Eurobarometer health survey. It clearly emerged from this health survey 
that physical diseases and mental health problems are frequent and can affect anyone 
among us. For instance, one in four people suffer from depression at some stage of their 
life cycle. This is a figure we should have in mind when a family member suffers from a 
mental health problem such as a depression. 
With the ever-increasing prevalence of mental health problems in the different Member 
States, it has become obvious that more quantitative data on the burden of mental health 
problems are needed. Thus we have funded another project under the Health Promotion 
Programme on the financial burden of mental health problems. For the first time, data 
on costs for treatment of some mental disorders will be collected and analysed, 
including the costs attributed to prevention and promotion measures. We shall share the 
results with the Member States and will promote an evidence-based approach in 
prioritising between measures of mental health care and mental health promotion and 
the prevention of mental health problems. 
We are also working closely with the WHO to develop a ministerial conference in 
January 2005 in Finland on mental health. This conference will help to raise the profile 
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of and encourage debate on mental health in our society. We also intend to support 
reparatory discussions focusing on specific aspects of the conference and linking with 
work done in the EU Public Health Programmes and their relevant networks and 
working groups. Thank you. 
 
 
Wolfgang Rutz, Regional Adviser, WHO Regional Office for Europe 
 
A Focus on Societies in Transition 
 
 
Ladies and gentlemen, social, environmental, and public mental health strategies, 
especially those focusing on the promotion of mental health, have frequently been 
questioned in recent years, demonstrating the conflicts seen between qualitative 
evidence and quantitative criticism, and even indicating a new biological, often genetic, 
reductionism which today can be found in the areas of psychiatry and mental health. 
I think, ladies and gentlemen, in this situation, it is important to remember again the real 
raison d’être of mental health promotion as well as disorder prevention, therapy and 
rehabilitation, as they are related to the realities which we have to cope with - mentally 
vulnerable as we all are - in Europe today. 
In the European region of the World Health Organisation, reaching from Ireland to 
Vladivostok, from Greenland to Malta, we see today consequences of heavy and 
dramatic societal transitions: 
? In the eastern European states belonging to the former Soviet Union that have 
recently become independent, 
? In central Europe where dramatic changes occurred during the last decade  
? But also in Western Europe, where people are exposed to dramatic changes, namely 
young women in Scandinavia; young men in Finland and England; farmers in Wales 
and Ireland; adolescents in France; elderly people in Portugal, Lithuania and Eastern 
Germany; indigenous people in Greenland; and immigrants in Denmark; but also 
people exposed to fear and terrorism in Israel, Spain, Russia and Northern Ireland.  
As a consequence of this societal stress, we find in these countries and populations a 
“Societal Syndrome” consisting of morbidity and mortality related to stress and mental 
ill-health, a cluster of depression and aggression, alcoholism and addiction, violence 
and suicidality, risk-taking behaviour and destructive lifestyles, cardio- and cerebro-
vascular diseases, as well as accidents, both traffic accidents and those in the workplace. 
In many countries, people are forced to reorganise their own lives, to develop new 
values and to swear off from those beliefs that earlier have guided them. The 
background for this we find in the consequences of the dramatic changes in society, the 
loss of dignity and identity, the loss of males, the unemployment and loss of dignity of 
not being the family provider, important for self respect and family respect in more 
traditional societies. Many people have, moreover, to live and cope with 
unpredictability and meaninglessness they have never had to experience before.  
Thus, in some of these countries of heavy transition, the rate of homicides and 
manslaughter, even those directed against children, have risen to figures nine times 
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higher than in the European Union, having before already been at a level somewhat over 
the EU average. 
Thus, from the macro-perspective of the WHO, we can see what has been reproduced in 
animal trials, namely how individuals in times of prolonged and all too heavy stress, 
hopelessness and helplessness, will not only break down, unable to cope or adapt, but 
also turn against each other and their own offspring. 
What has been said here, also seems to ring true for risk groups of the mentally ill and 
vulnerable, where recently increasing violence has recently been reported, in part 
certainly due to the deterioration of services, but also - as Scandinavian examples show 
- having a background in increased tension, split and stress in society.  
But there is also positive news. In some of the countries I have been describing, after a 
maximum deterioration in the middle of the nineties, positive changes can be noted due 
to economic and societal development leading again to optimism, hope and an increased 
feeling of control, participation and predictability. 
Ladies and gentlemen, dear colleagues. The World Health Report (WHR) 2001, the 
WHO year of Mental Health in 2001, and the activities and publications emanating 
from it have clearly underlined some important messages: that the burden of mental ill-
health and related conditions is immense, from 15%, related merely to strict psychiatric 
diagnoses, to 30 - 50% or still more, for conditions more or less directly related to stress 
and mental ill-health. The WHR also points out new possibilities for promotion, 
prevention, treatment and support, not so much related to singular new advancements in 
the field of neuropsychiatry or new techniques of psychotherapy, but by combining 
different approaches to holistic, therapeutic programmes, really reflecting the “Conditio 
Humana” of both being brain and mind. 
Thus, the WHR underlines the importance of avoiding a split between socio- and 
psychotherapeutic humanistic approaches on the one hand, and biological positivistic 
therapies on the other; between quality and quantity; and between nurture and nature. 
Through this, it stresses new scientific knowledge about the neuroplasticity of the brain, 
the mutual interaction and reinforcement between positive environments and cerebral 
strength as well as between adverse environments and cerebral dysfunction and 
structural pathology. 
How does this all fit into the need for rethinking social and public mental health 
approaches that are so strongly felt today? Looking at the community syndrome, 
consisting of depression and aggression, addiction and violence, self-destruction and 
suicide, cardiovascular and cerebrovascular diseases, accidents, risk-taking lifestyles 
and – let me call it – moral insanity, we see how this is related to the factors we today 
know as the most important determinants of mental health, namely existential cohesion 
and ethical values, social interaction and capacity, helplessness and control, identity and 
dignity. 
Following this, we identify a strong need for non-professional and professional support, 
in society as well as in the areas of mental health, primary health and public health. We 
also identify a strong need for the promotion of mental health with an engagement of all 
sectors of society, both on national and regional levels as well as in the communities. 
In the few institutions we absolutely need in a balanced system of mental health care 
and support, and in the many community-based supportive and advisory services which 
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have to be created, importance should be given to coping ability, integrity, autonomy 
and empowerment, to increasing social capacity, facilitating social cohesion, and the 
ability to maintain it, with a realistic self-image and adequate help seeking behaviour. 
Furthermore, in societies in the aftermath of war and internal conflicts, a focus should 
fall on the regressive phenomena of scapegoating, intolerance, fundamentalist ideation 
and social exclusion mechanisms which characterise people in stress. Here, I think of a 
social and societal responsibility of mental and primary health professionals and all 
sectors of society as well as a need for innovative social psychiatric and public mental 
health efforts, for raising awareness about the dynamic and regressive mechanisms 
behind psychopathologies both in individuals, in groups and in societies, and for 
analysing the consequences of societal changes, political decisions and policy 
implementations on public and mental health. 
What is needed are strategies of increasing coping ability, of empowering people, of 
increasing autonomy, self-control and participation, of catalysing social cohesion and 
competency, of facilitating realistic self-images, of counteracting anomy and of 
reinforcing a pluralism of value systems which enables individual choice – and finally, 
to make political decision-makers aware of the importance their decisions have on the 
mental health of a population. 
Knowledge should be created on how to facilitate a society which is kind to human 
beings’ serotonin-system, takes into account the biological presuppositions of human 
functioning, and is respectful to basic human needs related to the human condition of 
being body and mind in an indivisible unity. Psychosocial, psychiatric and general 
medical professionalism has a most important role to play here. Mental health and 
general health professionals in services and society should not and cannot any longer 
abdicate from their social responsibility. 
Thus, looking at the societies which I have described, we can see what speculatively and 
simplistically could be called a “societal serotonin syndrome”. We know today that 
serotonin-related systems in our brain function enable us to cope with stress and adverse 
environments, to fight or flee, to socialise, to control impulses and aggression, to enjoy 
nutrition, to feel emotions, to meet challenges, to develop coping strategies, to take 
pleasure in behaviours essential for reproduction, but also to keep attached to spiritual, 
ethical and metaphysical dimensions. Serotonin also influences cholesterol levels and 
cardiac diseases, premature mortality, risk taking as well as sensation seeking 
behaviours and lifestyles. Thus, all the conditions belonging to the community 
syndrome described before clearly reflect failures in these functions. Consequently this 
fatal “serotonin syndrome” described, leading to suffering, mortality and sometimes 
depopulation, needs to be counteracted. 
Thus, ladies and gentlemen, we need to recreate reward mechanisms that also motivate 
professionals to take up their social responsibility and to engage in a new type of public 
mental health knowledge in order to build better integrated and individualised support 
for individuals as well as more humanised, mentally more physiological societies. 
Let me think about a farmer, living in an accession country, entering the European 
Union. This man has his basic beliefs, his ethics, his identity and professional pride, his 
self-awareness, his dignity and self-respect. He has been able to cope with life in his 
family and in a rural community with its value systems. He has tackled life events and 
years of bad harvest, with a difficult workload and economical shortcomings. He has 
also acquired and maintained respect and identity, both in his own eyes and in the eyes 
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of his family and community. He probably will face helplessness in the years to come, 
maybe depression and suicidality, alcoholism or isolation, hypertension or diabetes II – 
or all of these together. 
What he needs are services, not only accessible but also acceptable for him, respectful 
to his needs and respecting his integrity and traditional masculinity. Maybe his primary 
health care centre would be much more suitable than any psychiatric service - given 
they have the knowledge and capacity. He also needs politicians who are aware that in 
his society economical support and materialistic solutions can not be the sole answer to 
the problems he has to face, and that proactive and comprehensive strategies have to be 
developed to assist people like him. This means that he needs innovative multi-
disciplinary and multisectoral social, health care and public health expertise that utilises 
modern knowledge about the interrelation of spiritual, psycho-social and biological 
determinants of mental health and human function. He needs professionals who take 
their responsibility in establishing services of support, treatment, promotion and advise, 
and are able to educate and to increase awareness, within their own professions, but 
especially amongst politicians, decision-makers, working environments, educational 
structures and the public in general. 
Finally, let me conclude: Mental health is the most valuable capital in society. It should 
be considered when we are discussing environmental and health concepts, when we talk 
about how to invest in health, and when we talk about the necessity of political 
decision-makers knowing about the impact of their decisions on the mental health of the 
population. With regard to the costs and suffering, this impact is certainly comparable to 
the impact of political decisions on the physical environment - an area where awareness 
and analysing today seem relatively well-established. 
No country, even the poorest one, can afford to not protect, promote, restitute and invest 
in mental health. The costs of inaction - and there is a lot of evidence for this – are 
immense. To do this, our professions are of imperative importance. We work in the area 
of public and mental health and are knowledgeable about the interaction between the 
environment and mental health, about innovative efforts in seeing mental health in the 
light of recent lay and scientific experience as probably the most important public health 
issue. 
Ladies and gentlemen, the WHO, the European Commission, the accessing countries 
and Finland as the main contractor for this conference have cooperated successfully to 
prepare this conference. This cooperation not only expresses a common area of interest 
in mental health and public health and the responsibility between us regarding the need 
for action and pro-activity, focusing on changes and transition to be expected in 
countries and populations in transition, it underlines also the character of this 
conference as an important step towards the WHO Ministerial Conference on Mental 
health to be held in Helsinki in 2005, with the Finnish government as host, several 
European governments as important contributors and the European Commission as well 
as the Council of Europe as important partners. 
Ladies and gentleman, I wish all of us all success for this important event. And thank 
you for your attention.  
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Vappu Taipale, Director General, STAKES, Finland 
 
Cooperation is Key to Increased Knowledge and More Concrete 
Action in Mental Health Promotion 
 
 
We Finns have a long history in bringing up the issue of mental health. Thirty years ago 
in Finland, the number of beds in mental hospitals in proportion to the population was 
very near the world record. Mental hospitals were filled with chronic patients, and 
serious mental disorders were met with fear and silence. High suicide rates were a 
typical problem. Fortunately, a strong expert organisation with great visibility was 
active in the field of mental health. On the other hand, attitudes towards the organisation 
among mental patients were prejudiced. Long-term, persistent and consistent efforts in 
the political and administrative domains were required to formulate strategies for 
tackling the problem. Although there have been ups and downs in this work, progress 
has been made. 
 
From this perspective, it was not purely by chance that Finland raised the issue of 
mental health within the European Union. I believe that similar problems exist or have 
existed elsewhere, and therefore the initiative could have been launched by many other 
countries as well. However, we are all well aware of the fact that one country alone 
cannot do much in the international context. It is precisely for this reason that it is 
delightful to see so many countries have committed themselves to backing these joint 
efforts that are underway within the EU and that are also closely linked with the work 
done by the WHO headquarters and WHO Euro.  
 
Today dozens of countries have accomplished extensive reforms to improve mental 
health services and promote preventive mental health work. Great amounts of money 
have been invested in mental health services in many countries. Being a matter of 
common concern, the issue of mental health has been given continuity as successive EU 
presidencies have fulfilled their commitment to the common agenda and addressed the 
issue from different perspectives.  
 
Here in Bilbao we will all see how the joint consideration of mental health issues has 
benefited all of us. Mental health has become a theme that is politically acceptable and a 
matter of general interest. Recognised experts will address the present conference, there 
is plenty of expertise available. The countries involved have notably increased their 
understanding of their own development and the impacts of mental health and related 
problems on the national economy and its competitiveness. We are also very pleased to 
have so many of the EU applicant countries and their expertise with us here. 
 
I want to thank all the participating countries for their commitment to mental health 
issues. The countries that participated in launching the first stage of the operation of the 
mental health policy network, including Holland, France, the UK, Sweden and Greece, 
have seen many new participants and strong supporters join the network, for instance, 
Belgium. As for this present conference, however, I want to offer special thanks to the 
DG Sanco of the European Commission, the Government of the Basque Country and 
Deusto University and all others who have given their support to this conference, 
including WHO-Euro and Mental Health Europe. Certainly we are all convinced that 
this cooperation needs to be expanded and strengthened. 
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KEYNOTE SPEECH 
 
Clive Needle, Director, EuroHealthNet 
 
 
Enlargement of the EU from the Point of View of Health-Related 
Issues 
 
Thank you for the invitation to join you today and to contribute some observations to 
help begin this interesting and important conference. Before such a distinguished expert 
audience I will of course not presume to try to advise you. I was recently invited to 
another international conference, and received a form from the organisers on which I 
had to indicate if I am an expert in public health or the media. As you know, politicians 
always have to tell the truth, so this gave me some considerable problems. Eventually, I 
decided to tick both boxes on the basis of an old English expression that probably 
applies to me: “Jack (apprentice) of all trades, Master of none”. 
 
In fact, this is very much another learning experience for me, to which I look forward. I 
have already been taught much by experts that I have come to consider friends within 
the organisations comprising Mental Health Europe and the European Mental Health 
Policy Network. The phrase “There is no health without mental health” is ingrained on 
my soul. Perhaps you should be a little proud of me: I used it in my speech at the Italian 
Presidency Conference on Healthy Lifestyles in Milan in September. Sadly – I used it to 
complain that there was no other mention at the Conference about mental health. 
 
That conference was supposedly about ways to improve communication, information 
and education about lifestyle determinants of health. People often say to European 
politicians that the jargon and technical language is impenetrable and contributes to 
poor communications, fears and misunderstandings about the EU. Conversely, I have to 
say to health professionals that, as someone who came into a parliament with no health 
background but who has become an advocate for this sector, it is not always easy to 
grasp exactly what is meant. I understand for example, that health education could mean 
something rather unpleasant and threatening in some of the countries of central and 
eastern Europe who are about to be welcomed into the EU. I went through my first 40 
years of life without hearing the word “paradigm” as much as I heard it in 40 minutes at 
a single WHO health promotion conference. Therefore simplicity and memorability can 
be virtues, and your expression (TINHWMH) achieves both. 
 
The other lesson about communication that I have learnt from political experience, is 
that you often have to repeat complex messages many times before even your 
supporters understand and remember. I expect that some of this audience can explain 
the relevant mental processes! I put that into practice at a Healthy Schools Conference 
in the Netherlands last year, by advising the audience to repeat key messages three 
times at least if they were to have an impact. As Chair for all subsequent plenary 
sessions, I came to regret that, as my advice was not only included in the Conference 
Report but also became a repetitive feature of almost every presentation. So if you want 
this Conference to finish on time, I recommend that you don’t repeat everything three 
times but find new ways to achieve your aims. 
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During the past decade I have spent most of my time trying to understand and interpret 
the flowing tides of European health policies, and specifically EU public and population 
health policies. What I shall try to do today will be to put your work in that context and 
to address your objectives: 
• How to take forward the work carried out so far 
• To focus on your identified key issues of: supportive infrastructures; impact of 
transitions and specifically the current enlargement of the EU; prevention of 
premature mortality; and socio-economic impact 
• To strengthen collaboration 
 
So, what is the current situation for health policy at the EU level? Although I am 
delighted to be here, I do regret that it is to replace some excellent Parliamentarians who 
cannot attend but who have made excellent contributions to advancing the case for 
health in the European Parliament during the last 4 years. For example, although he is 
technically my political opponent, the work of John Bowis MEP has been exemplary in 
this field – please do not tell my party that I said that! 
 
When I spoke in the Hungarian Parliament some years ago, a progress report on 
accession there had generated major concerns because the changes identified as 
necessary to health systems had more economic impact than any other aspect of joining 
the EU. Those changes do not just impact upon statisticians, but affect real people, and 
of course they tend to most adversely affect the more vulnerable people who have little 
or no choice in care or treatment. I note that your papers include the reports on the 
Social Situation in the EU, which consistently provide important reading for the health 
sector. 
My own network, EuroHealthNet, works primarily in the field of health promotion on 
issues such as improving health equity. To do so at the EU level, we increasingly work 
across the range of EU policies as I know the mental health networks do also, and it will 
be important that we continue to improve our collaboration. We invited social and 
health NGOs to participate in a seminar in Brussels earlier this year, and I am delighted 
to be able to anticipate that we will be awarded a multi-annual follow-up project 
contract with the European Commission to develop our work on the links between 
health and social exclusion. Clearly our work is interdependent and I will be happy to 
learn how we can link our work in this field as this second phase will very much seek to 
focus more on the situation in the new member states. 
 
The Bowis report makes the crucial point that not all the new member states are the 
same – there are very different cultures, traditions and circumstances, although of 
course eight health ministers in central and eastern Europe have recently signed the 
Prague Declaration as a commitment to partnership in the field of health, particularly 
concerning disease prevention and cross border mobility. 
 
But the report does note the particular problems concerning abuse of psychiatric 
practices in some states and the need for structural and social reforms over time, with 
strong support from the EC. I have learnt that it is a mistake to think of the new 
countries simply in terms of need – there is a common misconception that they are 
joining to benefit from the wealthy west and the flows will be west-east in terms of 
resources and east –west in terms of people. In fact, they have much to contribute: 
substantial cultures of learning and research, talent and experience. Of course it is true 
that health spending in the new states is about half the average percentage of GDP in 
current EU states, but it is not just an issue of resources. 
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It is and will be a difficult transition in many ways. We know that NGOs are developed 
differently and do not have the same access to resources as their western counterparts, 
and we know that the differentials in professional and financial status of health 
professionals is proving problematic in recognition of qualifications and mobility issues. 
 
But the EU has some powers to address that; Health Commissioner Byrne made a 
significant speech at the annual Health Forum in Gastein last week. He focussed mainly 
on health economics, and I know you have a fascinating session taking forward your 
work on mental health economics later in the programme. That is so important, because 
when we see Finance Ministers interested in the case for health we will really be 
making progress, and I urge you to engage with policy makers (not just politicians, but 
the people who prepare their briefs!) across the policy spectrum. 
 
Commissioner Byrne mentioned the need for health to feature in the reform of EU 
structural funds. At last! Apart from agriculture spending, this is the main financial 
instrument available to the EC, and it makes the EU Health Action Programme funding 
look like peanuts. Because of member state determination to control national health 
systems which still persists rightly or wrongly, spending on health has largely been 
excluded from these instruments, yet they affect exactly the poorest, most vulnerable 
parts of the European population that your work informs me is in greatest need. In some 
areas – Portugal, southern Italy or rural Wales for example, enterprising regional 
officials have managed to be creative with the rules to identify programs for community 
health and other initiatives. I even heard at a seminar in Brussels how health impact 
assessments were being carried out on farmers suffering from agricultural decline and 
crisis, or industrial workers suffering structural unemployment. What better use of 
community funds could there be than to complement national and local initiatives 
promoting good mental health and addressing the specific burdens of mental ill-health – 
the stress, the stigmas, the anxieties and depressions – in local communities. And how 
that would at last help to bring home some of the European ideal that is infusing those 
new member states, particularly as a good proportion of the EU funds in years to come 
should apply to those new states. 
 
The national governments currently meeting to confirm or change the draft European 
Convention have before them some wording that could underpin such progress. In the 
proposed new Treaty article on public health, article 179 part 5 states that European 
laws may establish incentive measures designed to protect and improve human health 
and combat the major cross border scourges. 
 
While health campaigners are right to be disappointed that the new EU objectives do 
not specify health, they do include sustainable development, which clearly does include 
community health. Moreover, for the first time in a European Treaty, healthcare is 
mentioned. The Charter of Fundamental Rights, adopted in December 2000, has been 
incorporated within the treaty and includes “Everyone has the right of access to health 
care and the right to benefit from medical treatment under the conditions established by 
national laws and practices. A high level of human health protection shall be ensured in 
the definition and implementation of all EU policies and activities". 
 
Words on paper. Just that. There is a big gap between words and actions – we know that 
from previous treaties. But you are an important part of what Commissioner Byrne 
called the campaign for health that is now needed – and he was backed by MEPs such 
as John Bowis who urged the health community to organise as effectively as the green 
lobby has on environmental policy. 
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And that is what concerns me as it did at Milan. For understandable reasons, the health 
gap is large and competitive. Research institutions and networks need money and often 
have to be competitive rather than collaborative to get some. I think that does not 
benefit research or good policy making, and this accounts for some of the mistrust 
between the sectors. I understand there is good evidence that ill health, or risk of ill 
health, is rarely confined to a single condition. You make important links in your 
programme with substance, tobacco or alcohol abuse and it will be vital to link with the 
specialists in those fields who are working on subjects of interest to you. Similarly there 
are many others working on healthy ageing, workplace health, social exclusion and 
inequalities, and I know you will already have some good links and can extend others, 
particularly in new countries. 
 
So why was mental health not part of the Milan agenda? There is still the divide 
between mental and physical, and we need to work together to end it. I campaign for 
integrated health policies – some of you may recall that I resisted including specific 
conditions in my 1999 report on future EU public health strategies in favour of an 
integrated approach. We need your special expertise as a key part of that, not a separate 
strand. 
 
I was reminded recently about the previous enlargements of the EU. Where were these? 
East Germany – not without its traumas and stresses, but a major social and economic 
undertaking offering great hope and vision. Before that, the enlargement in 1995 
brought Finland, Sweden and Austria into the EU, and their expertise and commitment 
has helped to put mental health at the top of successive ministerial agendas in the 
Council. Now, suddenly after Tampere and Evora and Nantes and Brussels and Athens 
we move on to obesity and tobacco and CVD. Fine – all are important, but does that 
mean mental health is forgotten at just the moment when the health status reports of 
new states suggest that it must not be? 
 
Those new states can make a real contribution in keeping mental health as part of the 
health agenda: not replacing the emphasis on other conditions, but by stressing the need 
for a holistic, evidence based approach focussed around the health economics case that 
Commissioner Byrne set out last week. 
 
It is crucial because it defines a clear role for the EU in partnership with the WHO. The 
EU is primarily a set of socio-economic institutions with clear purposes around stable 
markets. But to achieve its aspirations, to make the fine words in a treaty count for 
anything, it needs to relate to the real needs of its citizens. Time after time the 
Eurobaromter surveys and the Eurostat studies show that health needs are at the top of 
citizens agendas – and time after time they show that faith in the governments of 
virtually every country to meet those needs is declining alarmingly. Common problems 
amid cultural diversities. That is why your work is so valuable and crucial. Transferable 
learning and practical cooperation offer the way forward and I urge you to share your 
knowledge from all your varying perspectives as thoroughly as you possibly can. 
 
People are frightened of change. There is great change coming to Europe just as there 
are major global threats increasing insecurity and instability. Those are the challenges 
we all face and can only overcome by working together. But the change for Europe is 
not just about farm subsidies or new coins in pockets. The opportunity is freedom – to 
move across once blocked borders, but also to open minds and explore new ideas. That 
freedom must not be limited to the few who are lucky enough to have choice. 
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THEME 1: ECONOMIC AND SOCIAL IMPACT OF 
MENTAL ILL-HEALTH  
 
 Martin Knapp1, David McDaid2 and Claire Curran3, London School of Economics 
and Social Science, United Kingdom 
 
 
Key Presentation: Identifying and Tackling the Economic Impacts of 
Mental Health Problems  
 
INTRODUCTION 
Mental health services in Europe, in common with such services across the world, have 
as their primary and central objective the alleviation of symptoms. Increasingly, 
however, it is being recognised that other aims should also be pursued. In particular, 
most health systems are recognising the need to improve the broader quality of life of 
people affected by mental illness (patients, their families and other members of society 
more generally). Associated aims have therefore been to address the processes of care – 
for example, how are people with mental health problems involved in decision-making 
about their care – and the locus of care, as shown by, for example, the decisions taken in 
many European countries to shift the balance of provision from hospitals to the 
community, and by developing more effective ways of supporting people who live in 
‘ordinary’ community settings. 
Of course, there is also widespread recognition that resources are not limitless, although 
surprisingly this has somewhat belatedly led to recognition of the need to pay attention 
to the costs of mental illness (broadly defined) and the pursuit of cost-effectiveness in 
the ways that resources are used in treatment and support. 
This paper introduces some of the key economic questions being asked in relation to 
mental health in Europe today. It is based on a presentation given at the landmark 
European conference, Mental Health in Europe: New Challenges, New Opportunities. 
The presentation raised five questions that address the economic aspects of mental 
health in modern Europe: 
• Why should we be interested in the economic consequences of mental health 
 problems and their treatment? 
• What are the economic impacts of mental health problems?  
• Economic evaluations: what are they and how do we do them? 
• What do we know about cost-effectiveness? 
• What are the challenges facing Europe? 
                                                          
1 Professor of Social Policy, Personal Social Services Research Unit (PSSRU), LSE Health and Social 
Care, London School of Economics; and Professor of Health Economics and Director, Centre for the 
Economics of Mental Health, Institute of Psychiatry, King’s College, London, UK. 
2 Research Fellow, PSSRU and European Observatory on Health Systems, LSE Health and Social Care, 
London School of Economics, UK. 
3 Research Officer, PSSRU, LSE Health and Social Care, London School of Economics, UK 
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WHY IS ECONOMICS RELEVANT? 
Why should we be interested in economics in a mental health context? One reason – as 
we illustrate below – is the widespread recognition that the costs of mental health 
problems can be substantial, falling on those who are ill, their families, the health and 
social care system and the wider national economy. A second reason for the growing 
interest in the economics of mental illness is the apparently growing cost of treatment. 
Some of the newer modes of treatment for mental health problems – for example, the 
newer medications for depression, the atypical antipsychotics for schizophrenia and the 
cholinesterase inhibitors for Alzheimer’s disease – are marketed at higher prices than 
the older treatments they could potentially replace. Not surprisingly, many people feel 
that there is a pressing need to determine whether the newer treatments are cost-
effective. 
However, the fundamental reason for being interested in economics is because of 
resource scarcity: the level of resources that can be made available - professional, 
pharmaceutical, technological and others - for the treatment and support for of all types 
of health care problems, will never be enough to meet all needs. Scarcity is a permanent 
and pervasive feature of all societies. In the face of such scarcity, choices have to be 
made between alternative uses of the same resource or service. Economics can therefore 
be described as the ‘science of scarcity’ – it aims to provide decision-makers with data 
that can inform and assist their decisions as to how to allocate available resources. This 
obviously raises questions about the comparative costs and outcomes of the alternative 
ways to use resources, and we shall therefore describe later the methods that economists 
use to evaluate cost-effectiveness.  
There is also the question of who should be interested in the economics of mental 
health? A variety of stakeholders are affected by, or can affect, the economics of mental 
health. These include funding bodies such as governments or health insurance funds that 
should be looking to get the best value from their expenditure; treatment professionals 
can work out the most efficient use of their resources; while service providers can plan 
how best to organise and use their scarce resources. Economic studies can also examine 
the cost-effectiveness of interventions, providing information of relevance to health 
system decision-makers, providers of services and pharmaceutical companies looking to 
market their products. Finally, taxpayers and contributors to insurance funds should 
clearly be interested in the economics of mental health to ensure, for example, that their 
contributions are used in efficient ways and that money is not wasted.  
So, are economists obsessed with money? Yes, and no. Yes, because money is a 
convenient way to measure resources and it is the scarcity of those resources that gives 
them value, but also no, because money on its own is not very helpful. Economists also 
want to know about quality of life outcomes, social justice, behaviour patterns, 
incentives and barriers to change. These incentives or barriers might affect access to 
mental health treatment, employment or other publicly or privately provided services 
that can affect an individual’s quality of life. 
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WHAT ARE THE ECONOMIC IMPACTS OF MENTAL HEALTH 
PROBLEMS? 
The impacts of mental health problems are wide-ranging. Many impacts are also long 
lasting, given the chronicity of most mental health problems. As we have noted, these 
impacts will be felt not only by those people who are ill, but usually also by their 
families, neighbours and the wider society. Some impacts can be seen as ‘economic’ (in 
the narrow sense), having effects associated with the ability to work (for example, less 
than 20% of people with psychoses are in paid employment in the UK; Foster et al., 
1996), other productive contributions to the national economy, personal income, or the 
utilisation of health care and other support services. Together, these economic impacts 
are often considerable, as we illustrate below. 
However, we need to keep these ‘narrow’ economic impacts in perspective. They stand 
alongside the often huge ‘personal costs’ of mental illness – distressing symptoms, 
sometimes awful medication side-effects, co-morbid physical disorders, limitations on 
social functioning, stigmatisation by the rest of society, social isolation and so on. There 
might also be ‘intangible costs’ for the wider society associated with some mental 
health problems, stemming from the fear (sadly often exaggerated) for personal safety, 
given that there are proven links between, for example, severe psychosis and violent 
crime (Taylor and Gunn, 1999). 
Costs of mental health problems – international evidence  
It is helpful to provide specific examples of the direct health and social care costs as 
well as some of the wider (often called indirect) costs of mental health problems. 
Studies of people with schizophrenia in a number of countries have charted the broad 
cost impact on health and social care systems, the need for specialist housing, and the 
sometimes high contact rates with criminal justice and social security (income support) 
systems. The indirect costs of schizophrenia include premature mortality, lost 
productivity from employment because of morbidity, out-of-pocket payments and lost 
employment for families (Knapp et al., 2002a). Although research methods vary and the 
breadth of cost measurement is not consistent, a recently completed survey of studies 
from many countries found that these indirect costs usually outweigh the direct costs 
(Knapp et al, 2004). 
International, especially European evidence points to a number of common features 
with regard to the costs of schizophrenia – the sizeable indirect costs, the high 
proportional cost contribution of in-patient services, the low proportional contribution 
of drugs, the broad range of both health and other services used by patients. There are 
no strong reasons for believing that equivalent features would not also apply to the costs 
of other mental health problems: for example, see Rosenbaum and Hylan (2002) and 
Berto et al (2000) on depressive disorders; Jönsson et al (2002) and McDaid (2001) on 
dementia; Goldberg and Ernst (2002) on bipolar disorder; Crow and Peterson (2002) on 
eating disorders; Knapp et al (2002c) on obsessive-compulsive disorder. We shall, 
however, focus here on schizophrenia to illustrate some of these features. 
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Direct costs 
Health and social care service utilisation costs 
In well-developed health and social care systems people with schizophrenia use a range 
of services. This is illustrated by the EU-supported EPSILON study, which collected 
cross-sectional data on 404 patients with non-affective psychotic disorder across five 
European sites. The main purpose of EPSILON was instrument development, but the 
study also allowed cross-country comparisons (Becker et al., 1999). Care systems in the 
centres all subscribed to a broad model of community-based mental health care, but 
Figure 1 shows marked differences between them in actual service use patterns. Over a 
three-month period, 12% of patients utilised inpatient care, and the mean number of 
community contacts was 8.0. Mean days spent in residential care varied across sites 
from 25 to 7 days. Mean one-year cost per patient, in the total sample, was £5038, but 
Figure 1 shows that there was substantial cost variation between sites (and within sites, 
too, although not shown on the diagram). Closer analysis revealed that some of this cost 
variation was due to patient characteristics (especially levels of functioning and needs), 
but quite a degree of variation remained unexplained, almost certainly related in part to 
health system-specific factors (Knapp et al., 2002b). Indeed, a close association was 
found between mean in-patient costs in each site sample and the per capita provision of 
mental health beds in the catchment area (Chisholm and Knapp, 2002). 
The second broad conclusion to draw, therefore, is that there are marked differences 
between countries in the underlying costs of schizophrenia due in part – perhaps in large 
part - to differences in health and social care system structures and incentives. 
Consequently, research findings on costs or cost-effectiveness might not generalise well 
from one country to another without carefully placing those results in context and 
perhaps making appropriate adjustments. Indeed, there can be wide regional variations 
within countries for precisely this same reason (Haro et al., 1998). 
Figure 1: Annual service costs in five European sites 
(EPSILO N study)
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A third strong feature to emerge from the review of the costs of schizophrenia across 
countries is the sizeable proportion of total health care costs accounted for by in-patient 
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services. Even in Italy and the UK, where it has been national policy to close large 
numbers of in-patient psychiatric beds, hospitalisation remains a major cost factor. For 
example, in the 1990s, in-patient care contributed 41% of the total heath care costs of 
schizophrenia in Verona, Italy (Amaddeo et al, 1997), as much as 69% in England and 
Wales (Knapp, 1997) and also 38% in a model community-based service in Germany 
(Salize and Rössler, 1996). Countries in Eastern Europe continue to rely much more 
heavily than those in Western Europe on in-patient care. Concern about hospitalisation 
costs has energised the search for community care arrangements, although much more 
influential in the drive towards community-based care has been the belief that it will 
improve quality of care and patient quality of life, and promote patient rights 
(Thornicroft and Tansella, 2002). This concern has therefore also encouraged the search 
for drug and other treatments that can reduce the incidence and severity of relapse 
because of the (commonly) associated need for inpatient admission. 
Drug costs represent a low percentage of the total health costs of schizophrenia, 
typically 4-6% in the early/mid 1990s (Rouillon et al., 1997; Knapp, 1997; Salize and 
Rössler, 1996), and probably around 6-9% today in Western Europe, and higher in 
Eastern Europe. More recently the wider use of the higher priced atypicals will have 
pushed up this percentage. Methodological differences account for some of the observed 
inter-country variation, but bigger influences are likely to be the availability and relative 
costs of medications and in-patient services. Generally, countries that still rely heavily 
on (low-cost) hospital services will find their drugs bill makes a bigger proportional 
contribution to the total. This coupled with differences in relative prices across markets 
may even mean that treatments found to be cost-effective in (say) the US are not cost-
effective in countries with less well developed health care systems (Hosak and 
Bahbouh, 2002). 
Other agency costs  
Turning to another mental health area provides us with a graphic illustration that health 
and social care service utilisation costs are not the only economic impacts. In England, 
the National Treatment Outcome Research Study (NTORS), a research investigation 
into the social costs of illegal drug use (Healey et al 1998a), followed 1075 drug users 
and estimated the costs of criminal behaviour, health care and addiction services for a 
12-month period. The total costs for the group amounted to over £12 million over the 
year, the majority of which was attributable to (self-reported) criminal behaviour. The 
biggest element was the victim costs of crime, followed by criminal justice system 
costs, drug dependency service costs and finally other health service costs.  
Indirect costs 
Carer costs 
The international evidence points to the quite substantial size of the non-service costs, 
such as lost productivity associated with morbidity and mortality, and with caregiver 
impacts (Tarricone et al, 2000; Carr et al, 2003; Knapp et al, 2003). A study of families 
of people with schizophrenia in five European sites found that the principal family 
caregiver spent 6-9 hours per day (depending on country) with their relative with 
schizophrenia. The ‘impacts’ most commonly reported by family members were 
restrictions on social activities, disruption to family life and feelings of loss (Magliano 
et al., 1998). As noted earlier, the indirect costs – where they are measured in monetary 
units – will often outweigh the service costs (Rice and Miller, 1996). However, these 
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non-service cost estimates are rather sensitive to the method of calculation (Goeree et 
al., 1999). 
A study looking at the indirect costs of conduct disorder in childhood also found 
considerable costs falling on the informal carers (usually family members). Per child 
costs over the year (in 1996 prices) were £15,270 per child. These costs include health 
and social care costs, accounting for 16% and 6% of total costs respectively, but also 
include the costs of special education (32% of total costs), lost employment (26%), 
benefits (15%) household repairs (5%) (Knapp et al, 1999).  
Costs to the individual  
The economic impact of mental health problems on the individual with the problem 
should also be noted. These economic impacts include direct health care costs, indirect 
lost productivity costs and other indirect costs associated with premature mortality and 
the increased risk of somatic morbidity (Harris & Barraclough, 1998). A study of the 
social and personal costs of alcohol misuse in Finland (Heino and Salomaa, 1999) 
reported the impact of lost life-years to be more than double either the lost productivity 
costs or the direct health care costs. 
Cost impact over time 
Finally, mental health problems can of course have economic impacts over long time 
periods. A study that looked at the relationship between childhood mental health 
problems and various agency costs in adulthood found that children with a diagnosis of 
‘conduct problems’ at age 10 were likely to incur over an additional £16,000 in costs 
between the ages of 10 and 27 years, while children with a diagnosis of ‘conduct 
disorder’ (more severe than conduct problems) incurred over £60,000 additional costs 
between these ages. For both the conduct problem and conduct disorder groups, the 
largest proportion of additional costs were for criminal justice services, followed by 
extra educational provision, foster and residential care and state benefits; health care 
costs were smaller (Scott et al 2001).  
So we see that the economic impacts of mental health problems are broad, often leading 
to health and social care service utilisation as well as other agency costs, for example 
welfare benefit payments. Informal carer support costs may be substantial, often falling 
on family members, and the indirect economic costs both to the individual and society 
may be considerable. Further, as we have just shown, some of these cost impacts might 
be felt over very long periods of time. Finally, it should not be forgotten that there are 
also intangible costs borne right across society. Although difficult to value, these are 
undoubtedly profound, resulting from the widespread stigma and discrimination within 
most societies, compounded by an unjustified fear over the danger posed to society by 
those with mental health problems.  
TOWARDS EVALUATIVE EVIDENCE 
The cost description studies described above – often called cost-of-illness studies – are 
of limited value on their own, even when conducted very carefully. While they can 
provide baseline information on the economic impact of a disorder, they do not measure 
what outcomes result from these expenditures, and so cannot tell decision-makers 
anything about how to prioritise resources in order to improve cost-effectiveness. In 
other words, they cannot provide advice on how to improve the balance between 
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resources expended (costs) and outcomes achieved (effectiveness). This is the topic to 
which we now turn. 
What are the economic evaluations and how do we do them?  
Decision-makers face two key questions when considering whether to use or 
recommend a particular form of treatment for a specified mental health problem. The 
first is the clinical question, which asks whether a treatment is effective in improving 
patient health, or – when considering two or more treatment options – which of them 
has the better or best outcomes. Once the decision-maker knows that the treatment is 
effective, they want an answer to the second question: is it cost-effective? That is, does 
the treatment achieve the improved patient outcomes or quality of life at a cost that is 
worth paying? 
These two questions (Is the treatment effective? Is it worth it?) sit at the heart of cost-
effectiveness analysis. While it is always going to be necessary to reformulate these 
questions in ways that make them answerable with empirical research, their simplicity 
should never be forgotten. Of course, providing answers to these questions is not always 
so simple! 
It must also be emphasised that cost-effectiveness analysis does what its name suggests: 
it looks at both costs and effectiveness (outcomes). So, comparing the costs of one 
treatment with another, without any evidence on outcomes, does not constitute an 
economic evaluation. Such an exercise might be an interesting description of service 
utilisation patterns and associated costs, conducted with considerable devotion and skill, 
but it does not provide enough information to assist service professionals, managers or 
others facing the choice between two or more alternatives. Similarly, calculating the 
costs and outcomes of a single service could be interesting but cannot be classed as an 
economic evaluation unless those costs and outcomes are compared with equivalent 
data for another service, or even compared with the option of ‘doing nothing’, and so 
again the study cannot tell us whether the service is worth providing. Uncontrolled 
mirror design studies often run into this problem. It should also certainly be pointed out 
that a study that looks only at outcomes but neglects to look at costs is also inadequate: 
it can tell us whether a treatment is effective, but not whether it is worth delivering. 
Treatment-outcome-cost links 
Figure 2 offers a framework within which to locate health, quality of life and cost-
effectiveness and the links between them. On the left are treatments, including 
pharmacological and psychosocial therapies. Different treatments have different side-
effects, in turn leading to different rates of adherence with treatment plans (illustrated in 
the second column). Side-effects and adherence are what we might call ‘intermediate 
effects’, but the focus of attention should really be on the ‘final’ effects or outcomes, 
one categorisation of which is summarised in the third column. 
Successful achievement of outcomes could reduce the longer-term costs associated with 
the items in the final column of Figure 2. For example, successfully alleviating 
symptoms should reduce health care utilisation, and improved social functioning 
should, in time, reduce the need for social support. Figure 2 is a hypothesis map. Many 
of the suggested interconnections have been examined empirically, whilst others are 
assumptions awaiting robust testing. 
Therefore, interest in economic evaluation stems from three needs:  
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? costs – to find out the costs of a service, intervention or policy.  
? cost-offset – to see how the cost savings from the services (for example) might  
 compare with the amounts expended 
? cost-effectiveness – to understand the links between costs and outcomes.  
The third of these needs is the most important. 
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HOW DO ECONOMISTS EVALUATE COST-EFFECTIVENESS?  
There are a number of different evaluative methods available to the economist. Full 
details cannot be provided here, but excellent accounts of health economic evaluation 
methods (although with very few mental health examples) are given by Drummond et al 
(1997) and Drummond and McGuire (2001). See also Byford et al (2003a) for methods 
and examples in the social welfare and related areas, and Knapp (1995) on economic 
evaluation and mental health. 
As described below, there are five types of economic evaluation each of which has a 
different scope and suitability. The type of evaluation used should depend on the 
question that is being addressed. The underlying aim of each mode of economic 
evaluation is to examine the efficiency with which resources are being utilised.  
Efficiency comparisons 
If the evaluation is comparing two treatments, the question to be addressed is whether 
one treatment achieves better outcomes for patients and families than the other 
treatment, relative to their respective costs. These are efficiency questions and could 
obviously be employed to compare different drugs, psychosocial interventions, 
accommodation settings, family support arrangements or national policies. The various 
modes of economic evaluation frame these efficiency comparisons in slightly different 
contexts.  
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Cost-offset studies 
The simplest of economic studies are concerned only with costs, not (usually) because 
they see outcomes as irrelevant but because, in relation to the treatments or services 
under study, the health and quality of life outcomes have already been established from 
other research, or are (currently) not measurable because of conceptual difficulties or 
research funding limitations. One of these cost-only methods is the cost-offset study, 
which compares costs incurred with (other) costs saved. For instance, a new drug may 
have a higher acquisition cost (higher price) compared to an older drug, but may reduce 
the need for in-patient admissions and thus lead to cost savings downstream. (An 
example is provided by Hamilton et al, 1999, in the context of a fuller evaluation.)   
Cost-minimisation analysis 
Another ‘cost-only’ approach is cost-minimisation analysis, which seeks to find which 
of a number of treatment options has the lowest cost. A cost-minimisation analysis can 
proceed in one of two ways. It often proceeds in the knowledge that previous research 
has shown outcomes to be identical in the treatment or policy alternatives being 
evaluated. One illustration would be the randomised controlled trial of case 
management for homeless mentally ill people by Gray et al (1997) which found lower 
costs for the case-managed group (although the difference was not statistically 
significant, raising some important methodological issues which we cannot go into 
here). This cost analysis followed some months after the clinical evaluation (Marshall et 
al, 1995). In this sense the approach is really an “interrupted” cost-effectiveness analysis 
(see below). The other way a cost-minimisation analysis can proceed is to compare 
costs without any regard for outcomes. Such a dangerously narrow approach should not 
be encouraged. 
Well-conducted cost-minimisation analysis can be thought of as being a special type of 
cost-effectiveness analysis, where evidence on effectiveness demonstrates no difference 
between two or more interventions. In most instances, however, clinical outcomes will 
not be equivalent, and more complex evaluations are required, which can make them far 
more informative, but correspondingly more complex to conduct. Nowadays, these 
other forms of economic evaluation are commonly carried out alongside clinical trials. 
Cost-effectiveness analysis 
Probably the most intuitive and straightforward modes of economic evaluation are cost-
effectiveness and cost-consequences analyses. Both measure outcomes using 
instruments and scales familiar from clinical studies. Both are employed to help 
decision-makers choose between alternative interventions available to or aimed at 
specific patient groups. A cost-effectiveness analysis (CEA) looks at a single outcome 
dimension - such as the number of life-years saved, the number of symptom-free days 
or the duration of time to relapse - and then computes and compares the ratio of the 
difference in costs between the two treatments being evaluated to the difference in 
(primary) outcome. For example, Essock et al. (1996) computed costs and scores on the 
Brief Psychiatric Rating Scale for patients given clozapine and those given other 
medication in three US state hospitals.  
A common problem is that the majority of evaluations of new treatments or 
interventions find them to be both more effective (the outcome profiles are better than 
for old treatments or interventions) but simultaneously more expensive. Decision-
makers therefore face the challenge of weighing up the outcomes against the higher 
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expenditure necessary to secure them. The decision is far from straightforward in these 
cases. The widely used cost-effectiveness ‘plane’ illustrates the range of possible CEA 
results and the difficult decision-making task.  
Figure 3: The cost-effectiveness plane
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The cost-effectiveness plane is illustrated in Figure 3, and shows the possible 
combinations of outcomes and costs when comparing two interventions or treatments. 
The point marked as B in Figure 3 indicates that the new treatment (say a new drug) is 
both more effective (it has better outcomes) and less costly than the old treatment. In 
these circumstances the task for the decision-maker looks quite straightforward: 
recommend wider use of the new treatment. However, many of the new interventions 
being introduced or considered for introduction in health systems are more like point A: 
they produce better outcomes than older interventions but at a higher cost. The decision 
now is more complex, because a trade-off is needed: are the better outcomes worth the 
higher costs? 
To aid such decision-making, economists have developed cost-utility analysis (see 
below) and more recently the net benefit approach, linked to the construction of cost-
effectiveness acceptability curves. These show the probability that a new intervention 
will be cost-effective for each pre-specified or implicit valuation of an outcome 
improvement by the decision-maker. Comparisons are then possible across quite 
disparate clinical areas. This kind of decision context is, of course, exactly the one faced 
by decision-makers one or two steps removed from the patient interface. An example of 
the use of the net benefit approach and acceptability curves is provided by Byford et al 
(2003b), linked to the clinical evaluation reported by Tyrer et al (2003). 
An obvious weakness with the strict cost-effectiveness methodology is the enforced 
focus on a single outcome dimension (in order to compute ratios) when most people 
with mental health problems have multiple needs for support and when most clinicians 
would expect to achieve improvements in more than one area. Carrying multiple 
outcomes forward in an analysis is less tractable analytically, but three options are 
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available, associated with three other modes of economic evaluation. One option - 
which is cost-consequences analysis - is to retain all or most outcome dimensions (using 
standard clinical scales). The other two options weight the outcomes, either in terms of 
money (cost-benefit) or in terms of utility (cost-utility).  
Another weakness in the whole approach is that most interventions have never been 
evaluated properly, so that comparators in trials may not always be appropriate and the 
opportunity costs within health care systems of narrow economic evaluation outcomes 
may be unfavourable (see Oliver et al, 2002, for a discussion of this). 
Cost-consequences analysis 
A cost-consequences analysis has the ability to evaluate policies and practices in a way 
that arguably comes close to everyday reality. For each treatment alternative the 
evaluation would compute total (and component) costs and would measure change 
along every one of the relevant outcome dimensions. The cost and outcome results 
would need to be reviewed by decision-makers, the different outcomes weighed up 
(informally and subjectively), and compared with costs. The decision calculus is 
therefore certainly much less tidy and more complicated than when using cost-
effectiveness ratios or monetary or utility measures of impact (see below), but it could 
be argued that decision-makers in health care systems - from strategic policy-makers at 
macro level to individual professionals at micro level - face these kinds of decisions 
daily. 
On the other hand, the weighting of the various outcomes is implicit, subjective and 
‘technocratic’, whereas the choice of the single outcome dimension in a CEA and the 
weighting algorithms in other evaluative modes are explicit, less susceptible to 
influence from the value positions of one or two individuals and (potentially) reflective 
of societal values. One example of ‘cost-consequences analysis’ is a study of 
motivational interviewing to improve adherence with medication which looked at costs, 
insight, attitudes to medication, global functioning, symptoms and of course adherence 
(Healey et al, 1998b). 
Cost-utility analysis  
Another and increasingly popular evaluative mode which seeks to reduce outcomes to a 
single dimension is cost-utility analysis (CUA), which measures and then values the 
impact of an intervention in terms of improvements in preference-weighted, health-
related quality of life. The value of the quality of life improvement is measured in units 
of ‘utility’, usually expressed by a combined index of the mortality and quality of life 
effects of an intervention. The best known and most robust index is the Quality 
Adjusted Life Year (QALY). CUAs have a number of distinct advantages, including 
using a uni-dimensional measure of impact, a generic measure which allows 
comparisons to be made across diagnostic or clinical groups (for example, comparing 
psychiatry with oncology or cardiology), and a fully explicit methodology for weighting 
preferences and valuing health states. These same features are also sometimes seen as 
disadvantages: the utility measure may be too reductionistic, the weights for health 
states may derive from unrepresentative populations, the generic quality of life indicator 
may be insufficiently sensitive to the kinds of change expected in mental health 
treatment, and a transparent approach to scale construction paradoxically opens the 
approach to criticism from those who question the values thereby obtained (Chisholm et 
al, 1997; McCulloch 2003). 
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On the other hand, CUAs avoid the potential ambiguities with multi-dimensional 
outcomes in cost-consequences studies and are obviously more general than the single-
outcome CEA. The transparency of approach is also to be welcomed. The result is a 
series of incremental cost-utility ratios (potentially from across the widest diagnostic 
range i.e. not just from mental health) that can then inform health care resource 
allocation decisions or priority setting. 
A broadly similar approach, although one that does not use utility measures, examines 
costs alongside changes in ‘disability adjusted life-years’ (DALYs). This again allows 
comparisons across diagnostic groups although the outcome measure (DALY) is not as 
sensitive as QALY measures when carrying out ‘micro evaluations’ such as clinical 
trials. DALYs are of more value for macro-level discussions (for example, at national or 
regional level).  
Cost-benefit analysis 
Cost-benefit analysis (CBA) addresses the extent to which a treatment or policy is 
socially worthwhile in the broadest sense: Do the benefits exceed the costs? This 
potentially would allow decision-makers to consider the merits not only of allocating 
resources within health care but also to consider whether it would be more appropriate 
to invest in other sectors such as housing, education or defence (Tudor-Edwards and 
Thalanay, 2001). All costs and benefits are valued in the same (monetary) units. If 
benefits exceed costs, the evaluation would recommend providing the treatment, and 
vice versa. With two or more alternatives, the treatment with the greatest net benefit 
would be deemed the most efficient. CBAs are thus intrinsically attractive, but 
conducting them is especially problematic because of the difficulties associated with 
valuing outcomes in monetary terms.  
Some CBAs have chosen to focus on a subset of the outcomes. A good example is the 
classic evaluation of assertive community treatment (ACT) by Weisbrod et al (1980) 
which compared a quite wide measure of costs with a relatively narrow monetary 
outcome: patient earnings from employment. A CBA of this kind can describe only a 
part of the overall impact of an intervention, in this case the employment effect of ACT, 
but fortunately Weisbrod and colleagues also used what we would now call a cost-
consequences approach, covering a larger set of outcome domains.  
Recent methodological advances in health economics offer a way to obtain direct 
valuations of health outcomes by patients, relatives or the general public. These 
techniques ask individuals to state the amount they would be prepared to pay 
hypothetically) to achieve a given health state or health gain, or observe actual 
behaviour and impute the implicit values (e.g. see Diener et al, 1998). However, they 
are likely to be quite difficult to apply in mental health contexts. Another approach that 
has been developed and is increasingly used to value health interventions is ‘conjoint 
analysis’. Individuals are asked to rank different real world scenarios, which may 
consist of several dimensions (including, for instance, health outcomes, time inputs, 
discomfort, possible externalities and stigma) and by including cost as one of these 
dimensions a monetary value can be elicited. Although complex, this approach has the 
advantage of not specifically asking individuals to put a monetary value on health states 
or health gain, which can make the technique easier to administer than traditional 
willingness to pay studies (e.g. see Ryan, 2000; Ratcliffe, 2000). 
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WHAT DO WE KNOW ABOUT COST-EFFECTIVENESS? 
The accumulating evaluative evidence in some fields is now sufficient to warrant over-
arching reviews. Examples include substantive commentaries and systematic reviews of 
economic evidence on interventions for depression (Rosenbaum and Hylan, 2002), 
dementia (Jönsson et al, 2002), schizophrenia (Knapp et al, 2002a), child and adolescent 
mental health problems (Romeo et al, 2003). The Cochrane collaboration also includes 
economic evidence in some of its reviews. 
A very recent systematic review of economic evaluations (looking at both costs and 
outcomes) of mental health in adults and older people has reported on evaluations 
published between May 2002 and April 2003 (Byford et al 2003c). This review found 
28 studies that fitted the criteria of an economic evaluation of mental health problems in 
adults or older people. The authors suggest that the quality of evaluations is improving 
over time. US studies dominated (over 50% of the studies), with 25% conducted in the 
UK. Twelve of the studies found were cost-effectiveness analyses, two were cost-utility 
analyses, two were cost-benefit analyses and the others were not complete evaluations. 
Costs and outcomes were found to be measured narrowly in quite a number of these 
studies. Many economic evaluations are linked to randomised controlled trials (39%). 
An earlier review by Evers et al (1997) reported 30% of evaluations were linked to 
RCTs.  
While this increased demand for economic evidence is encouraging, there continue to 
be significant challenges to facilitating the use of economic evidence (Milbank 
Memorial Fund, 2000). One issue that we touched on earlier is the challenge of 
determining whether the results and conclusions of a study produced in one context or 
setting can be generalised or adapted to fit other contexts or settings. An important step 
is to produce economic evidence using common standards such as those in widely 
accepted international guidelines. Using such standards should mean that information 
can be presented in a transparent fashion, allowing, for instance, different costs to be 
applied to resources to adapt to local settings. 
Until recently, dissemination and implementation of evidence have been overshadowed 
by the need to produce evidence, but it is clearly essential to facilitate improved use of 
economic evidence in the decision-making process. Economic information needs to be 
both relevant to decision-makers’ needs, and presented in accessible forms. To help 
strengthen the ‘receptor capacity’ for evidence, some people have argued for an 
investment in training a new cadre of professionals, who would have expertise both in 
the policy-making arena and also in scientific disciplines such as epidemiology and 
health economics (Lomas, 2000). These so called ‘knowledge brokers’ could act as 
conduits between the policy-making process and economic research, helping to 
facilitate use of the latter as part of the decision-making process. 
Well-conducted economic evaluations can make significant contributions to our 
understanding in almost every aspect of policy and practice development in the mental 
health field. They can support decisions relating to the funding and provision of services 
and can help to improve the efficiency with which scarce mental health resources are 
allocated.  
BALANCING EFFICIENCY AND EQUITY 
Overlaid onto these cost-effectiveness or efficiency analyses are questions of equity in 
the availability and utilisation of resources and in the attainment of health and welfare 
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improvements. Are efficiency improvements achieved at the cost of greater inequity? 
Do the costs of a new policy fall disproportionately on an already disadvantaged group? 
Are the beneficial effects of a new treatment made available only to patients who are 
perhaps not seen as the greatest priorities for support? 
Of course the meaning of equity is not itself straightforward and there are numerous 
definitions, which include  
? equal access to health care for equal need,  
? equal use of services for equal need, and  
? equity in final health outcomes.  
This last concept goes beyond everyday consideration by decision-makers, as many 
other factors may influence health outcomes, including for instance income and its 
distribution, nutrition, housing, and lifestyle. Equal access to health and social care for 
equal need – the first option above - is perhaps more appropriate if the focus is confined 
to health and social care services alone, where individuals (with equal need) face a 
reasonably equal opportunity to access necessary interventions. Thus the aim should be 
that their use of services is not influenced by ‘extraneous’ factors, such as their ability 
to pay for the service, the location in which they live, or their race or gender.  
There is much evidence indicating that many of the needs of people with mental health 
problems remain unmet even when ability to pay for services is not a barrier (e.g. 
Andrews et al, 2001; McAlpine and Mechanic, 2000; Zuvekas, 1999). In part this may 
be due to the impact of stigma, social exclusion and a fear of being labelled, or in some 
cases, even because the ability to make judgements on service use are impaired. Thus 
simply having equity in the opportunity to access services may not be enough. 
Decision-makers may also have to consider how policies and interventions can help 
secure a level of use of services that is consistent with the level of population need. 
However, adopting this perspective on equity raises delicate issues, as some mental 
health services may be used involuntarily, and personal liberties might be constrained. 
Bearing these equity caveats in mind, we can however, use economic analysis to 
provide decision-makers with information about the efficient use of resources. 
CHALLENGES FOR EUROPE 
Growing awareness of the need to improve not only the effectiveness but also the cost-
effectiveness of health care interventions has produced various streams of demand for 
economic evidence. First, there are requests for measures of the overall resource or cost 
impact of a particular health problem, leading to cost-of-illness and ‘global burden’ 
studies. In particular, a lot of attention has recently focused on some of the non-health 
care costs – which can be very large in mental health contexts. Second, there are 
demands for economic evaluations of particular treatments or policies, generating cost-
effectiveness and similar analyses, either carried out alongside clinical trials or 
independently. Third, there are searches for new service and health system 
reconfigurations that can improve the efficiency of use of available resources. Examples 
of such changes with potential efficiency consequences are the managed care changes in 
the US and the less dramatic developments in ‘sectorisation’, privatisation of provision 
and care programming in some European countries.  
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Decision-makers in Europe are facing both challenges and opportunities in the mental 
health arena. Economic studies can help. Economic analysis belongs within the broader 
policy context, and policy-makers need to consider the broad and long-term 
implications of their decisions. This is especially pertinent when one recalls that 
neglecting to make decisions can often cost more than taking the appropriate and timely 
action. There is also much benefit to be derived from greater cooperation and 
collaboration across Europe and beyond. Such collaborative endeavour has the ability to 
improve our understanding of the ways in which different mental health care systems 
are organised and function, and can help to build common approaches to data collection. 
Such action could therefore help to improve the generalisability of research, and also 
contribute by pooling and augmenting access to health economics expertise, which 
remains very limited in some parts of Europe. As we have shown, mental health has 
impacts on many different sectors and a continuing challenge will be to produce 
economic evidence that ranges beyond the health care sector to encompass inputs from 
and impacts on the social care, housing, education employment and criminal justice 
systems. 
The recently established Mental Health Economics European Network, supported by the 
European Commission, represents one approach to improving cooperation across the 15 
Member States, Iceland and Norway (see Box 1). The Network is currently collecting 
data and exploring issues across a number of dimensions. Such initiatives might be 
expanded to include the new Member States. What is needed is a body of expertise 
ready to help Europe tackle the many challenges facing mental health systems. These 
include the need to collect more and better information on the economic aspects of 
mental health and mental ill-health in Europe, and to develop policies for the funding, 
prioritisation and evaluation of services. One particular emphasis might be to research 
further the complex relationships between mental health and employment. Member 
States should also be encouraged to introduce promotion and prevention policies for 
mental health in the workplace as well as evaluating services that promote employment 
for individuals with more severe mental health problems, emphasising strategies aimed 
at gaining and retaining work. Finally, the economic evidence clearly points to the need 
for the mental health of children and young people to be given more attention in 
European health systems. 
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Box 1 – The Mental Health Economics European Network (MHEEN) 
 
This Network has been established as an 18-month EC funded programme. It started in November 2002. 
The Network spans the 15 EU Member States, Norway and Iceland. It is co-ordinated by Mental Health 
Europe and the Personal Social Services Research Unit at the London School of Economics. 
 
The Network has three main aims: 
? to prepare a framework for data collection on relevant economic dimensions; 
? to collect some data to allow cross-country comparisons to be made; and 
? to learn about mental health economic issues and how they are being addressed in each 
country. 
Through this partnership programme, seven major themes have been identified by the Network as areas 
for exploration. These include: 
• mental health care financing 
• expenditure and unit costs 
• provision: services and professionals 
• employment (of people with MH problems) 
• economic evaluation summary 
• epidemiological data with economic potential 
• resource allocation 
 
Papers on the financing of mental health services across Europe and employment issues for people with 
mental health problems are being prepared at the moment. Data collection for the next major research area 
(expenditure, unit costs and provision of resources) is due to begin in early 2004. 
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Silvia Evers, Maastricht University4, The Netherlands 
 
Response 1: Mental Health Economics Research 
 
 
WHAT IS VALUED IS COUNTED! 
One of the main reasons why we should pay attention to health economics in mental 
health care is by the simple fact that “What is valued is also counted”. Health care 
professionals, policy-makers, and politicians have an urgent need for systematic 
information about national health care expenditures. In the Netherlands (1) a study has 
been performed which looks at the total costs of health care for the year 1999. In this 
study every euro spent on Dutch health care has been attributed to a diagnosis. For each 
health care sector, data have been used about the utilisation of care by diagnosis group 
by all the people that were ill in that year. The framework for the division into 
diagnoses is given by the International Classification of Diseases, Injuries and Causes of 
Death: ICD, 9th revision. 
The study showed that in 1999 in the Netherlands about 22% of the budget is spend on 
mental disorders. Because of these figures research in the field of mental health is put 
on the research agenda in the Netherlands. This is especially true for economic 
evaluation studies; this is a technique developed to provide a decision-making 
framework to help in assessing the costs and benefits (effects) of alternative mental 
health care intervention. Another interesting finding of this same study was that within 
the group of mental disorders, mental retardation consumes the largest part of the 
budget, about 36% followed by dementia (22.6%). This was not visible in the Dutch 
health care sector, as care for the mentally retarded falls within a separate sector with its 
own financing. 
 
"MENTAL HEALTH ECONOMICS IS ABOUT HEALTH ECONOMICS ONLY 
MORE SO…" 
Frank and McGuire (2) stated that “Mental health economics is about health economics 
only more so …” pointing to the fact that mental health economics can claim no special 
methodology, but due to its peculiarities, has always been a separate subfield within 
health economics. These specific problems relate to the financing and organisation of 
the mental health care sector (§ 3) and additional problems, which one has to confront 
as a researcher in the field of mental health economics (§ 5). In my response, attention is 
paid to the “state-of-the-art” in mental health economic research (§ 4). Furthermore 
attention is paid to the need for early economic evaluation studies in the field of mental 
health care (§ 6) and the possibility of using economic evaluation studies from other 
countries for results in you own country (§ 7). Finally, I will highlight some of the 
information which is already available and which you can use when performing 
economic evaluations in the field of mental health care. 
 
                                                          
4 Silvia Evers, Maastricht University, Faculty of Health Sciences, Department of Health Organisation 
Policy and Economics P.O. Box 616, 6200 MD Maastricht The Netherlands, tel: +31-43-3881602, fax: 
+31-43-3670960, e-mail: S.Evers@beoz.unimaas.nl, Internet: http://www.beoz.unimaas.nl 
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FINANCING AND ORGANISATION 
In September 2001 the European Commission organised a conference entitled "Future 
Mental Health Challenges in Europe" which revealed that too little information was 
available in the field of mental health economics. Mental Health Europe (3) in cooperation 
with the London School of Economics and Political Sciences started therefore the "EU 
Mental Health Economics Project". The purpose of the project was to identify and gather 
economic information, which is relevant to the mental health care sector, and to formulate 
indicators which make comparisons between countries feasible. To realise this, the 
"Mental Health Economics European Network (MHEEN)" was built with partners from 17 
European countries (4). Based on a study looking at the financing and organisation of the 
mental health care sector in the MHEEN countries it can be concluded that in all European 
countries the financing and organisation of the mental health care sector is quite different 
from the somatic health care sector. This study revealed that for the mental health care 
sector, in comparison to other health care sectors, governments pay more and private 
insurers less. When looking at the financing and organisation of the mental health care 
sector, two shifts are visible: the first is a shift from public financing to private financing; 
the second is a shift from the health care sector of several facilities towards the social-
welfare sector. The problem with this latter movement is that access to the health care 
sector is a basic right in most countries, whilst access to social-welfare facilities is often 
not seen as a basic right. Finally, overall in the MHEEN-countries there is access to mental 
health care facilities. 
MENTAL HEALTH ECONOMIC RESEARCH: STATE OF THE ART  
A good overview of state of the art in of mental health economic research can be gained 
from a review which was published in 1997 (5). The reason for endeavouring with this 
study was that overall a rapid increase in economic analyses in health care was 
observed. However one could question whether this increase in volume also means a 
rise in the quality of these studies.  
This review considered the quality of economic evaluations in mental health care. 
Economic evaluation, if well performed, has great potential for improving the quality of 
decision-making and for making mental health programmes more effective and 
efficient. The purpose of the review was to provide insight into the status and quality of 
economic evaluation in the field of mental health care. Although it is somewhat dated 
recent reviews show that its conclusions are still valid today. The review showed that 
only a few comprehensive economic evaluation studies have been undertaken in the 
field of mental health care. Most of the studies were restricted to analyses of the costs 
only, that is, they did not look at the costs of intervention in relation to its effects.  
Regarding the epidemiological design, randomised controlled trials are generally 
regarded as the most scientifically rigorous method of hypothesis testing. However the 
possibilities for randomisation in mental health care are not always realistic. In the 
review 30% of the studies were based on randomised controlled trials. Almost all of the 
studies used clinical outcome measures or an assessment of the consumption of 
(medical) resources to value the consequences of the treatment. Few studies used 
health-related quality of life measures, although quality of life is regarded as the 
broadest concept for valuing consequences. Especially in mental health care, where 
intangible costs such as psychosocial consequences play an important role, quality of 
life assessment and utility measurement should be used to quantify these effects. Finally 
only a few studies explicitly measured production losses and caregiver costs. 
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PROBLEMS IN MENTAL HEALTH ECONOMIC RESEARCH 
One of the reasons why the quality of the studies in the field of mental health care is not 
optimal might be that researchers in the field of mental health care will always confront 
some additional problems. These problems relate to informed consent and 
communication, the organisation of the trial, the measurement of costs and the 
measurement of effect. 
Informed consent and communication 
With regard to informed consent and communication, the researcher has to confront the 
problem that treatments in the field of mental health care can be involuntary. 
Furthermore patients are often cognitively impaired and have difficulties expressing 
opinions and evaluation. Because of this they might not be able to give their own 
consent and proxy consents have to be used. Finally the assumption that the psychiatric 
patient is self-interested in treatment is dubious, possibly leading to a lesser likelihood 
of participation in research. 
Organisation of the trial 
First, the organisation of the trial is difficult as uncertainty and variation in diagnosis 
and treatment are greater than in somatic care. Furthermore the success of treatment for 
any chronic disease may vary over time. For instance, how long must an alcoholic be 
alcohol-free in order to label the outcome of the treatment a success? Finally, it is 
difficult to limit follow-up due to the fact that mental illnesses are long-lasting while an 
external subsidiser requires a limited follow-up. 
Measurement of costs  
Looking at the identification of costs, this is often difficult due to comorbidity, and the 
social and external consequences of the disease (unemployment, crime, violence, 
homelessness, “burden on the family”). As an indirect cost "foregone wages" are an 
important item in economic evaluation, especially the measurement of lost paid working 
time due to an illness or treatment. The mentally ill are, however, less likely to be 
employable. Furthermore, psychiatric patients often lose their jobs in the prodromal 
phase, before they are actually diagnosed as being mentally ill. This implies that one has 
to look not only at paid working time gone, but also at non-paid working time, leisure 
time, decreased possibilities etc. These latter aspects are much more difficult to measure 
and value. Next to this, some valuation methods (human capital) are discriminating to 
the unemployed, and psychiatric patients.  
Measurement of effect 
Finally regarding the measurement of the effect of an intervention, the impaired 
cognitive function of a patient in mental health care is a limiting factor. Outcome 
measurement in mental health economics is often done by utility measurement. In a 
utility measurement, patients rank their current health status on a range from death (0) 
to perfect health (1). The problem with this valuation technique is that some mental 
health care patients might prefer death over life. As a result, traditional utilities 
measures are not valid. Another aspect, which is difficult to take into account in a 
traditional outcome measure, is that in the field of mental health care one has also to 
take into account the reduced possibilities which psychiatric patients may have. As the 
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psychiatric problems may start early in life, patients with psychiatric problems are likely 
to attend less schooling and are not able to build a career. This is difficult to include in 
traditional outcome measures. 
NEED FOR EARLY ECONOMIC EVALUATION 
In the clinical research organisation there is a tendency to first look at the effectiveness 
of a mental health care intervention and then to study the costs of an intervention in 
relation to its effects. It is however important that economic evaluation studies are also 
planned in the early phases of the clinical trial. One of main reasons is that interventions 
otherwise diffuse, i.e., enter and become part of the mental health care system, even if 
they are not proven to be cost-effective. 
Another reason is that it is often ‘effortless’ to also include costs alongside a clinical 
trial which looks at the effects of an intervention. These piggy-back studies, in which 
the additional economic and health outcomes needed for an economic evaluation are 
added to a randomised controlled trial, are efficient, and provide timely information that 
builds on existing clinical trial data. 
TRIALS IN OTHER COUNTRIES 
With the rapid growth of economic evaluation studies in the field of mental health care 
at an international level a lot of information is becoming available. Decision-makers in 
some countries, for instance the new member states of the European Union, who have 
limited resources to perform their own economic evaluation studies, may wish to 
reinterpret in their own country the results of an economic evaluation study that was 
done elsewhere. However one should be cautious about using results from other 
countries, as in most cases it is not possible to transfer results from one country to 
another without performing additional analysis. There are a number of reasons why 
economic evaluation results are not easily transferable. These include differences in 
epidemiology, ways of coding principal diagnosis and comorbidities, use of definitions 
and outcome measures, availability and use of treatment option, and organisation of the 
health care system (policy and reimbursement). 
INFORMATION AVAILABLE 
What is mentioned above does not mean that one has to start from scratch to gather all 
the information which is necessary to perform an economic evaluation study. For a 
description of the health care system in the various countries one can use the European 
Observatory on Health Care Systems (6). Epidemiological information and information 
on the burden of the disease is gathered by the “Project Atlas Mental Health Resources 
in the World” (7). The consumption of pharmaceuticals might be revealed by the IMS 
(8). Information regarding the availability of services can in part be deduced by using 
the information which is gathered by the OECD and the European Service Mapping 
Schedule (9-11). Information on the burden on the family and labour participation can be 
collected respectively by the EUFAMI-project (12) and the “European Network on 
Workplace Health Promotion” (13). Finally, within the WHO-project “On common health 
interview surveys in Europe (EUROHIS)” initiatives have been undertaken to formulate 
indicators in the field of mental health within the European Health Inventories. 
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Response 2: Burden of Mental Ill-Health in Transitional Countries 
 
 
Slovenia is a country which has fortunately escaped the majority of transitional 
problems, but when someone analyses our situation more precisely and closely, several 
problems can be found. 
MAIN DETERMINANTS OF HEALTH IN TRANSITION PERIOD 
Since mental health is just one part of health, the overall worsening of health 
determinants applies also to mental health. There are a number of health determinants 
that are important in the phase of transition: People's lifestyles undergo quite dramatic 
changes; Life becomes more stressful due to increased alcohol related problems, drug 
related problems, criminality, and violence. 
Loss of cohesion and lower security are important factors and they are part of the family 
and community support system. Culture has slowly oriented towards greater 
marginalisation and stigmatisation of disabled people. In some transitional countries we 
can see alienated children – especially the disabled ones, under severe stress, and often 
left alone. Polluted environments can be found around work and living areas. 
CONSEQUENCES 
We can imagine the consequences. The burden of mental and somatic disorders 
increases in the population. But due to other severe economical, political, ethnical, 
religious and other problems, mental health issues are not usually considered as major 
health problems. 
In environments with the previously mentioned factors we can expect an increased 
incidence and prevalence of stress-related mental and physical disorders. The needs of 
the population and special groups within the population (vulnerable, disadvantaged and 
marginalised groups of people) have increased enormously.  
Here is an example: there was an increased incidence and prevalence of stress-related 
disorders in Bosnia and Herzegovina after the war while the resources (infrastructure, 
communications, health care facilities, especially hospitals) were largely insufficient or 
quite often even destroyed. 
HOW TO USE OUR SHARED KNOWLEDGE? 
It is difficult to transfer results obtained in one country to another. There are several 
reasons for this: 
1. Most health economic studies have been done in western countries while data on 
southern and eastern countries are usually lacking. 
2. Some analyses require subjective estimates of studied parameters, and these may 
be culturally specific. 
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3. The transition burden is not the same in all countries. Different countries have 
different priorities. 
It is important to have national and international studies on mental health economics in 
transitional countries. It is also important to get data on the burden due to specific 
mental disorders in each country – the use of this methodology would provide evidence 
for setting better priorities. For example in Slovenia there is a high suicide rate and 
alcohol-related morbidity, which needs a different approach to other countries which 
may have some other major mental health problems. 
SCARCE RESOURCES AND DIVERSITY OF PROBLEMS ARE A REALITY 
IN TRANSITION COUNTRIES 
The first set of problems consists of incomplete data on mental health and data on the 
evaluation of programmes and policies. This is a consequence of scarce resources not 
only in services for people with health problems but in research and governmental 
services as well. Many health professionals are involved in different tasks (clinical 
work, research, teaching, policy making etc.). Health statistics are often incomplete with 
regard to mental health data due to a lack of health seeking behaviour and problems 
with recognition. 
Possible solutions: 
1. projects that give evidence for decisions, plans, and evaluations of programmes  
2. a greater awareness of the importance of mental health economics 
It is important to encourage local professionals to use up-to-date methodologies for the 
economic evaluation of programmes, and to set and analyse policies. 
The second set of problems arises from the methodology of mental health economics 
which is sometimes difficult to understand, use and integrate with the results of other 
studies. 
Possible solutions: Education is needed. Sometimes international collaboration helps 
with the setting of standards or indices. Some kind of standardisation might be possible 
in the field of mental health economics using minimal data sets for comparisons. 
The third set of problems comes from the process of transition itself. In the transition 
towards a market economy and the adoption of democratic forms of government, it's 
possible that before long-term gains are seen we will see a short–term 
deterioration.Possible solution: Specific research could be done about the impact of the 
following issues on health and their costs: reduction of income and widening of income 
disparities; stress and stress-related behaviour; a lax regulation of environment and 
occupational risks; a breakdown of basic health services and so on. 
FINAL REMARK 
Bearing in mind that it is possible to calculate the costs of war we may wonder whether 
is it possible to calculate/estimate the costs of transition? 
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WORKSHOPS 1A+1B REPORT: Identifying and Responding to the 
Economic and Social Burden of Mental Disorders 
 
Co-ordinator: John Henderson, United Kingdom 
Facilitators: (1A) Vidar Halsteinli, Norway and (1B) Luis Salvador-Carulla, Spain 
Rapporteurs: (1A) Fransesco Amaddeo, Italy and (1B) Gregor Henderson, United 
Kingdom  
This is a joint report from the two parallel theme 1 workshops: 1A: Identifying and 
responding to the economic and social burden of serious mental illness, and 1B: 
Identifying and responding to the economic and social burden of common mental 
disorders.  
THE IMPACTS 
Existing evidence across Europe underlines the substantial social and economic impacts 
of mental illness on individuals, families and communities, work places, services and 
society. For example, recent WHO figures show that 20% of the burden of illness 
(DALYs) in the European Region is due to mental ill health.  
THE EVIDENCE 
Existing evidence also shows that there are effective and cost-effective interventions for 
caring and treating mental illness and supporting individuals and families. The evidence 
is strongest for interventions responding to serious mental illness, and there is some 
promising evidence for interventions at both the individual and population level 
responding to more common mental health problems. There is also promising evidence 
on the effectiveness of both prevention and promotion programmes in reducing the 
economic and social impact of mental ill-health. 
CONCLUSIONS AND RECOMMENDATIONS 
1. Need for data and economic information on mental health and mental ill-health 
We recommend: the collection, presentation and dissemination of comparable national, 
regional, cross-national and cross-regional information on epidemiology, cost 
consequences, effectiveness, satisfaction, service provision and access; information to 
cover promotion, prevention and care, and treatment. 
Therefore, we invite Member States and the other European Countries to: 
• produce data and economic information on these key areas; 
• support the use of existing well developed methods for collecting information; 
• support national and cross-national evaluations of the performance of the mental 
health system(s) of promotion, prevention, care and treatment. 
• work collaboratively to present transparent and understandable information and 
encourage cross-national and cross-regional training in these key areas which 
incorporate mental health economics. (WHO and EU support for data collection and 
dissemination) 
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2. Funding of services 
We invite Member States and the other European Countries to: develop national 
policies and strategies on mental health which should be integrated and funded across a 
range of sectors and agencies; 
• give priority to promotion, prevention and community services development, 
particularly for service reforms in the accession countries; 
• develop regional and national evaluations of system performance. 
3. Employment and Workplaces 
Based on information on cost-effectiveness and other evidence, we recommend that 
Member States and other European Countries: 
• encourage a focus on mental health promotion and prevention within employment 
and workplaces as part of wider efforts to improve employability and health and 
safety at work; 
• emphasise and support employment for people with severe mental illness through 
national and regional policies and actions; 
• emphasise strategies and programmes aimed at gaining and sustaining work for 
people with common mental health problems. 
4. Children and young people's mental health 
For children and young people's mental health, based on the promising evidence base 
and information on the social and economic costs of not taking action, we recommend 
the Member States and the other European Countries: 
• encourage a focus on mental health in the early years (infant mental health) through 
parenting programmes, early recognition and identification of mental health 
problems and provision of home-based support and support for parents with mental 
health problems; 
• encourage mental health promotion and prevention programmes (2 years and older) 
involving mental health promotion and prevention as part of a universal approach to 
preschool development; 
• encourage education policy to address mental health issues including: 
– health promoting schools which include mental health promotion 
– support for children’s emotional and mental health within the school 
            – awareness-raising of mental health and mental ill-health and self-help   
               development (improving mental health literacy within the school) 
– support to teachers 
– support to families 
            – support by more specialist professions and agencies to work with and within 
schools as part of an integrated approach to child health. 
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Actions for the European Commission 
We invite the Commission to support the following actions, which we believe will 
greatly assist in reducing the economic and social impact of mental ill-health across 
Europe: 
• encourage collaboration across EC directorates; 
• encourage collaboration with both national and regional governments and agencies; 
• continue collaboration with WHO; 
• encourage and facilitate exchange and learning on the social and economic aspects 
of mental health promotion, prevention and care; 
• support and fund long-term research particularly in the areas of promotion and 
prevention. 
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THEME 2: THE IMPACT OF TRANSITIONS ON 
MENTAL HEALTH  
 
Dainius Puras, Vilnius University, Lithuania 
 
 
Key Presentation: The Impact of Transitions on Mental Health 
Europe is facing an unprecedented process of rapid change. On all levels – individuals, 
families, communities, countries and the European Union – we are witnesses and 
participants of rapid transition. There is an increased demand for coping with such kinds 
of situation for both individuals and institutions. What are appropriate coping 
strategies? What is needed for successful coping in our joint task to improve the well-
being of Europeans? What is the impact of transitions on the mental health of European 
citizens and what should be done to protect mental health as one of our greatest values 
in the modern world? 
These are not easy questions for which to find the right answers. Transition should be 
viewed not only as a risk factor, but also as a unique chance for renewal and further 
progress. There have been many difficult moments in the dramatic history of Europe, 
when threatening challenges were stimulating further progress of the human mind, 
social welfare and quality of life; already in those times the lessons were learned that 
flexible adaptation, solidarity and mutual trust are the key issues for successful coping. 
Now, when the concentration of dramatic events and decisions in temporal dimensions 
has reached an extremely high level, we are in need of effective and balanced solutions 
about the future of our continent ant its citizens. Wise solutions need good mental 
health, and this is why we are today here in Bilbao. 
IMPACT OF TRANSITIONS ON INDIVIDUALS AND INSTITUTIONS 
Transitions affect individuals and institutions in many ways (Fisher S., Cooper C.L., 
1990; Friedli L., 2000;  Warr P., 1987;  Wintrobe R., 1998).  On an individual level, the 
current situation throws up enormous challenges. Non-normative patterns of transition 
are increasing. All age groups are affected by the fragility of a rapidly changing 
situation. Europe is ageing, the number of lone-dweller households has strikingly 
increased, children and young people are facing challenges in a new equality (school 
exclusions, youth violence, high divorce rates). Uncertainty about the future raises the 
level of anxiety in individuals. 
In such situations the network of social institutions (including state, church, private 
sector, NGO’s) should mobilise all their efforts to support individuals who need 
protection during these critical moments in their lives. However, institutions themselves 
appear to be in a dramatic state of transition, and one of the effects of global change 
(globalisation, unemployment, migration, the demands of an emerging information 
society, the threat of terrorism) is that the role of traditional social institutions is 
diminishing, and individuals are often left alone to cope with the increased challenges 
of transition. Moreover, institutions appear not to be immune from a crisis of trust and 
values, and they themselves need now – because of their erosion, vulnerability, and lack 
of flexible adaptation to new environments - support in order to restore confidence and 
trust both internally and externally. 
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RESPONSE FROM EUROPEAN UNION TO THE IMPORTANCE AND 
UNIQUE VALUE OF MENTAL HEALTH 
The European Union, along with other international partners, has been doing its best to 
respond to the new situation and to the new research data adequately (Murray C.J.L., 
Lopez A.D., 1996). Starting from the middle of the 90’s, the general response included 
putting one more key word “mental health” on the European agenda and then – with 
each subsequent year increasing the emphasis on this key word. After many decades of 
residing in mental hospitals and the offices of psychiatrists and psychotherapists, mental 
health has now emerged as a cornerstone of modern concepts in the broad field of 
public health and social well-being. The concerted efforts of EU bodies, the WHO, the 
World Bank, Member countries and other partners (Harvard report, 1995; Putting 
mental health on European agenda, 1996-2000; Tampere conference ,1999; EU Council 
resolution, 1999; Brussels conference, 2001; World Health Report 2001; World Report 
on Violence and Health 2002; EU Presidency activities of Member countries) have 
contributed effectively to the implementation of new approaches and practices in the 
field of mental health promotion and prevention at this dramatic point of transition in 
Europe (Lehtinen V., 1997). Many important messages have been formulated and sent 
throughout the continent during this remarkable series of events since 1995. But what is 
most important is that we need to continue this remarkable process with increasing 
energy, confidence and knowledge, because we are all facing a very special challenge – 
the enlargement of Europe. This challenge will be one more task of extraordinary 
complexity, because the major task now is to convert transition as a risk factor into 
transition as a protective factor. 
Rich knowledge about the risk and protective factors influencing the mental health of 
individuals and societies has accumulated during the last few years in Europe and 
worldwide. With the help of innovative projects (including large-scale European 
projects such as the Key Concepts Project, Mental Health Promotion for Children up to 
6 Years, Unemployment and Mental Health, Establishment of Indicators for Mental 
Health, Mental Health Promotion of Adolescents and Young People, Mental Health 
Promotion and Prevention Strategies for Coping with Anxiety and Depression in 
Europe) a paradigmatic shift was made from the traditional understanding of the mental 
health field as a field of treatment of mental disorders to integrating mental health into 
the public health approach and general social policy agenda.  
We now have a great deal of evidence that effective strategies to support individuals 
should be focused on increasing emotional resilience through interventions designed to 
promote self-esteem, communication, negotiation and healthy relations between 
individuals. Cost-effective interventions should be used to increase individual and group 
capacity to cope with life events, transitions and stresses (e.g., parenting, adolescent 
crisis, loss or change of job, retirement, bereavement). Another focus has to be directed 
to the strengthening of communities – increasing social inclusion and participation, 
improving the neighbourhood environment, developing flexible community based 
health and social services, child care schemes, healthy and safe workplaces, supporting 
and facilitating social and self-help networks. If we manage to remove structural 
barriers to mental health through effective initiatives to reduce stigma, discrimination 
and inequalities, and to promote access to education, meaningful occupation, adequate 
housing, appropriate services and support to vulnerable groups, it will contribute 
positively to the good health (and good mental health) of the general population. 
As we know, the Social Policy Agenda and the programme of Community Action in the 
Field of Public Health were launched as important parts of the EU roadmap for 
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implementing new strategies which aim at economic and social renewal and an effective 
investment in a healthy Europe. With the EU facing economic slowdown and 
governments having difficulties with unemployment, pension reform and health care 
reform, the value of Europe’s social model centred on investing in people is greater than 
ever. The challenge now is to update it in the context of the transition from EU-15 to 
EU-25, and the role of mental health issues becomes of utmost importance in this 
context. 
CHALLENGE OF EU ENLARGEMENT AND MENTAL HEALTH 
The process of enlargement of the European Union puts all our accumulated knowledge 
and skills to a very special test. Next year, 10 countries will join the EU, and 8 of them 
are facing a very specific and heavy transition from a system based on a communist 
ideology to an open society and market economy. The challenge is even more dramatic 
because we are obliged to have a broader view on Europe. Behind these 8 countries who 
have been invited to join the European Union as leaders in the process of management 
of change, we an additional 18 countries – members of the Council of Europe and WHO 
European region. In general – despite obvious progress made by the countries of Central 
and Eastern Europe - we should talk about the heavy transition, poor mental health and 
lack of coping skills and effective governance in 26 new democracies with a combined 
population of over 400 million people. This is a region with very high rates of self-
destructive behaviour (in the list of 10 countries of the world with the highest suicide 
rates, 9 countries are from Central and Eastern Europe), violence, stigmatisation of 
vulnerable groups, and a heavy burden from the culture of dependence in the everyday 
activities of individuals and institutions. 
Of course, it would be a big mistake not to see the huge diversity of the region. The 
countries of Eastern and Central Europe (including Southeast Europe) have very 
different cultures, economies, religions, and the processes of reform are also very 
different – both in quantity and quality. However, historically all of them have 
experienced the influence of a totalitarian ideology for 50 to 70 years, which now 
appears to have left long lasting effects on the ability of individuals, groups and 
societies to manage change. 
Though it is a sad message, we should therefore understand and admit that the first 
decade in most of these countries witnessed a failure of transition in human lives and 
human services with tragic consequences for the health and well-being of the 
population. Despite widespread hopes for a rapid move to democracy and prosperity 
(R.Dahrendorf, 1990), the transition to the market economy has brought about an 
unprecedented recession and significant increases in poverty, morbidity and mortality in 
most of the countries of Eastern Europe. An analysis made by G.A.Cornia and 
R.Paniccia (2000) concludes that the huge public health crisis was mainly a result of the 
inability to cope with unexpected and prolonged psychosocial stress. Traditional coping 
skills, based on an experience of social passivity and full dependence on the state as a 
condition for survival in a totalitarian system, could not help any more in the new socio-
economic environment; while new coping skills – based on a proactive response to 
challenges, individual initiative and competitiveness – appeared to be lacking among a 
large part of the population.  
In most of the countries of Central and Eastern Europe, morbidity and premature 
mortality has increased dramatically due to a cluster of stress and helplessness-related 
conditions, including suicide, violence, risk-taking behaviour and self-destructive 
lifestyles, and even cardiovascular and other psychosomatic morbidity (Rutz W., 2001).  
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As we know, any transition affects to a larger extent the most vulnerable groups. So it 
also happened during this transition but what was different this time was that the male 
population appeared to be one of the most vulnerable groups with huge losses in 
mortality, morbidity and quality of life. In some countries of the region, the rate of 
suicide among men exceeds the rate among the female population by 5 times and more. 
We could hardly find a more illustrative example to demonstrate how these dramatic 
changes in social roles and other social determinants of health should be addressed by 
an adequate response of new health and social policies in these countries. 
And even if in some accession countries the situation started to stabilise and slowly 
improve by the end of 1990s and the beginning of 21st century, this does not mean that 
epidemics of mental ill-health are over and that we can be satisfied with the general 
situation in the field of mental health of the population of Eastern and Central Europe. 
Data from the WHO database indicates there is still very poor mental health in most of 
these countries, with a tendency for basic improvement only in Central European 
countries. Thus, rates of suicides remain extremely high in Baltic States and Russia 
(Varnik A., 2000). Another important indicator of social “toxicity” could be the rate of 
youth homicides. As indicated in the World Report on Violence and Health, while most 
of EU countries have less that 1 case of youth homicide per 100 000 of youth (10-29 
years) population, in Central European countries this indicator is 1.2-1.6, and in Baltic 
countries 5.4-7.7 and in Russia – 18 (World Report on Violence and Health, WHO, 
2002).  
One could make a logical conclusion from such data that striking difference of 
indicators of “social toxicity” should send a clear signal to the policy makers in the 
countries of Eastern Europe to invest in human resources and human relations so that 
protective and curative factors can be strengthened to support and empower individuals 
and communities as responsible participants in an improving public health system. But 
how is it in reality - what has been the governmental and societal response to these new 
kind of epidemics – epidemics of learned helplessness, destructive and self-destructive 
behaviour, and increased physical morbidity and mortality due to a lack of new coping 
skills to respond to psychosocial stress? Cornia G.A. (2000) and other experts conclude 
very clearly that the response was far from adequate. So what can we do in order to 
avoid a repetition of similar strategic mistakes in the following years? 
Firstly, a need for open debate and evidence-based research of existing situations is 
urgent. This has to be done by local independent researchers with support from the EU. 
Some first attempts to evaluate context and policies in the field of mental health 
(initiated and supported by Open Society Foundation, Geneva Initiative on Psychiatry 
and other international organisations) were carried out in 1998-2001 and revealed very 
important preliminary findings. Attitudes and Needs Assessment in a Psychiatry study 
(ANAP) provided an analysis of prevailing attitudes and needs in the mental health 
scene in six different countries of larger Europe (Azerbaijan, Kyrgyzstan, Ukraine, 
Lithuania, Bulgaria, and Hungary), and drew attention to the major hidden obstacles for 
effective implementation of the basic principles of mental health care reform in the 
region in general and in concrete countries specifically (Tomov T., 2001).  
As a part of an international mental health policy, programs and services project, a 
“Country profile” instrument was used (2000-2002) for assessment of the mental health 
policy and services in Lithuania, Bulgaria, Georgia, Ukraine and Azerbaijan. In a 
concrete example from one of the countries, analysis of contextual factors in Lithuania 
revealed high levels of social pathology (including violence, suicides and other self-
destructive behaviours) and its combination with severely stigmatising approaches by 
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the general population to mentally disturbed people and other vulnerable groups. An 
analysis of existing data about financial and human resources invested in the mental 
health care system allows us to raise questions for policy makers about whether it is 
effective to continue traditional patterns of investment. The largest proportion of 
physical and human capital is concentrated in separate psychiatric institutions with large 
numbers of beds and psychiatric staff, and an increase in funding for medications. 
Meanwhile, attempts to develop new components of care which have been ignored by 
former systems and should be of vital importance to combat stigma and social exclusion 
– such as mental health promotion activities and new services like housing, 
psychosocial and vocational rehabilitation for mentally disturbed people, and 
community based child mental health services – face serious attitudinal obstacles from 
the traditional system and a lack of political will from policy makers.  
A lack of balance in developing a bio-psychosocial model should be mentioned as a 
major strategic problem. After many decades of domination by an extremely 
medicalised mental health concept in communist countries, new European democracies 
are once more under threat of the same imbalance. On all levels (allocation of resources 
in the health care sector, priorities in medical education, and the culture and practice of 
health services) the psychosocial component still continues to be undervalued and 
usually loses in the battle for limited resources to the biomedical model which is backed 
by a much stronger lobby.  
In Lithuania, for example, the cost of reimbursement by the national health insurance 
for each of several modern psychotropic medications exceeds the total amount of 
expenses (including all human resources invested in the system) allocated by the 
national obligatory health insurance fund to all child and adolescent mental health 
services throughout the country. It is no surprise then why so little has been done in 
Eastern Europe to involve individuals and communities in the protection of mental 
health. Only investment in new psychosocial and managerial technologies may prevent 
the systems and individuals from ineffective and unethical use of modern bio-
technologies. In this situation, and especially in the Eastern European context, the words 
of Rudolf Virchow that “Medicine is a social science” becomes of strategic importance 
and should be seen as one of the basic messages from the EU to policy makers and 
leaders of academic medicine in the countries of Central and Eastern Europe. 
Basic support is needed for the countries of Central and Eastern Europe in the field of 
development and implementation of evidence based mental health policies. In many 
countries statistical accounts keep the tradition of presenting processes delivered by 
services as outcomes, while a modern culture of evaluation of outcomes of services, 
programs and policies is often lacking. In the absence of an evidence-based evaluation 
practice of outcomes of existing services, the threat of reinforcing numerous “vicious 
circles” increases. Decisions by policy makers to continue investment in the traditional 
system and culture of mental health services – if even these services contribute to social 
exclusion, stigma, and exclude citizens and communities from involvement and 
participation – may be both a consequence and cause of the high burden of stigmatising 
approaches among the general population and lead to a further increase of “toxic” 
factors in the social environment and again provoke the next cycle of growth of stigma, 
social inequalities and social exclusion.  
The findings from “Country profile”, as well as other tools for systems research, may be 
very useful for the development of modern mental health policies in the countries of 
Eastern and Central Europe which have been deprived for several decades from the 
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possibility of introducing and nurturing a tradition of evidence-based mental health 
policies and services. 
WHAT IS MISSING IN NEW EUROPEAN DEMOCRACIES? 
A preliminary analysis of contextual factors and obstacles for effective reforms in CEE 
countries in the field of mental health and related areas lead us to the question: what is 
missing in the new democracies? It is obvious that the countries have enough physical 
and human capital, and there have been a lot of innovative developments throughout the 
region in the last decade which indicate huge human resources. However, the major 
obstacles for healthier development of societies may be hidden in the lack and slow 
growth of positive social capital (Paldam M., 2001), while negative social capital is still 
in abundance as an effect of the former system and different realities coexisting in the 
post-communist environment. Trust in relations between individuals, groups and 
organisations and a sense of citizenship are missing in new democracies, as well as the 
presence of civil society in the governance of health issues (Kickbusch I., 2002). In 
many post-communist countries the field of public health and health care remains one of 
the most closed areas for the curative impact of an emerging civil society. It is obvious 
now that a participatory involvement of citizens, a regaining of mutual trust between 
citizens and state, the strengthening of civil society – these are the most powerful 
protective and curative factors for coping with a societal public health crisis.  
The defensive styles prevailing in the traditional system of governance of human 
services leads to a lack of self-reflection and critical analysis of the contextual factors, 
the process of resource utilisation, the effectiveness of services and an evaluation of 
outcomes. A sense of coherence and social cohesion is lacking in the culture of 
individual and organisational relations (Rutz W., 2001). Ideas promoting social 
inclusion are still often met with scepticism, while policies and practices based on social 
exclusion remain popular among the general population and politicians who want to be 
popular among voters. This may lead again to a vicious circle where the difficulties of a 
society in transition provoke a public health crisis, the growth of social inequalities, 
feelings of helplessness, behaviour patterns of survival, and corrupted relationships; this 
in turn leads to further scapegoating and stigmatisation of vulnerable groups, poor 
governance, the pressure to continue social exclusion strategies, the threat of populist 
decisions by national authorities, and – as a result of the vicious circle - again an 
increase of social pathology, inequalities and exclusion. This was actually the 
mechanism which led to an increase in the number of institutionalised children in CEE 
countries (UNICEF, 1997) – a sad consequence of prevailing attitudes which stigmatise, 
moralise and blame families at risk instead of supporting them through development of 
a community based network of preventive services.  
WHAT ARE THE NEEDS OF ACCESSION COUNTRIES IN THE FIELD OF 
MENTAL HEALTH IN AN ENLARGED EUROPE? 
What are the needs of accession countries in their challenging task to cope with the 
adversities of transition and to fully integrate as equally healthy societies in the 
European family? 
The main strategic concept of support for accession for CEE countries should be based 
on investment in the further growth of civil society, a sense of citizenship and positive 
social capital. A new quality of humans and organisational relations based on trust, civil 
participation and transparency has to be nurtured. The public mental health approach as 
a basic strategic concept should be facilitated, by the support of innovative mental 
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health promotion/prevention activities and community based mental health care 
programs. On the level of academic institutions it is very important to introduce new 
training schemes based on a broad public health approach and to support the growth of 
the research capacity in the field of mental health policy and services. Support for 
alternatives challenging the strict medical model – such as interventions which increase 
resilience, family and community involvement, and are based on strengthening of 
protective factors – would be of enormous importance. 
The question “what to do?” is somewhat easier to answer in comparison to the questions 
“who will do it and how will it be done?” Civil society cannot be imported from abroad 
but what can be done with the support of the EU is to facilitate the cooperation of all 
actors in the mental health scene (national and local authorities, NGO’s, professional 
organisations, informal networks of interested citizens) so that mutual trust between 
institutions and organisations is rebuilt, human resources are activated and positive 
social capital is finally increased. The EU should be aware of the fact that major 
international donors – which have been committed to invest in positives changes in the 
field of mental health and mental disabilities - are currently in the process of leaving 
accession countries because those countries are now becoming a part of the EU and also 
because it has been estimated by classical economic theories (Dahrendorf R., 1990) that 
10 years will be enough to secure sustainable changes in post-communist democracies. 
However, the challenge appears to be more complicated than expected, and it is not so 
obvious today if national and regional authorities will take over responsibility for the 
support (either with national resources or by applying to EU funds) of innovative 
projects directed at the building of an open society; to the promotion of mental health 
and the prevention of social exclusion, violence, suicide, the institutionalisation of 
children, mentally disturbed persons, or the stigmatisation of other vulnerable groups of 
the population. 
All stakeholders in Central and Eastern Europe – both in accession and in other 
countries - should receive a clear message from EU bodies that Europe is concerned 
about the mental health crisis in Eastern European societies – a crisis which is 
threatening both social cohesion and economic progress. Social and economic problems 
in the new democracies of Europe will not be resolved through fiscal or medical 
solutions but need broad societal consensus and energy (Kickbusch I., 2002). The public 
health crisis will not be resolved through one-sided investments in sophisticated 
biomedical technologies but need a new public health approach in which a modern and 
transparent governance of systems is facilitated by an involvement of citizens and an 
investment in human resources and human relations. 
Clear messages have to be sent to governments, organisations and citizens across the 
larger Europe that the practices of stigmatisation, social exclusion, and 
institutionalisation of vulnerable groups (especially of children and adults with mental 
health needs) belongs to the past and has no place in the system of values of Europe in 
the 21st century. 
New approaches – accumulated during the last decades in the developed European 
countries – of mental health promotion and prevention of mental health problems 
should be replicated in a creative process throughout new European democracies, with 
the clear message that they are working effectively only for individuals and 
communities who are motivated and committed to participation, involvement and 
positive change. 
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The NGO sector should be supported in their attempts to grow and become independent 
and strong partners of governmental institutions. Citizens of new democracies have to 
get a sound message that there are no miraculous methods to make people happy and 
healthy in this world except realising that their future and the future of their children 
depends firstly on their sense of citizenship - on how much they themselves will 
participate in the life of their communities, countries and a united Europe.  
Accession countries could learn from countries like Spain, Portugal or Greece how to 
manage the transition from totalitarian systems to a democracy and an open society. The 
EU should facilitate an open dialogue between all players and stakeholders in the huge 
field within and around mental health – and to facilitate new democracies in learning to 
better play the difficult game of democracy – with shared responsibility, mutual trust 
and genuine human values. By assisting new countries in recovering from severe crisis, 
the developed countries of Europe will  no doubt become stronger in solving their own 
problems. There is no need and sense to make divisions in Europe when we talk about 
our major joint tasks for good mental health – they are equally important to all 
European nations and citizens. We have to  
• rebuild peace, trust and mutuality;  
• invest in healthy relationships between individuals, organisations and nations;  
• perceive and manage transition as unique opportunities for positive change and 
growth of social, human and economic capital;  
• maintain a healthy balance between traditions and innovations; 
• learn from other fields how to use new technologies in management of change.This 
strategy – the strategy of sharing responsibility, mutual support, tolerance and trust, 
investing in good quality of relations between individuals, institutions and nations – will 
lead us to better health and to a better quality of life. There will be no need to add 
“mental health” to “health” every time because it will be clear without needing to say 
it.. There will be no need to draw numerous vicious circles because we shall be able, as 
a united Europe, to learn from the mistakes of the past, to combine tradition and 
experience with flexibility and innovative approaches and to turn the vicious circle into 
a circle of success and empowerment for the citizens of a united Europe. 
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José Agustin Ozamiz, University of Deusto, Spain 
 
Response 1: Social Capital and Mental Health Promotion in Social 
Transitions 
 
 
IMPACT OF TRANSITION ON MENTAL HEALTH 
When considering the impact of the transition on mental equilibrium, it involves 
acquiring a somewhat diverse perspective as regards to mental health problems existing 
in medicine. Most doctors are essentially concerned with relieving symptoms and how 
to deal with syndromes. When speaking of the transition and its impact on mental 
health, we are considering critical situations which require re-adaptation and re-
balancing. This perspective is more suitable for dealing with primary prevention and for 
promoting mental health. 
All societies throughout the history of humanity have developed strategies for dealing 
with periods of transition in life, known as life cycles. All civilisations have developed 
rites which facilitate the transition and essentially the social recognition of the new 
status to the individual who may have to develop a new role. Rites of transition, also 
referred to as rites of passage, are thus fairly significant for the social balance and 
mental health of members of a community. 
On the other hand, social transitions have been slow and there have even been societies 
which have changed little over the centuries. Industrialisation involved a profound 
social transition. It took the industrialised societies over 100 years to reflect on the 
social and psychological repercussions of that change and to face up to them with 
models of social organisation that provide a balance and social well-being to 
communities.  
The change we are experiencing in our era may be more profound than the change 
experienced in the 20th and 21st centuries in Europe. Now it is clearly faster. The speed 
of the transition we are experiencing makes it difficult to adopt social strategies in the 
same time-frame as the individual who has to adapt much faster during the course of his 
or her transitions in life to new situations.  
Uncertainty and risk are the characteristics of our society which our psyche has to face 
throughout life. These include: professional uncertainty, uncertainty in terms of work, 
uncertainty when faced with vital projects and sometimes even about the support that 
may be provided by the family, and uncertainty as regards environmental safety and 
pollution. Faced with this outlook, it is essential to adopt conceptual strategies which 
may enable us to deal efficiently with the negative consequences of the impact of 
transitions in the mental balance of the person. The positive thing about the era in which 
we live is that it provides us with precious instruments of communication that may help 
us to exchange information, and reflect jointly on matters which may facilitate the 
development of strategies for dealing with problems. 
Dainius Puras's exposition is an example of the knowledge provided by this possibility 
of exchanging information. I should like to draw attention to three ideas from this 
brilliant exposition and add some comments about them. 
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NEED FOR CONCEPTUALISATION  
Puras suggests new concepts and strategies for dealing with the promotion of mental 
health both on an individual level (skills of pro-active response when faced with new 
situations of challenge and competitiveness) and on a social level (the concept of social 
capital). In this sense, I should like to stress the need to draw up suitable concepts and 
strategies for this new situation of rapid change and the increasingly technical nature of 
communication. 
The need for conceptualisation may be established on three levels:  
1. The level of the individual: The reflexiveness mentioned by Puras is put forward by 
different authors as the essential characteristic that the person needs in our times in 
order to face new emotional situations and situations of interaction, and for which he or 
she has no safe models of conduct to refer to. Yet this reflexiveness must be developed 
in company with others; sometimes with experts in the form of counselling and 
psychotherapy; at other times with equals such as in self-help groups. 
In this sense, strategies which incorporate this conceptualisation in terms of the type of 
intervention in the primary prevention of mental health should also be developed, such 
as crisis intervention, network therapy and interventions of different types.  
2. The institutional level: Working environments, educational institutions and the 
family reflect the impact of social transition. In this sense, I think that the MHPP 
Project, to be discussed in this conference, has collected models of best practices for 
preventing common mental illnesses and promoting mental health. This also needs a 
new conceptualisation in order to be able to understand what occurs in these 
institutions. 
3. The level of social structures: Literature which reinforces proof in terms of the 
effectiveness of social organisation and socio-economic structures in promoting health 
is becoming increasingly more widespread. The concept of social capital, as pointed out 
by Puras, is frequently resorted to in order to describe social cohesion, trust and 
confidence, the system of values of a society and security in terms of interactions, and 
what may be positive in reinforcing social participation and positive integration in 
society. 
This concept and its interaction with mental health is promising, although research on it 
new, and there remains a long way to go before it becomes suitably developed. On the 
other hand, demonstrating the influence of mental health today in strengthening social 
capital is as important as describing the impact of positive social capital on mental 
health. This will prove to be very useful when convincing politicians and administrators 
of the need to invest in mental health for the balanced development of a society. We 
have been able to prove that pointers of positive mental health such as social 
participation, quality of life and levels of satisfaction with health institutions and social 
services are as important as production rates, the gross domestic product rate and 
inflation, and that negative pointers such as suicide rates and levels of drug dependency, 
etc., must be considered as they really are.  
My suggestion is that this social conceptualisation and resulting research also requires 
the incorporation of new instruments which are already proving to be useful. We need 
to be aware, for instance, of studies that typify situations of social transition, in order to 
be able to be more effective in putting our recommendations into practice. Thus, 
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methods of analysis of social policies also prove to be useful in understanding the 
obstacles existing in implementing plans which in principle are carried out with the best 
will in the world, but which prove to be mere pipe dreams.  
We also need, as Esping Anderssen says, a new theory in political economics in which 
the concept of social capital and its relation with mental health may be one of the keys. 
In short, the task of conceptualisation, reflection and implementation in promoting 
mental health must be multidisciplinary. The medical prospect must be enriched using 
social, cultural and anthropological outlooks in order to be able to help social planners 
in social engineering and in the development of effective mental health policies. 
LEARNING FROM EACH OTHERS' EXPERIENCE 
Puras says that eight of the countries from the authoritarian system of the Soviet Union 
that will be joining the EU next year, can learn from the experiences of Greece, Portugal 
and Spain, countries that have also undergone a similar transition from totalitarian 
systems. It would be of great interest to us to share the experience of these last two 
decades of transition, and I hope that this conference may be an occasion to establish 
contacts and agreements in this sense. 
It would be very useful to share the methods we have used and the results obtained 
throughout this process of change in psychiatric care and the promotion of mental 
health. These range from the study of attitudes towards mental illnesses, which we 
carried out as a starting point, to the introduction of the accumulative psychiatric case 
register, to drawing up of a plan for mental health and psychiatric care, and finally to the 
development of training programs and epidemiological research geared towards 
understanding social factors that influence the outcome and development of mental 
illnesses. It would be very useful to share these experiences with countries that are 
attempting to face up to these changes. 
Yet what we consider very advisable is to compare the practices of the different 
countries of the European Union with different situations, transitions, experiences and 
plans that they have developed, and the results obtained. In this sense, we must 
acknowledge the good decision taken by the DG-Sanco of the European Commission as 
regards promoting a Working Party for such a purpose. I believe that there is wide 
consensus regarding the need for comparable statistics and monitoring of different 
situations. New information and communication technologies will no doubt facilitate 
this task.  
AVOIDING BIOLOGICAL REDUCTIONISM 
Puras reminds us that medicine is a social science and criticises the costs of new 
psychotropic drugs; it is typical in some transitional countries for the purchase 
administration to take up a larger proportion of the budget than on all other health 
resources devoted to psychiatric care put together, including human resources.  
I should like to emphasise something that has been repeatedly said in meetings of 
experts called by the DG-Sanco of the European Commission: A way of facing these 
dynamics of biological reductionism of mental illnesses is by promoting 
epidemiological research sponsored by institutions other than the pharmaceutical 
industries. In this sense, responsibility on the part of the public administration in 
research about psychosocial factors that influence mental illness, and in promotion of 
training professionals, teachers and social workers in psycho-sociology and promotion 
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of mental health, must be emphasised. While the monopoly concerning the research in 
psychiatry continues to be enjoyed by pharmaceutical companies, this work will require 
a special effort on the part of public administration. 
In this sense, the stands of the World Health Organisation in Europe and the DG-Sanco 
of the European Commission, should be praised. However, the European Union 
Member States, as well as regional authorities, must make a special effort with regard to 
this and invest energy and budgets on the psycho-social research of mental disorders, on 
epidemiological studies and on prevention.  
 
 
Richard Plette, NCPH National Institute of Occupational Health, Hungary 
 
Response 2: The Impact of Societal Transition; the Case of Hungary 
 
 
INTRODUCTION 
In Central and Eastern Europe, thus in Hungary too, the changeover - after the year 
1990 - indicated important challenges for society. The relative constancy was typical in 
the earlier years. Employment was practically full and in the workplace people could 
count on mostly secure, but low wages. The firms showing a deficit were subsidised by 
the state with credit support. It was possible to supply incomes in the so called 2nd and 
3rd economy. In order to “whiten” the “black” or “grey” economy, (to legalise dodgy 
businesses by taxing them), since 1981 the state has made it possible to found small 
enterprises. Consequently self-exploitation has started; it means that workers to attain 
their minimal goals (such as having a holiday abroad, buying a plot or a car often on 
credit) have had to work 4-6 extra hours besides the 8-hour core time, often at their 
workplace (self-exploitation became a must because of the accumulation of debts). 
So the changeover has found the population of Hungary in a tired and exhausted state of 
health. The worsening of the mortality rate of middle-aged males began in the early 
1980s, culminated in 1992-93, and later in recent years it has decreased to a small 
degree (Figure 1). 
Today, the mortality rate of young and middle-aged (25-44 years old) men in Hungary 
is higher, not only in the EU countries, but also in the other CEE countries. This is 
mainly caused by the above mentioned physical and psychical overloading, respectively 
the “shock therapy” of transition. The decreasing trend of the mortality rate shows some 
promise concerning the future. 
The unfavourable public health rates – the worst being a stagnation in life expectancy – 
has two causes: 
• trends in the frequency of unhealthy behaviour, 
• quality of the socio-economic environment 
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Figure 1. 
According to Hungarian researchers, only 40% of deaths are caused by harmful health 
behaviour; in the majority of cases (60%), it is the lack of adequate responses (bad 
strategies for coping with stress) to the challenges that causes higher levels of morbidity 
and untimely deaths.  
The pattern of mortality rates caused by cardiovascular diseases (Figure 2.) shows the 
impacts of the same socio-economic changeover. The double peak of the curve shown 
in Figure 2 reflects the impact of the self-exploitation in the 1980s as well as the mental 
shock of the transition. 
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Figure 2. 
According to researcher’s opinion, this reflects an unrealistic demand and a wish to not 
fall behind in a dynamically polarised society. Striving for this creates a feeling of 
constant stress and exclusion from society. This is characteristic especially of the 
unemployed, for those with low qualifications and for the relatively poor groups that are 
fighting with daily problems and are living at the bottom of the settlement society. 
These are people who do not have the chance to change their situation or the ability to 
modify it even though they might have the possibility. Repeated stress and the risk of 
bad health are caused by the inability to cope with these difficulties; there is a constant 
need to secure further subsistence as well as avoiding a more serious crisis. 
In those socialist countries, where change to the system was carried out dynamically 
and with a significant political divide, the loser and the winner positions are well 
identifiable. In Hungary, the feeling of alienation is increasing among the people who 
have an unfavourable position in the labour market after seeing other groups rapidly 
increasing their gain. These poorly positioned groups have difficulties in changing their 
situation for the better. In the current circumstances their future is not promising, as 
there is no sign of change. This situation leads to harmful behaviour and psychosomatic 
illnesses.  
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THE TRANSITION IN HUNGARY 
Large factories went bankrupt in large numbers. In addition, complete branches of 
industries went broke, e.g. the heavy industry and the mining industry. At this time, so 
called "green field" investments started by means of which new workplaces were 
created. Foreign firms introduced new technology, and often also a new organisational 
culture. It also demanded a high commitment to work and a new and different work 
ethic. 
The economic change resulted in mass unemployment. In particular, the unskilled and 
elderly people suffered losses during this process. The blue-collar workers who had 
been doing hard physical work for decades could not seize the opportunities arising 
within the technologically more advanced workplaces. The end of the secure way of life 
and relative equality that they were previously accustomed to found the population 
unprepared; the whole philosophy of the former political system was based on these 
values of worker equality and security. The majority of the population became poor, 
while at the same time certain people, who were close to the source of wealth, made  
huge fortunes. 
Figure 3 shows the rate of unemployment in Hungary in the years of transition. This 
tendency was falling from its peak in 1993 to 2001. 
Following the changeover – and with the opening of the frontiers – the crime rate 
increased sharply. In Hungary, from 1970-1995, the number of publicly reported crimes 
quadrupled (from 125 000 to 502 000). In 1989 there was a rise in explored criminal 
cases to 225 000, a level never seen before (see Figure 4). In 1990 criminal statistics 
registered 341 000 publicly known criminal cases. The next peak was in 1995 when  
502 000 cases were registered. 
The high crime rate has been stagnant since 1996. Public opinion suffered a shock 
because of the increasing crime rate. The Hungarian people had only three years 
between 1989 and 1992 to come to terms with the booming crime rate, compared to the 
Western Europeans’ two decades in which they were able to adapt to similar 
circumstances. A similar situation was forming in the neighbouring countries. All of the 
countries going through changes in the political system experienced a doubling, if not 
tripling, of crime rates. 
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Figure 3. 
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THE IMPACTS 
Psychological impacts 
Conflict between the individual and social environment causes frustration: 
• Frustrations of needs (basic needs like a lack of material resources; need for 
security: lack of security at workplace; social needs: feeling of falling behind)  
• Pressure of adaptation 
• Overwork, stress 
Earlier, people weren’t used to saving money. Most people lived from hand to mouth, 
because their daily bread still seemed to be guaranteed. The change in this situation also 
shocked society. A large profusion of goods – going together with a shortage of money 
– urged some people to satisfy their demands by means of credit, which resulted in their 
running up debts. Losing property due to redundancies led to real tragedies in private 
lives. 
Some people became wealthy very quickly causing great dissatisfaction in the others. 
The society could hardly adapt to this situation in a short period of time. All this fight 
for survival caused physical and psychical overload, stress and a state of decay in 
health. 
Stress appears when one cannot cope with all the pressure of work or cannot adapt to 
demands – when all of these exceed our strength. Concomitant psychological stress 
reactions are anxiety, anger, aggression, insensitiveness, and depression. Stress in the 
long run affects the immune system. It weakens the body’s resistance to diseases. 
Research suggests an unambiguous association between the increase of disease rates 
and the appearance of stress.  
The issue of depression and suicide is a major problem in Hungary. In the last century 
(excluding the last 5 years), our annual suicide mortality had been the highest in the 
world. In the last 15 years (and especially in the last 7-8 years) the suicide rate in 
Hungary has been falling steadily. (The peak of suicide mortality was 4600 persons in 
1984.) This 30% decrease has been the most dramatic in the world, and obviously this 
tendency is the result of many factors. Recently, Hungary has lost its position at the top 
of the world rankings and now stands in 5th place. This position is still unsatisfactory, 
because the annual mortality rate per 100 000 people is one and half times more than in 
Austria, and triple that in England and the USA. 
The overall mortality rate of middle-aged (55–64 year old) men in Hungary today is 
higher - even in absolute terms - than it was in the 1930s. Within this age bracket the 
death rate is extremely high among the lower socio-economic classes. The odds ratio of 
the incidence of death is 1.8 times higher among males aged up to 74 years with no 
high-school education compared to the same age groups with higher education. Some 
40% of this difference can be accounted for by the self-destructive behavioural risk 
factors (alcoholism, tobacco smoking) being more prevalent in the lower socio-
economic groups.  
According to the results of the national survey (Kopp-Csoboth) in Hungary among 
12640 subjects in 1995, 45% of the males and 26.6% of the females smoked. Among 
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the male and female cohorts under 45 years of age the rate was 47.9% and 31.9%, 
respectively. Among the males the number of daily cigarettes consumed and the volume 
of daily alcohol imbibed was inversely related to the educational level. This negative 
correlation was not so clear among the female sample. The health promotion 
programmes can only achieve their goals if they target the psychological and 
motivational background of self-destructive behavioural risk factors.  
FINAL REMARKS 
In recent decades, the morbidity and mortality crises which have characterised the 
period of transition in Hungary offer a great challenge to the behavioural sciences as 
well as to public health and biological research.  
The oft-repeated Central Statistic Office (KSH) surveys indicate that health as 
something to value has become most important as a major value for the population of 
Hungary, above categories like family, money and being successful in a career. 
In 2000 the “Society for Healthier Workplaces” made a survey on values among groups 
of employees (7 companies with 750 employees took part in the research). The results 
are shown in the following table. 
 
 
Rank 
 
Varied value label Mean of 
values 
1. Health 1.79 
2. Family 2.14 
3. Money 3.93 
4. Well-paid workplace 4.03 
5. Healthy lifestyle 4.67 
6. Successful work 4.76 
7. Friends, nice colleagues 5.16 
 
The results clearly show that health and healthy lifestyles head the list, above the 
leading value of earlier years. But it can be seen as a problem that the category of 
healthy lifestyle is only in 5th place. Therefore, the most important task is promoting 
health, giving information about healthy eating habits, living a healthy lifestyle and 
coping with stress. We need to learn how to analyse stressful situations and manage 
them.  
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WORKSHOP 2A REPORT: The Impact of Transition on the Mental 
Health of Individuals 
 
Coordinator: Karl Kuhn, Germany 
Facilitator: Thomas Kieselbach, Germany 
Rapporteur: Helga Gumplmaier, Austria 
 
A rather small group of 10 people found their way to this workshop. 
At first the facilitator, Thomas Kieselbach, gave a rather comprehensive introduction. 
He started with statements about transitions in general and then he gave us a more 
detailed analysis of a special example: occupational transitions on which he has been 
working for many years. He gave us a good analysis of the status quo and future 
perspectives of the labour market, outlining the challenges on the labour market, and the 
action which should be undertaken. To conclude, he gave an overview over the main 
results of an EU project he has lead. After this not so short introduction we discussed 
the main points of his presentation.  
LIFE PER SE IS A PERMANENT TRANSITION 
During our life cycle we always have to go through more or less smooth or stressing 
transitions. Birth is the first such transition; death is the last transition in our lives. Both 
of them, birth as well as death are normative transitions which happen to every person. 
Other examples for such normative cycles are the first day at school, the period around 
puberty, the first steps into working life, and eventually retirement.  
Non-normative transitions are not predictable, they are not happening to everybody; 
examples are marriage, divorce, loss of a partner by accident and severe illness. 
Stress potential of transitions: 
• disruption of routines 
• loss of security and predictability 
• confrontation with inadequate resources 
• fear of the future 
• loss of social integration  
• risk of social exclusion 
There is a risk to mental health if the person cannot cope with these stress factors.  
Challenges and risks of transition to individuals: 
• Life transitions can enable the individual to explore new ways of life and free them 
from control and constraints by overcoming situations in which one is stuck without 
the chance for personal growth. They can help to overcome routines by entering new 
zones of innovation. 
• The effective adaptation to and constructive coping with transitions require adequate 
personal and social resources. If they are lacking, transitions pose a great risk to the 
mental health of vulnerable groups as well as being a risk for social exclusion. 
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Dimensions of transtions: 
The dimensions of transition are very helpful for judging the risk factors of transitions 
(Source: Nicholson, 1989) 
1. Speed  How often do they occur? 
2. Amplitude  How radical is the change? 
3. Symmetry  How much time adjusting vs. time performing? 
4. Continuity  Are there meaningful connections between transition phases? 
5. Discretion  How much autonomy in controlling the process? 
6. Complexity  Are multiple adaptations and adjustments required?  
7. Propulsion  Who started the cycle and why? 
8. Facilitation  Who/what helps progress throughout the cycle? 
9. Significance Do adjustments change the individual or  
   organisation? 
 
ACTIONS WE NEED 
General actions 
• Strengthening of personal resources and social resources accompanied by inclusive 
policies.  
• Enabling people to cope with transitions in general, this action must start very early 
- already in school. 
• Building up compensating institutional offers of help that are accessible, acceptable 
and problem-sensitive. 
• In research, analysing the cycle of transitions: typology and dimensions, protective 
factors and vulnerability factors. 
Actions especially for occupational transitions 
• Employability as adaptability to future transitions in the labour market: Long-term 
employability policies by the social institutions and companies 
• Creating awareness among employers: New Corporate Social Responsibility (CSR) 
going beyond the actual employment 
• Re-evaluation of the meaning of employment (by widening the perspective to 
voluntary work/advocacy, integration in submerged economy as a buffer against the 
unemployment-stress) 
• Better balance between insiders and outsiders of the labour market: e.g. sabbaticals, 
integration of learning periods into employment 
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WORKSHOP 2B REPORT: Impact of Transition on Societies and 
Organisations 
 
Coordinator: Karl Kuhn, Germany 
Facilitator: Oldrich Vinar, The Czech Republic 
Rapporteur : Michel Vallée, France 
 
To introduce this workshop, three questions were proposed to the participants: 
- what is the function (characteristic) of transition for society ?  
-  what are the roles of the social institutions in transitions ?  
-  what are the relevant areas of social transition for mental health ? 
Actually, transitions happen everywhere, in the whole world and in every 
circumstance. Even if the European actuality focuses on the transition of the 
accession countries, the transitions they are coming across are part of a larger and 
'meta-global' context of transitions. 'Old' European countries are at the same time 
going through the same and other transitions; so the topic of transition must be 
studied globally and adapted to specific contexts.  
Crucial issues in transitions are their frequency, speed and intensity. It seems that most 
people and populations are unable to keep up with the speed, intensity and diversity of 
changes. As a consequence we observe an intensified impact on individual and 
collective mental health. Whether this period is difficult or not, it is our reality, actual 
and inescapable. Actually, one can observe various dangerous attempts to escape. They 
may be unconscious, even irresponsible, costly and useless. Being reality, transitions 
form factually at an individual and collective level, a challenge to learn. How to accept 
and integrate this challenge?  
If we compare ourselves with the metaphor of stress (and this choice is legitimate as 
stress concerns more than 50% of the population), we experience our transitions within 
a systemic combination of determinants, states of health, impacts on lifestyle, and 
effects on people, organisations and societies. That is to say, people live simultaneously 
through several transitions, and several vicious and virtuous circles, imbedded within 
each other.  
In reacting to determinants, people may be hopeful or pessimistic; and this difference in 
attitude leads to quite different paradigms and consequent scenarios. Without referring 
here at all to the reality of somatic and psychic suffering or the rehabilitation and 
prevention processes, the way towards hopefulness and pessimism mostly depends on 
the perception and interpretation of situations.  
This debate took place in the workshop, and one should not of course neglect these 
realities, and the effective actions needed. It was also stressed that a minimum level of 
ability to cope with the situation is needed, such as to enter into the "challenge to learn".  
Nevertheless, and whatever be the state of the situation, it was agreed that hopeful or 
pessimistic scenarios depended mostly on perception and interpretation! Thus, if this is 
true, how do we see and act on the reality in a 'positive' way, at the level of 
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organisations and at the level of societies? Two essential conditions are needed. These 
two conditions are full of meanings and consequences: 
A) - The need for a coherence in the roles of every actor in companies and institutions, 
of places to participate (it is known from most 'ex-western' countries since the seventies 
that false participation may be manipulation whereas people from 'ex-eastern' countries 
know "by heart"), and of global and holistic common values, although respecting their 
original differences. 
 B) - Conditions of credibility, which closely correlate with trust. Here the responsibility 
on politicians, the media, and all stakeholders (that is to say, "ourselves") is high. It was 
noticed by most participants that actually, in Europe, there is no model, no truth, no 
political or ethical authorities, to "trust", neither ideology nor religion after experiences 
of the old and near past. We can only agree on an idea of humanism not clearly defined! 
But, when more than 50% of the population (and in several contexts of increased stress 
more than 70%), appear to be involved, the question of transitions shows once more 
how mental health becomes a politically global issue.  
How should this be done? Encountering such issues as 'accepting', 'integrating', speed of 
change as a challenge to learn' we need a simultaneous top-down process: 
• Down: Near the reality of the field, mental health questions always ask for 
multidimensional models and practices. They can only be in transversality about 
understanding, approaches, ways of action, the professional and social status of 
involved actors.  
• Top: At the level of European shared values, on a geopolitical scale, with trends 
and priorities clearly oriented by them.  
Concretely, in regard to the global issue it might be reassuring to see that we 'have' 
already the materials, at least a good part of them. In fact there is already from recent 
years a lot of experience in Western, Eastern, Northern and Southern countries with 
models of good practice, funded at the EU, or national and regional levels. But we don't 
know how to capitalise on them, change them into shared knowledge, and by that 
transfer and disseminate them, in ways adapted to each cultural and socio-economic 
context. 
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THEME 3: NEEDED SUPPORTIVE INFRASTRUCTURE 
FOR MENTAL HEALTH PROMOTION AND 
PREVENTION OF COMMON MENTAL DISORDERS  
 
Heinz Katschnig and Beate Schrank, University of Vienna, Austria 
 
 
Key Presentation: Prevention of Mental Disorders and Promotion of Mental 
Health: Exploring the concepts 
 
INTRODUCTION 
If compared with “treatment of diseases” the concepts of “prevention of diseases” and 
“promotion of health” have arisen rather late in modern societies and have for a long 
time been neglected. The roots for this neglect, manifested in the lack of routine public 
financing mechanisms, do not only lie in the historically more pressing need of fighting 
already developed diseases and in the lack of knowledge how to prevent them, but also 
in the conceptual uncertainties surrounding the idea of “prevention” (differentiated 
today into concepts such as “primary, secondary, tertiary”, and “universal, indicated, 
selective” prevention, whose definitions are neither universally known, let alone agreed 
upon). If moving to the concept of “promotion of health” these definitional problems 
become even larger and the evidence base for actions gets smaller. In some sense one 
could say that treating diseases is a clear and hard business - the “enemy” is visible, 
whereas prevention and promotion are vague and soft with no clear “enemy” to attack. 
Also, the traditional individual-centred approach of medicine with its focus on the 
treatment of single patients is conceptually easier than the public health approach of 
prevention of disorders and promotion of health which is related to groups and 
populations. 
 
These difficulties are potentiated if one tries to apply these already difficult concepts not 
to physical disorders and physical health but to mental disorders and mental health. 
There, the lack of a common understanding of what mental disorders are is an 
impediment to action (if one regards the many versions of international classification 
systems over the last few decades and the still often competing definitions of ICD-10 
and DSM-IV), let alone the many different meanings of mental health.  
 
Unfortunately, such a common understanding is only starting to emerge and, 
consequently the present paper has a cautionary tone in fully acknowledging the natural 
tension between the still unsatisfying state of knowledge in preventing mental disorders 
and promoting mental health and the perceived need for action. It begins with the 
traditional medical concepts of “disease” and “therapy” and gradually builds up the 
conceptually more complex issues of “prevention of mental disorders” and “promotion 
of mental health”. 
 
FROM BASIC TO COMPLEX CONCEPTS 
 
Societal actions are invariably tied to financing mechanisms. Such mechanisms do exist 
for medicine. The traditional target variables of medicine have since long been 
“diseases”, and the corresponding interventions are called “therapy”. In modern welfare 
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societies, the financing mechanisms for diagnostic and therapeutic medical procedures 
are relatively clear: Either health insurance systems (as introduced by Bismarck in 
Germany in 1883) or tax funded systems (initiated by Beveridge in 1948 for the UK) 
guarantee that medicine can be practiced, i.e. that medical doctors and related 
professionals have jobs and that a larger proportion of the population can afford medical 
treatment once a physical disease has developed. In short: Medicine, as a societal 
undertaking for treating diseases, exists not the least because financing mechanisms 
exist. 
 
Already in this traditional world conceptual and practical difficulties arise, if the field of 
acute medicine is left behind and chronic diseases become a matter of concern – there 
the financing mechanism are less clear.  
 
The simple sequence of “disease” and “therapy” has been steadily supplemented by 
other concepts over the last half century or so, first by “rehabilitation” which aims at 
restoring (as far as possible) the original health and functional state. The financing 
mechanisms for rehabilitation are again less clear, not the least because rehabilitation 
involves many social and other non-medical activities, but also because it has brought in 
a new target variable, namely disabilities. 
 
Today a plethora of concepts and suggested activities makes the situation increasingly 
complex. In table 1 a selection of such new concepts and terms is intermingled into the 
“old” concepts. Each of these many terms and concepts seems to make sense. But in 
order to make them operational as a whole - in the same way as medicine has become 
operational - , a systematisation of this babel of terms is necessary – especially in view 
of the fact that public health actions have to be carried out in cooperation between the 
health sector and practically all non-health sectors of society.  
 
 
Table 1: The babel of health states and health related states and corresponding actions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Risk factors 
Primary prevention       Primary disability 
     Aftercare 
        Context 
 Universal prevention   Behaviour 
 Selective prevention       Impairment 
    Care    Quality of life 
      Handicap 
Premorbid disability  Disease ? Treatment     
Maintenance treatment 
  Reintegration    
    Secondary Disability   Prevention of relapse  
Salutogenesis       
   Indicated prevention   Rehabilitation 
Disability        
  Secondary prevention   Tertiary prevention   
     Protective factors 
 Promotion of health      Life style  
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First, the concept of “disease” as the traditional target of medical interventions has been 
supplemented over the last decades by the concept of “disability” (disturbed functioning 
in daily life as a consequence of a disease), which has become a target of rehabilitation. 
Both the disease and the disability concept relate to a deficit in relation to the desirable 
normal state and are rather clearly defined. Therefore they are suited for actions. A good 
example for disabilities are walking difficulties after a stroke, where physiotherapy is 
usually financed. Concerning psychiatric disorders, loss of social skills in schizophrenia 
with social skills training as a rehabilitative measure is an example (with however no 
guaranteed financing in many places).  
 
In a parallel development “normal”, i.e. desirable states, namely “health” and “quality 
of life” have been given increasing prominence, not only as outcome variables when 
preventing and treating diseases or preventing and “rehabilitating” disabilities, but as 
constructs in their own right (Table 2). The WHO (1948) definition of health as “a state 
of complete physical, psychological and social well-being and not merely the absence of 
disease or infirmity” is a forerunner of this development.  
 
Table 2: Old and new undesirable and desirable health and health-related states 
 
 
Health and health-related states 
 
 
 
Undesirable /  
abnormal state 
 
 
Desirable /  
normal state 
 
Symptoms 
 
Disease Health 
Domains  
Functioning in 
daily life 
 
Disability Quality of Life 
 
 
Health corresponds to disease, and quality of life to disability in this new movement 
towards stressing these “normal states”, which are considered as deserving being 
“promoted”. In this sense “promotion of health” aims at going even beyond the normal 
state in order to create a kind of especially good health, and as one must say logically, to 
improve quality of life beyond the “normal” values in a given society. 
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Table 3: Actions aimed at undesirable and desirable states 
 
 
The corresponding actions aimed at the desirable/normal states are called “promotion of 
health” and, as we might say, also “promotion of quality of life”. Actions targeting the 
undesirable/abnormal states are called “prevention”, “therapy” and “rehabilitation”. 
Prevention and rehabilitation do not only relate to diseases (disorders) but also to 
disability (Table 3). 
 
MENTAL DISORDERS AND MENTAL HEALTH5 
 
The concept of mental disorders  
 
Over the past decades, because of its negative connotations, the term “mental illness” 
has been replaced in the psychiatric literature and the corresponding diagnostic systems 
more or less completely by the plural ”mental disorders”. This is also appropriate from a 
logical point of view, since a) there is no such thing as a general “mental illness” and b) 
the illness concept derived from physical medicine does not automatically apply to 
abnormal mental states, so that the neutral term “mental disorder” is more suitable. 
While these disorders are included in a disease classification, the “International 
Classification of Diseases”, they are practically all called disorders in Chapter F 
(Mental and Behavioural Disorders) of the ICD-10 (World Health Organisation 1992). 
There is still controversy about the validity of the definitions of many specific mental 
disorders – reflected by the rapid succession of new versions of classifications – ,but the 
introduction of operational criteria has certainly improved the reliability of psychiatric 
diagnoses and contributed a great deal to the upgrowth of scientific research in 
epidemiological and biological psychiatry. The Diagnostic and Statistical Manual of 
Mental Disorders, in its fourth revision (DSM-IV), produced by the American 
Psychiatric Association (APA 1994), and the International Classification of Diseases, in 
its tenth revision (ICD-10), published by the World Health Organization (WHO 1992), 
are the spearheads of this development. 
 
                                                          
5 Some parts of the following text have been adopted or adapted from Katschnig et al (1999) 
                                  
Actions aimed at 
 
 
Undesirable/abnormal state 
 
Desirable/normal state 
 
 
Traditional 
 
Therapy of disease _  
 
New 
 
 
Prevention of disease 
Prevention of disability 
Rehabilitation of disability 
 
 
      Promotion of health 
      Promotion of quality of life 
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However, while already for many physical disorders no clear demarcating lines can be 
drawn, this applies even more to mental disorders, where we rather deal with a dividing 
fog than with a dividing line between the normal and the abnormal. The concept of 
“sub-threshold” disorders reflects the need of clinicians to sometimes go below the 
strict operational diagnostic definitions.   
 
The World Health Organization estimates that several hundred millions of people suffer 
from such disorders world-wide. The World Health Report 2001 (WHO 2001) states 
that surveys conducted in developed as well as developing countries have shown that, 
during their entire lifetime, more than 25% of individuals develop one or more mental 
or behavioural disorders. In table 4 the life time and 12-month prevalence rates for the 
most frequent psychiatric disorders are presented, as they were found in a large 
epidemiological survey, the US National Co-morbidity Survey (NCS; Kessler et al., 
1994).  These and earlier estimates of the prevalence of psychiatric disorders have been 
criticized as being too high. Narrow et al (2002) have revised these rates “for more 
accurate projections of treatment need” and arrived at a total 12 month prevalence rate 
(of any disorder) of 18,5%. Recently, after repeating the NCS in 2001 and 2002 , 
Kessler at al (2003) have confirmed at least for major depression the original high rates 
of their 1994 paper. 
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 Table 4: Lifetime and 12-Month-Prevalence of Psychiatric Disorders (DSM-III-R)  
  
  Male Female Total 
  Lifetime 12 mo Lifetime 12 mo Lifetime 12 mo 
Disorders % % % % % % 
Affective disorders             
    Major depressive episode 12,7 7,7 21,3 12,9 17,1 10,3 
    Manic episode 1,6 1,4 1,7 1,3 1,6 1,3 
    Dysthymia 4,8 2,1 8,0 3,0 6,4 2,5 
    Any affective disorder 14,7 8,5 23,9 14,1 19,3 11,3 
Anxiety disorders             
    Panic disorder 2,0 1,3 5,0 3,2 3,5 2,3 
    Agoraphobia without panic disorder 3,5 1,7 7,0 3,8 5,3 2,8 
    Social phobia 11,1 6,6 15,5 9,1 13,3 7,9 
    Simple phobia 6,7 4,4 15,7 13,2 11,3 8,8 
    Generalized anxiety disorder 3,6 2,0 6,6 4,3 5,1 3,1 
    Any anxiety disorder 19,2 11,8 30,5 22,6 24,9 17,2 
Substance  use  
disorders 
            
    Alcohol abuse without dependence 12,5 3,4 6,4 1,6 9,4 2,5 
    Alcohol dependence 20,1 10,7 8,2 3,7 14,1 7,2 
    Drug abuse without dependence 5,4 1,3 3,5 0,3 4,4 0,8 
    Drug dependence 9,2 3,8 5,9 1,9 7,5 2,8 
   Any substance abuse/dependence 35,4 16,1 17,9 6,6 26,6 11,3 
 Other disorders             
    Antisocial personality 5,8 … 1,2 … 3,5 … 
    Nonaffective psychosis 0,6 0,5 0,8 0,6 0,7 0,5 
 Any NCS disorder 48,7 27,7 47,3 31,2 48,0 29,5 
  
Source: Kessler et al, 1994 
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In terms of prevalence the dominating disorders are what are traditionally called 
”minor” psychiatric disorders, i.e. anxiety and mood disorders, as well as substance use 
disorders. Schizophrenia (subsumed in the table under “nonaffective psychosis”) is 
clearly less frequent than these ”minor” disorders, but since it starts early in life and 
often becomes chronic, it is nevertheless burdensome. 
 While the distress caused to patients and their families by these psychiatric disorders is 
justification enough for taking preventive action, this is even more so, since it is not 
uncommon that 
• two or more of these disorders are present simultaneously (co-morbidity), 
• these disorders complicate many (especially chronic) physical disorders and 
prolong their duration (e.g. increase the duration of a hospital stay), 
• they are associated with an increased mortality, due both to suicide and natural 
causes,  
• they are disabling in the fields of self care, personal relationships, family life, 
child rearing and work, 
• they cause enormous direct and indirect costs (e.g. loss of productivity). 
 
It has to be stated, though that the use of operational diagnostic criteria doesn’t render 
justice to mental suffering and “mental ill health” and that psychiatrists are criticised for 
just demarcating their professional interests in using (and “overstating”) the disease 
model of mental disorders. It is suggested that the disease model of mental disorders 
might need some reconsideration because, at least in some instances, it artificially 
“medicalizes” problems of everyday life (for an overview of this criticism see Katschnig 
2001). In view of this criticism the public health approach of prevention of mental 
disorders and promotion of mental health might serve as a stimulus towards a 
development of a more comprehensive view of the field of mental health and mental 
disorders. 
  
The concept of mental health 
 
In a public health context the term “mental health” is now used as an umbrella term for 
both the normal state, i.e. “mental health” in the proper sense, and mental disorders. 
Unfortunately, not only is the borderline between mental health and mental disorders 
blurred by the introduction of this umbrella term, but also misunderstandings abound. 
 
As a broad term designating the field of mental health as opposed to physical health, it 
would be advisable to add something like “field” or “issues”, i.e. “mental health field” 
or “mental health issues”. Within such a broad field a “positive” and a “negative” pole 
can be distinguished. In fact, the term “positive mental health” as opposed to “negative 
mental health” can be found in the literature. Most often, however, it remains unclear 
what is meant by “mental health”, whether the whole field or just positive mental health 
(sometimes the term “mental health” even refers to mental disorders). If one talks about 
the promotion of mental health, one clearly means “positive mental health”.  
 
The situation is similarly confusing on the negative side, where terms like “ill mental 
health”, “mental ill health, “mental health problems” or “negative mental health” are 
used. Obviously these terms include all states of not feeling or not being well 
psychologically, no matter whether or not this state would be called a mental disorder 
by psychiatrists. Often these negative mental health terms are used, when someone 
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clearly means mental disorders but wants to avoid this term because of its negative 
connotation in relation to stigma. Such uses blur the issue, like in the following example 
from Lahtinen et al (1999): “There are many false assumptions concerning mental 
health. It is, for instance, widely believed that mental ill-health cannot be treated or 
prevented. The worst social consequence of such false assumptions is the stigma of 
mental ill-health”. Here it is clear that “mental disorders” are meant, since it is them 
which carry the danger of stigmatization, while states of reduced psychological well-
being are usually not stigmatized. 
  
In two consensus monographs of STAKES (Lehtinen et al, 1997; Lahtinen et al, 1999) 
three concepts of “mental health” are distinguished: (1) the positive model, (2) the 
functional model and (3) the continuum model. 
  
According to the positive model mental health refers to qualities such as life skills, the 
ability to manage changes and to actively influence the social environment, to positive 
self-esteem, assertiveness and enjoyment or a state of experienced well-being. These 
qualities are considered as values in themselves, not only as signs of absence of illness 
or disorder. This reminds one of the WHO (1948) definition of health in general, which, 
as stated already, is regarded as a state of “complete physical, psychological and social 
well-being and not merely the absence of disease or infirmity”. 
  
According to the functional model, certain psychological qualities are considered 
protective (e.g. above average intelligence, good social competencies, well developed 
problem solving skills, internal locus of control orientation, high self esteem, feeling of 
coherence, close relationship with a parent who is responsive, a supportive social 
network). These factors can make it easier for people to stay healthy even during 
severely stressful times. According to this model mental health could be seen both as a 
protective factor (resilience), and as social capital. It is noteworthy that modern social 
psychiatry sees such factors as also present to a certain degree in persons suffering from 
mental disorders and regards them as healthy parts of their personality which are 
valuable for coping with their disorder and for their self-esteem. 
  
The most traditional of the models, is called the continuum model in the STAKES 
report. It is in accordance with mainstream medical perspectives and in this model 
mental health and mental illness (or mental ill health) are seen as ends of the same 
continuum and mental health is defined as the absence of mental illness. By implication, 
the degree of mental health can be improved by reducing mental disorders. This model 
is opposed to the WHO (1948) definition of health, yet it is the favoured model within 
psychiatry (where the proper term would not be “continuum”, but “discontinuum” 
model - given the operational definitions with their clear borderlines). 
  
Vaillant (2003) has recently pinpointed several pitfalls in research on mental health, 
such as equating average with healthy, failing to distinguish trait from state, and 
overlooking cultural norms. The most common pitfall is that different authors attach 
different meanings to the term “mental health”. Vaillant describes six such meanings, 
which in some sense differentiate the just described positive model (meanings 1 to 5) 
and coincide with the functional model (meaning 6). In projects of promotion of mental 
health several of these overlapping meanings can be found, and it is recommended to 
use Vaillant’s typology to know where one fits in (in the following descriptions 
Vaillant’s wording is partly directly used). 
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(1)   Meaning one is “above normal”, represented somehow by the upper end of the 
Global Assessement of Functioning (GAF) Scale of DSM-IV (APA, 1994): “Superior 
functioning in a wide range of activities; life’s problems never seem to get out of hands; 
is sought out by others because of his or her many positive qualities; no symptoms”. As 
an example where this concept plays a practical role Vaillant mentions the selection of 
astronauts.  
  
(2)   A second concept of mental health implies “positive psychology” and is derived 
from Maslow’s (1970, 1971) concept of self-actualization and humanistic psychology. 
Optimism, self-efficacy, a positive cognitive style and future mindedness are 
ingredients of “positive mental health” in this view (Snyder and Lopez, 2002). 
  
(3)   The third model follows the concept of “adult maturity”, implying that greater 
maturity reflects greater mental health. In this concept mental health has different 
meanings in different life stages. Building on Erikson’s (1950) model of adult social 
development with the stages of identity, intimacy, career consolidation and generativity, 
Vaillant adds two more tasks to be accomplished in later life, namely “keeper of the 
meaning” and “integrity”, i.e. the task of achieving some sense of peace and unity with 
respect to one’s own life. 
  
(4)   “Social and emotional intelligence” is the content of the fourth meaning. It is the 
capacity to discern and respond appropriately to the moods, temperaments, motivations 
and desires of other people and includes accurate conscious perception and monitoring 
of one’s own emotions (Goleman, 1995; Gardener, 1993). 
  
(5)   The fifth meaning is mental health as “subjective well-being” which has an 
intuitive appeal as being the gist of positive mental health. There are several pitfalls 
though with this concept as outcome variable of activities of promotion of mental 
health. First, hypomanic, manic or dissociative states are correlated with subjective 
well-being but are not “healthy”. Also, after several decades of research on happiness 
and well-being it seems that subjective well-being has more effect on the environment 
than the environment exerts on it (Diener et al 1999). Finally, the concept of quality of 
life (see below) is intimately related to the concept of subjective well being (Katschnig 
et al 1997) and the question arises whether quality of life should be upheld as a concept 
which is different from the concept of mental health. 
 
(6) The sixth meaning identified by Vaillant is mental health as “resilience”, which 
roughly corresponds to the “functional model” of the STAKES reports discussed above. 
It has to do with the coping mechanisms that humans use to overcome stressful 
situations. Three broad classes of such coping mechanisms can be distinguished: 
consciously seeking social support, conscious cognitive strategies that we intentionally 
use to master stress, and, finally, involuntary mental coping mechanism (often called 
“defense mechanisms” or “denial”). 
 
Kovess and Beaudet (2001) provide a useful overview of instruments for measuring 
several of the above mentioned aspects of mental health. 
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DISABILITIES AND QUALITY OF LIFE AS COROLLARIES OF MENTAL 
DISORDERS AND MENTAL HEALTH 
The concept of disability 
Disabilities refer to deficits in functioning in daily life. Disabilities may be corollaries 
of diseases. However, they may also develop, although in a given person a symptom 
pattern does not qualify for a full disorder in an official classification system. Also, 
disabilities may persist although the disorder has disappeared. Thus, disabilities are 
partly independent from mental disorders and constitute an entity in its own right, 
deserving itself preventive activities. 
As early as 1980 the WHO has published the International Classification of 
Impairments, Disabilities and Handicaps (ICIDH), whereby “impairment” relates to 
symptoms or impaired body functions, “disability” to impaired activities, and 
“handicap” to impaired social roles. In a major revision these “negative” terms were 
replaced by neutral ones. In the new “International Classification of Functioning, 
Disability and Health” (ICF, WHO 2002) “impairment” is replaced by “body functions 
and structures”, “disability” by “activities” and “handicap” by “participation”. 
  
The most commonly used term to capture reduced functioning in daily life is still 
“disability”. When using this concept in an action oriented environment it is useful to 
distinguish three types of disabilities (Wing1963): Premorbid disability  (present before 
illness onset), primary disability (impaired activity due to symptoms, e.g. thought 
disorders and depression which both disturb communication), and secondary disability, 
which arises due to ascribed roles, stigma, discrimination, hospitalism and self-
stigmatization. Secondary disability is an important concept from the viewpoint of 
prevention, since many interventions are possible to reduce such secondary disability, 
which can be regarded as avoidable consequences of disease and would fall under the 
traditional concept of tertiary prevention (see below).  
  
The ”Global Burden of Disease” report (Murray and Lopez, 1996) shows that 
disabilities associated with mental disorders are comparable to those associated with 
physical disorders. In developed regions of the world, neuro-psychiatric conditions are 
the leading cause of disease burden, accounting for 22% of all ”Disability Adjusted Life 
Years” (DALYs, a global measure for disability, which takes the duration of disability 
into account).  
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Table 5: Leading causes of disability-adjusted life-years (DALYs) in two World Health 
Organisation (WHO) regions (the Americas and Europe), estimates for 2000  
 
          % total DALYs                       % total 
DALYs 
The Americas      Europe 
Unipolar depressive disorders 8.0  Ischaemic heart disease 
 10.5 
Perinatal conditions   5.0  Cerebrovascular disease 
 6.8 
Violence    4.7  Unipolar depressive disorders
 6.1 
Ischaemic heart disease  4.5  Alzheimer and other dementias
 3.0 
Alcohol use disorders   4.3  Alcohol use disorders  
 2.9 
Road traffic accidents  3.2  Hearing loss, adult onset 
 2.6 
Cerebrovascular disease  2.8  COPD    
 2.4 
Congenital anomalies   2.5  Road traffic accidents 
 2.4 
Diabetes mellitus   2.3  Osteoarthritis   
 2.4 
Lower respiratory infections  2.3  Self-inflicted injuries  
 2.3 
 
Source: Üstün et al. 2004 
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Üstün et al (2004) have recently published a new analysis of DALYs for the 6 WHO 
regions in the year 2000. The results for the Americas and Europe are presented in table 
5. In the Americas unipolar depressive disorders are the leading group in terms of being 
responsible for 8% of the total DALYs in that region, in Europe unipolar depressive 
disorder is third, followed by Alzheimer and other dementias (4) and alcohol use 
disorders (5); self-inflicted injury is at place 10. In sum: In Europe depression, 
Alzheimer and other dementias, alcohol use disorders and self-inflicted injuries account 
for nearly 15% of the total disability adjusted life years (DALYs) calculated for the 
European region of the World Health Organisation. 
It is important to note that this analysis refers to all types of physical and mental 
disorders. Also the authors noted an increase from 1990 to 2000, when of the total 
number of years lived with disability (YLD) the percentage due to depression rose from 
10.7% to 12.1%.  
These results may help to make politicians and health administrators aware of the 
enormous importance of mental disorders, not only in terms of individual suffering, but 
also in terms of the societal burden which is finally reflected in enormous economic 
losses. 
 
The concept of quality of life 
  
Over the last two decades a new concept for non-medical aspects of diseases has 
emerged, the concept of quality of life (Katschnig et al 1997) . It is a neutral term, in 
contrast to “disability” and follows the trend already shown in the ICF above. As 
“Health related quality of life” it brings the subjective experience of persons suffering 
from specific disorders into the arena. For the field of mental health the best approach is 
to regard “quality of life” as a multidimensional concept, covering the three aspects of 
“subjective well-being”, “functioning” and “external resources”. 
 
In some sense the quality of life concept understood in this way has many overlaps with 
“mental health”. Also here the term is used in a neutral fashion, designating a field of 
interest (with a plus and a minus pole, corresponding to good and bad quality of life), 
but also in a positive sense meaning per se a good “quality of life”. If it comes to 
measurement issues and empirical research, attention must be paid to many instruments 
used today, because there is often a “measurement overlap” between quality of life 
instruments and instruments measuring mental health or even mental disorders 
(Katschnig 1997; Katschnig and Angermeyer 1997). 
 
  
PREVENTION OF MENTAL DISORDERS AND PROMOTION OF MENTAL 
HEALTH  
 
Prevention of mental disorders  
 
Among psychiatric clinicians and other mental health workers a certain reservation 
about the concept of prevention of mental disorders can be observed, let alone about the 
concept of promotion of mental health. While one reason for these doubts may be 
rooted in the lack of public health education among most clinicians, another reason 
might lie in the fact that in clinical practice treatment and prevention can often not be 
clearly distinguished. For instance, prevention of comorbidity and relapse prevention 
can also be regarded as treatment. Or: Since it is well established that anxiety disorders 
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are a frequent precursor of depression, the successful treatment of anxiety disorders can 
also be regarded as a measure for preventing depression.  
 
The word prevention is derived from the Latin verb “praevenire”, which literally means 
to “arrive before someone or something else arrives” or "to act in anticipation of”. In 
Latin the word means "come before, anticipate, hinder”. (Preventive in the medical 
sense is recorded from 1646; Online etymology dictionary, 
http://www.etymonline.com.) In everyday language the term has received the 
connotation of acting in order to avoid something or to keep something undesirable 
from happening – in a general sense (such as a fire, an accident, an economic crisis) or 
in a more personal and situational sense (such as a pregnancy). Such preventive 
interventions can be of a structural nature (i.e. building safer cars or safer roads in order 
to prevent accidents) or directed towards individual persons or subgroups of persons 
(such as teaching better driving).  
 
Logically, prevention means to reduce the risk that an undesirable event occurs. Usually 
this means that the risk factors which contribute to the occurrence of the undesirable 
event are known and also the factors which are protective. The increased risk for an 
undesirable event results from the interplay between risk and protective factors, and all 
preventive interventions  must either reduce risk factors or increase protective factors. 
These risk and protective factors can be specific for a certain disease, or “general” in the 
sense that they refer to several diseases or to disease in general. Activities called 
“promotion of health” (see below) can be regarded as strengthening “general” protective 
factors. 
 
In relation to diseases two meanings of prevention can be distinguished: a disease can 
be  either prevented from developing at all, or one can prevent a disease from getting 
“worse”. The first concept is theoretically clear and has its basic example in the 
paradigm of immunisation/inoculation against infectious diseases. The second concept, 
to prevent a disease from getting worse or lasting longer than necessary, can mean (1) to 
treat it as early as possible (if effective treatments are available); in order to do this one 
would have to a) provide the therapeutic resources for those cases which have already 
been detected and  diagnosed and b) detect undiagnosed cases as early as possible and 
treat them appropriately; preventing a disease from getting worse can also mean (2a) to 
tackle risk factors which make the disease worse (including iatrogenic ones, such as 
hospitalism and malpractice), which lead to  negative consequences (like disabilities), or 
contribute to relapse, or (2b) vice versa, to use empirically proven interventions which 
prevent such negative consequences (such as relapse prevention in bipolar disorder 
through lithium).  
 
While these basic possibilities for the prevention of diseases are quite clear-cut, the 
existing terminologies and classifications for these different types of interventions are 
not consistent and not consistently used. One classification is the traditional 
classification of “primary”, “secondary” and “tertiary” prevention, another one is the 
classification of “universal”, “selected” and “indicated” prevention. These different 
classifications do overlap to some degree, but are by no means identical.  
 
The „primary, secondary and tertiary“ (P-S-T) concept of prevention is clearly related to 
a temporal perspective, i.e. these different concepts apply to specific stages before or 
during the development of a disease. The classification of “universal, selective and 
indicated” (U-S-I) prevention is related to both a temporal perspective and the target 
populations (universal and selective prevention are aimed at people who are not yet ill, 
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the first group being the general population, the second group being persons with high 
risk factors; indicated prevention being directed at persons who have already 
symptoms). 
 
The “primary – secondary – tertiary prevention” classification (P-S-T) 
 
In the World Health Report on Mental Health of the WHO (2001, p.64), primary 
prevention is equated with prevention in the proper sense, i.e. the prophylaxis of an 
illness. Astonishingly, secondary and tertiary prevention, have little to do with the 
common understanding of the term prevention, since secondary prevention is equated 
with treatment and tertiary prevention with rehabilitation. This goes back to a 
suggestion by the US Commission on Chronic Illness (1957). There prevention was 
classified into primary, secondary and tertiary prevention, whereby primary prevention 
was defined as prevention in the proper sense, i.e. the reduction of the incidence of a 
specific illness; secondary prevention as the reduction of the prevalence of an illness, 
and tertiary prevention as the reduction of the amount of disability resulting from a 
specific illness (see also Leavell and Clark 1965). 
 
Building on these definitions and considering the types of preventive activities 
discussed above it is suggested here to use the concepts of primary, secondary and 
tertiary prevention in the following way: 
 
Primary prevention = reducing the incidence of mental disorders by 
eliminating/reducing risk factors and/or strengthening protective factors (the 
latter also by actions/interventions conceived of as “promotion of mental 
health”) 
             
Secondary prevention = reducing the prevalence of (already existing) mental disorders 
by 
 appropriate treatment of known cases, but mainly - and more to the point of the 
concept of prevention - by detection of unknown cases and their appropriate 
treatment, especially by early detection of beginning disorders and early 
treatment (e.g. inpatients in general health services, such as primary care or 
general hospital wards - a specific example would be post partum depression) 
 
Tertiary prevention = reducing the incidence and prevalence of “complications” of 
already 
 existing disorders by preventing the development of disabilities and relapses  
(reduction of incidence), and by rehabilitation concerning existing disabilities  
(reduction of prevalence) 
              
It is commonplace that, the further we come down this list, the more evidence based 
strategies are available (e.g. detection and early treatment by general practitioners of 
persons suffering from depression; relapse prevention in bipolar disorders; preventive 
work with high expressed emotion family members of persons suffering from 
schizophrenia).  
 
In appendix 1 examples are provided for each of these types of prevention.  
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The “universal-selective-indicated prevention” classification (U-S-I) 
 
Gordon (1987) has suggested a different classification for preventive activities for 
physical illnesses, which was adopted by the Institute of Medicine’s (IOM) Report on 
“Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research” 
(Mrazek & Haggerty 1994, from whom we are quoting here). It was based on the 
assumption that prevention of disorders and promotion of health are feasible without 
fully understanding causal mechanisms but by only observing empirical relationships. 
The classification relates to the populations targeted by preventive activities and 
comprises three types of preventive measures: “universal”, “selective” and “indicated”. 
In “universal” preventive programmes the general population is addressed; an example 
is prevention of smoking. “Selective” preventive measures are directed towards 
individuals who belong to a subgroup whose risk of becoming ill is above average, e.g. 
malaria prophylaxis for persons intending to travel into specific countries. In both 
“universal” and “selective” prevention the intervention is directed towards persons who 
are well.  
 
In contrast, “indicated” prevention applies to persons who individually have been 
identified as having a risk factor, condition or abnormality that identifies them as being 
at high risk for the future development of a disease (e.g. individuals with already high 
blood pressure). Since the transition to a real disease is only probable, “indicated” 
interventions pose an ethical problem, because these interventions might be costly and 
also potentially harmful to the individuals concerned. These “risk factors, conditions or 
abnormalities” can also be seen as early symptoms (e.g. in a recent development in 
schizophrenia prevention, where early recognition is now promoted). This strategy 
would be subsumed above under “secondary prevention”.  
 
The Institute of Medicine (IOM) has taken over Gordon’s classification but has made an 
important change to the definition in the just mentioned sense: Indicated prevention also 
concerns individuals with early symptoms and not only those with markers (Mrazek & 
Haggerty 1994). 
 
Table 6: Cross tabulation of the P-S-T and U-S-I prevention classification 
Target group 
 
Universal Selective Indicated 
Primary √ √ - 
Secondary - √  √ 
T
em
po
ra
l 
pe
rs
pe
ct
iv
e 
 
Tertiary - - - 
 
 
In table 6 these two classifications are cross tabulated. It shows that primary prevention 
can be universal or selective (in the latter case if higher than average risk populations 
are selected for the primary preventive measure), secondary prevention corresponds to 
indicated prevention in the case of persons already known as suffering from symptoms 
(which, however, do not yet fulfil diagnostic criteria) but may also be subsumed under 
“selective” prevention in the case of screening for mental disorders among patients in 
general health services who are known to have a raised risk for mental disorders, which 
are often not detected in routine care (see above). Tertiary prevention has no 
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correspondence in the U-S-I system (unless one regards persons who are defined by an 
already existing illness as a target group for indicated prevention). 
 
Effectiveness of prevention 
 
Prevention programmes must also fulfil a number of criteria in order to have a chance to 
work: they must be effective (usually this means that the risk and the protective factors 
are known and that proven interventions exist; for an overview of the risk and protective 
factors of the most important mental disorders see Mrazek and Haggerty 1994); they 
must be cost effective, they must be acceptable to the targeted persons and they should 
have no negative effects (which would pose an ethical problem).  
 
Concerning the effects of prevention programmes on the incidence of new cases of 
mental disorders Cuijpers (2003) has argued that “about 1000 controlled studies have 
examined the effects of mental health programs aimed at preventing mental health 
problems at school, substance use and abuse at school, work-related stress, distress 
among caregivers for the elderly, depression, aggression and behaviour problems in 
children, child abuse, and several other conditions. This considerable body of research 
has shown that some prevention programmes in mental health are capable of 
strengthening protective factors, such as social skills, problem solving skills, stress 
management skills, prosocial behaviour, and social support; that these programmes can 
reduce the consequences of risk factors, psychiatric symptoms and substance use; that 
they may have positive economic effects. Despite this large body of research, few 
studies have examined whether these prevention programmes are actually capable for 
reducing the incidence of new cases of mental disorders”. Furthermore, Cuijpers argues 
that one major reason why the prevention of new cases of mental disorders has hardly 
been examined is that very large numbers of subjects are needed to yield sufficient 
statistical power to be able to show significant effects on incidence. He states that this 
“power problem” is related to the lack of understanding of the exact pathways leading to 
mental disorders and to the very low specificity of most known risk factors, which 
implies that most subjects who are exposed to risk factor do not develop the disorder 
and that one such risk factor by itself is not sufficient to produce the disorder. In order 
to increase the statistical power in prevention research Cuijpers suggests (among other 
measures) to focus on populations with high incidence rates of mental disorders by 
concentrating on indicated prevention, on high risk groups with multiple risk factors and 
on target groups with multiple disorders. 
 
Jané-Llopis et al (2003) draw somewhat less pessimistic conclusions in their meta-
analysis of predictors of efficacy in depression prevention programmes. Also a project 
supported by the European Commission on mental health promotion and prevention 
strategies for coping with anxiety, depression and stress related disorders in Europe 
comes to a more optimistic conclusion laid down in ten key recommendations referring 
to children, working adults and old people (see Annex 2). 
 
Anyhow: Preventive programmes aimed at primary prevention of mental disorders may 
have effects also if they finally do not prevent the development of a disease: they may 
delay the onset, i.e. they reduce the short term incidence of new cases. E.g., mothers 
who might become depressed while they have small children (which would be harmful 
to the children) might become depressed later on and then their depression might at 
least not be harmful to their children anymore. Also, delaying the onset of Alzheimer’s 
disease means delay in stress and reduction of problems of caregivers. Finally primary 
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preventive interventions while not preventing the disease from developing may render a 
disease less severe or shorten its duration.  
 
Promotion of mental health and promotion of quality of life 
 
Concerning the prevention of mental disorders the concept of “promotion of mental 
health” has its logical place as a way of strengthening the resilience of an individual 
against the development of mental disorders. In this sense “promotion of mental health” 
can be regarded as part of “primary prevention of mental disorders”. 
 
While this use of the concept of promotion of mental health is probably acceptable to a 
wide range of mental health professionals, a more general use in the sense of increasing 
mental health above a kind of medium level is more debatable. Mental health would be 
equated in this sense with well-being or good quality of life, and this use approaches 
more the aims of politics in general in western democracies were repeated elections 
urge politicians to promise a better life. One of Lyndon B. Johnson’s election speeches 
is often quoted as being the historically first example of using the concept of quality of 
life in politics: "Goals cannot be measured by the size of our bank account. They can 
only be measured in the quality of lives that our people lead." After all, the “pursuit of 
happiness” is written into the Declaration of Independence as one of the “unalienable 
rights” of people. The concept of quality of life is only a different way of expressing 
happiness, well-being and positive mental health. 
  
On a more technical level, the suggested general measure for the promotion of mental 
health include both structural, i.e. community oriented measures and interventions 
aimed at individuals or groups of individuals. The former comprise programs of 
creating healthy communities or healthy organizations (such as healthy hospitals, 
healthy companies), the latter include educational programs aimed at groups of people, 
e.g. in schools or in the workplace. The aim of such interventions are increasing positive 
mental health as outlined in the STAKES reports (Lehtinen et al 1997, Lahtinen et al 
1999), by Vaillant (2003) and by Kovess and Beaudet (2001) and improving functional 
capacities of the individual to cope with stress (resilience).  
 
Recommendations for activities on the European level, presented in detail in the 
following, underline the need for R&D activities such as policy surveys, mental health 
monitoring and assessment of mental health promoting programmes; specific practical 
efforts; and the need to foster European co-operation in mental health issues (Lahtinen 
et al 1999).  
 
The STAKES reports provide a comprehensive list of suggested activities of 
“promotion of mental health”, which are quoted here from Lahtinen et al (1999). 
 
• Enhancing the value and visibility of mental health 
 
Establishing  large scale public information campaigns on mental health 
Starting mental health impact evaluation in all administration 
Identifying EC action linked with mental health and providing a supportive  
information exchange capacity  
Integrating mental health aspects to all health promotion programmes 
Including mental health instruction in school education thoroughly 
Emphasising mental health in all professional training 
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• Empowerment, participation and Information Society 
 
Enhancing participatory, community-based mental health promotion  
Raising awareness concerning strengths-based approaches and effective forms of 
self- and peer-help. 
Establishing innovative projects to develop ‘good telematic content’ and ‘good 
telematic interfaces’  
Evaluating the risks of marginalisation resulting from increased use of 
information technology  
Reorienting mental health services and promotion in line with the developing 
Information Society 
Setting up a network focusing on the telematics of social inclusion and mental 
health promotion.  
 
• Towards mental health promoting working life 
 
Raising  employers’ awareness of the importance of mental health and its 
promotion in the work place 
Disseminating information on practices in work place mental health promotion, 
e.g. by 
Identifying common goals and enhancing the positive aspects of the work 
process and environment  
Recognising the balance between job demands and occupational skills  
Enhancing social skills training and possibilities for collaboration and joint 
opportunities 
Developing the psychosocial climate at the work place 
Providing counselling for special groups, e.g. carried out before organisational 
or other changes 
Applying strategies focusing on enhancement of working capacity and early 
rehabilitation’ 
 
• Unemployment, underemployment and re-employment 
 
Evaluating comprehensively real effects of unemployment  
Preventing stigmatisation of unemployment 
Supporting re-employment trough job creation  
Supporting re-employment by developing the physical and mental resources of 
the unemployed  
Searching actively intermediate statuses between work and unemployment  
Developing multimodal programmes focusing on unemployment leading to 
marginalization 
 
• Support and protection of children, young people and families with children 
 
Developing written strategic plans on promoting the mental health of children 
and young people  
Increasing knowledge of the pathways leading to healthy development or 
marginalisation 
Collecting data on the extent of child exploitation and creating protection for the 
children affected 
Sharpening the focus on children’s needs in all health promotion programmes 
targeted at adults 
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Focusing on self-esteem, non-violent behaviour; and good communication and 
social skills in education 
Collecting and disseminating information on programmes supporting early 
parent-child interaction 
 
• Enhancing quality of life of elderly people 
 
Preventing stigmatisation of old age and discrimination of elderly people  
Supporting independent living by policy and programme measures 
Developing programmes promoting self-support by intellectual and physical 
measures 
Developing effective and feasible measures of preventive action  
 
• Promoting mental health of alcohol and drug abusers 
 
Developing measures focusing on prevention and reduction of combined 
substance abuse  
Developing tolerant services for mentally ill intoxicant users who are out of the 
scope of rehabilitation efforts 
Supporting research and development regarding the co-occurrence of intoxicant 
misuse and psychiatric disorders  
 
• Supporting research and development 
 
Emphasising transnational comprehensive evaluation of activities in promotion 
of mental health 
Emphasising long-span implementation research looking at factors associated to 
effectiveness and at quality 
Establishing mental health policy surveys and a policy data base 
Studying and developing the role of health care and social services in promotion 
of mental health 
Enhancing information exchange between the researchers, administrators and 
implementers 
Emphasising dimensions with European relevance like equity, participation and 
experienced quality in all R&D action 
 
• Development of information and dissemination systems concerning mental 
health 
 
Establishing a comprehensive mental health monitoring system by e.g. 
Collecting information on existing mental health indicators and their definitions 
Collecting information on existing mental health information systems and 
analysing their quality, coverage and validity 
Developing a mental health monitoring system for the use of the Member States 
and the Commission  
Testing the dimensions of the mental health monitoring system in pilot projects  
Establishing a high-capacity network for the collection, dissemination and 
analysis of relevant information 
  
The IOM report “Reducing risks for mental disorders” (Mrazek and Haggerty, 1994) 
out rightly renounces to discuss at any length the issue of “promotion of mental health”. 
The report states though that enormous amounts of money are spent publicly and 
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privately in so-called mental health promotion programs, but the evidence that they 
achieve their goal is inconsistent, not the least because the definitions of what mental 
health is varies a lot among theses programs. The IOM report, though, outlines a 
lengthy research agenda on the topic, but one wonders how this can be ever 
accomplished. 
 
 
CONCLUDING REMARKS 
 
There are different degrees of evidence supporting the discussed concepts and actions. 
While health and quality of life, as well as promotion and prevention, have more ositive  
and optimistic connotations than disease, disability, treatment and rehabilitation, the 
latter are clearly more evidence based than the former. Concepts with a positive 
connotation (promotion, health, quality of life) are important from a PR perspective, for 
the self-esteem of persons affected by mental disorders, and from an EU policy 
perspective, but they are vaguer than the negatively tainted concepts of disease, 
disability, treatment and rehabilitation. The concept of prevention lies in between in 
both aspects: it is less vague than the concept of  promotion and it still carries a positive 
connotation: If it is expanded from primary prevention, to also meaning secondary and 
tertiary prevention, than it brings a positive aspect to the field of disease and disability. 
We suggest to concentrate the always scarce resources on the elaboration of the field of 
prevention of mental disorders and the related disabilities, not forgetting at the same 
time that activities of promotion of mental health and of quality of life should become 
an integral part of a mental health care system which emphasises the participation of 
citizens and their empowerment. 
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Appendix 1 
Examples for primary, secondary and tertiary prevention of mental 
disorders (from Katschnig et al 1999) 
Primary prevention 
A recent report “Primary Prevention of Mental, Neurological and Psychosocial 
Disorders”, published by the World Health Organization (1998b), emphasises that the 
primary prevention of mental and neurological disorders often falls outside the usual 
remit of mental health professionals (often outside the health sector altogether – 
involving legislators, the media and many others). The report discusses the primary 
prevention of mental retardation, epilepsy, suicide and burn-out in health workers/care 
givers– conditions with a high incidence or prevalence; connected with substantial 
impairments, disabilities and handicaps to the individual and burden to others and for 
which efficient measures exist. Judging from the large number of pages devoted to 
mental retardation (46 of 102), this is the condition for which the best empirical basis is 
available for primary prevention. The reader is referred to the WHO report which 
provides an elaborate discussion on the primary prevention of the four mentioned 
disorders. In pointing out possible areas for primary prevention, the following 
discussion goes beyond these four examples, but cannot present its examples in the 
same depth.  
A certain proportion of cases of organic brain disorder and mental retardation are 
consequences of physical disorders or trauma (such as malnutrition; infectious diseases 
which affect the brain, e.g. measles encephalitis; road accidents). The prevention and 
adequate treatment of these physical disorders constitutes a primary preventive activity 
for psychiatric disorders. Examples are:  
•  immunisation of women against viral infections, 
•  improvement of maternal care during pregnancy and delivery, including 
education about the detrimental effects of cigarette smoking and alcohol,  
• screening for inborn metabolic disorders in new-born infants (e.g. for 
phenylketonuria), in order to prevent brain damage.  
 In a few instances (e.g. Huntington’s chorea), genetic counselling can be regarded as a 
primary preventive strategy, although this has complex ethical implications. Prevention 
of cerebrovascular disorders by reducing tobacco smoking and hypertension is another 
example.  
There is no firm evidence that preventive psychosocial actions in childhood have a 
sizeable effect on the reduction of the incidence of non-organic adult psychiatric 
disorders (such as anxiety, mood disorders and schizophrenia). Targets suggested for 
such interventions include child abuse which seems to be linked (among others) to later 
post traumatic stress and borderline personality disorders. Since abused children, when 
parents themselves (often at a very young age), have increased likelihood of repeating 
their parents’ behaviour (towards themselves in the past), intervention programmes 
might be effective in this risk group. Psychiatrically ill parents are also discussed as a 
possible target group for behavioural interventions aimed at the prevention of mental 
disorders in their children. Finally, it has been shown that emotional and behavioural 
problems in children after parental divorce, school changes or stressful medical 
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procedures, may be prevented by intervention programmes. It is unclear though, 
whether such interventions prevent adult psychiatric disorders.  
It is now clear that traumatic events in adulthood can lead to severe psychiatric 
disorders. Post traumatic stress disorder is prototypical of these disorders, but anxiety 
and mood disorders also have a raised incidence after traumatic events. Awareness of 
the possibility of the development of these psychiatric consequences after traumas as 
diverse as traffic accidents, rape, sudden death of a loved one or natural disasters, and 
early help with coping with the trauma, might reduce the incidence of later psychiatric 
disorders. 
Suicide is another possible target for primary prevention. Suicide rates vary from 
country to country, but even in countries with low to average rates, the total numbers of 
deaths are very high, often exceeding deaths from road traffic accidents. An essential 
strategy for preventing suicides is the early recognition and early treatment of the large 
number of psychiatric disorders with a raised suicide risk. Disorders belonging to this 
group are anxiety disorders, depression (including the recurrent and the bipolar form, 
and also depression in the elderly, especially elderly men), substance abuse and 
schizophrenia. A number of Governments, including Finland, Norway, Sweden and the 
UK have begun to construct national strategies to tackle suicide. Suicide strategies need 
to be cross-departmental or pan-governmental as a range of sectors are involved, not 
only health agencies. Suicide reduction strategies need to be multi-factorial in approach 
and include several core elements: 
• educating primary and secondary health and social care professionals about the 
assessment and management of suicidal risk, 
• supporting high risk occupational groups (these will vary but may include 
groups such as doctors, nurses, farmers, vets and pharmacists), 
• reducing access to the means of suicide (e.g. safety measures relating to 
weapons and medicines), 
• auditing all suicides to learn the lessons for prevention, 
• research into causes and effective prevention,  
• working with the media to ensure more responsible reporting of suicides. 
 For the prevention of alcohol and drug abuse, early recognition and treatment of 
anxiety and mood disorders seems to be essential (given the high co-morbidity). 
The debate whether violence can be prevented, by reducing violent features in the media 
and the availability of weapons, is not yet settled and further research is necessary. The 
effect on violent deaths and suicides of recently introduced new legislation in some 
European countries should be studied. The reduction of violent acts by psychiatric 
patients living in the community is more a matter of the provision of adequate 
specialised services, dealt with in this report under the heading of tertiary prevention.  
 
Secondary prevention 
 
Psychiatry has made tremendous advances in its ability to diagnose reliably, and 
adequately treat, mental disorders. New pharmacological, psychotherapeutic and socio-
therapeutic techniques have been developed over the past forty years and the principal 
efficacy of most of these treatment methods is now beyond doubt. What remains 
unresolved is the task of bringing such treatments to those who need them, both at an 
early stage and once a disorder has fully developed, i.e. the effectiveness of these 
treatments in whole populations is still not achieved.  
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One reason for this deficiency is the delay in receiving adequate professional help for 
mental disorders at an early stage. This is mostly due to: 
• lack of knowledge 
• fear of stigma 
• geographical, temporal and financial inaccessibility of services  
• legal factors and 
• disorder related lack of insight (in psychotic disorders).  
 Lack of knowledge and fear of stigma are the most important barriers to early 
recognition and early treatment. Recent surveys of the general population in Austria, 
Germany and Australia have shown that, among the general public, there is still a 
tremendous lack of knowledge about the nature and possibilities to treat mental 
disorders (Jorm et al 1999). Such low ”mental health literacy” has especially 
unfavourable consequences for professionals who deal with large numbers of people at 
risk of mental disorders (such as teachers or the police). Psycho-educational strategies 
should aim to provide relevant information about mental disorders and their treatment, 
educating people to recognise the secondary effects of medications and treatments, or 
identify symptoms at an early stage of a developing disorder by:  
• teaching teachers to recognise social phobia in teenage school children,  
• developing better understanding of schizophrenia, which usually develops in the 
late teens or early twenties,   
• highlighting the difference between transient depressive reactions and depressive 
illness,  
• antenatal education about postnatal depression .  
 One of the most powerful psychological factors preventing help-seeking at an early 
stage is the stigma attached to mental disorders and to those using psychiatric services. 
The phenomenon of stigma is partly related to lack of knowledge, but cannot be reduced 
to cognitive factors.  
There are two strategies to deal with the effect of stigma on the delay of help-seeking. 
One is the reduction of stigma by complex measures, ranging from anti-stigma 
campaigns in the media, educational campaigns among school children and the 
inclusion of mental disorder issues into school curricula, at both primary and secondary 
level, to the reduction of financial discrimination of psychiatric services and the 
reduction of legal discrimination of psychiatric patients. Anti-stigma campaigns have to 
include not only education but also go beyond cognitive aspects to consider emotional 
factors, such as fear. The World Psychiatric Association is currently carrying out a 
schizophrenia anti-stigma campaign along these lines. 
The second strategy is the establishment of low-threshold and non-stigmatising points 
of entry to professional help. It is generally agreed that general practitioners are the 
optimal point of entry for this purpose, in non emergency situations. Since patients 
admitted to non-psychiatric services in general hospitals have a risk (up to 30%) of 
suffering from mental disorders, the establishment and extension of psychiatric 
consultation/liaison services is an important means of early recognition and treatment of 
patients suffering from mental disorders. Specialised services for psychiatric 
emergencies and crises should be available around the clock and geographically easily 
accessible. They should be based in general hospitals, with crises beds, day-patient, out-
patient and mobile components. 
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Next to educating the public and reducing stigma, the single most effective measure for 
secondary prevention of high prevalence mental disorders is to educate, support and 
resource primary care physicians and services. Epidemiological studies show that large 
proportions of patients attending primary health care services suffer from anxiety 
disorders, depression and alcohol problems. Co-morbidity between these disorders is 
high, early recognition and adequate treatment of one of them may prevent the 
development of the co-morbid condition.  
Typically, anxiety disorders – if not recognised and treated adequately – may lead to 
alcohol abuse on the one hand (alcohol being an effective anxiolytic agent) and to 
depression on the other. Depression, in turn, may lead to alcohol abuse, and alcohol 
abuse, with its many associated psychosocial problems, may lead to depression. A 
recent WHO multi-site study across the world showed that in both developing and 
developed countries, around one third of patients presenting in primary care suffer from 
these psychiatric problems, and that the most common of all chronic disorders (physical 
or psychological) is depression (Sartorius et al 1996). Even more remarkable, and cause 
for alarm, is the finding that only every second of these patients was recognised as 
suffering from a psychiatric disorder by the primary care physician, even fewer were 
offered treatment. 
Primary care physicians must be trained to assess, diagnose and manage these common 
mental disorders, including how and when to refer to specialists. This means ensuring 
adequate attention to common mental disorders during the undergraduate, postgraduate 
and continuing education of doctors. Primary care physicians need to maintain close 
links with specialist psychiatric services so that they can access regular support for their 
work and feel confident about their ability to refer more severe and complex disorders. 
While it is important that primary care physicians recognise all psychiatric disorders at 
an early stage, the common lack of resources suggests concentration on anxiety 
disorders, depression and alcohol in a first stage. For public health, this restriction is 
also justified because these disorders are by far the most prevalent, create a substantial 
amount of disability and have effective intervention strategies linked to them. Primary 
care physicians should certainly also be able to recognise eating disorders, obsessive 
compulsive disorders, schizophrenia, mania, drug dependence, dementia and others at 
an early stage of their development. These disorders are far less prevalent, however, and 
for some the link between mild manifestations and development of the full disorder is 
less clear. For instance, it has recently been shown that mild cognitive impairment is not 
necessarily a precursor of dementia.  
 
Tertiary prevention 
 
The concept of tertiary prevention is used in a broad sense here. It includes not only the 
prevention or reduction of disabilities and improvement of the quality of life of patients 
suffering from mental disorders and their families, but also the reduction of the duration 
of the disorder by adequate treatment and the prevention of relapse.  
Personality disorders, schizophrenia, bipolar disorders, treatment resistant depression 
and anxiety disorders, mental retardation and substance abuse are the most relevant 
disorders – but not the only ones, by far - for tertiary prevention. In order to prevent the 
development of disabilities and to improve quality of life, reduce the duration of the 
disorder and the risk of relapse, these disorders require the provision of psychiatric 
services according to the principles of modern community psychiatry, such as 
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continuity of care, co-ordination, empowerment and inclusion of the family. In short, 
the development of comprehensive local specialist health and social services is 
necessary, where an adequate provision for active co-operation is offered to those 
affected by mental disorders and their families. 
For many countries, appropriate legal and financial provision has to be made in order to 
guarantee the implementation of these principles – for some this will mean fundamental 
legal changes and changes in the system of financing health care. 
Countries vary in their capacity to resource a comprehensive range of specialist local 
health and social services, and even the richest will never be able to afford sufficient 
psychiatric specialists to deal with all mental health problems. There must, therefore, be 
an appropriate balance of specialist and primary care services to allow specialist 
services to target those with the greatest needs. 
Research has demonstrated the long term damage caused to health and social 
functioning by prolonged institutionalisation. Most countries are attempting to care for 
people with severe mental illness in their own homes or in homely environments, as 
close to home as is compatible with the health and safety of the patient and the safety of 
the public.  
In many regions the principal resource is still a large psychiatric hospital, often remote 
from much of the population it serves. In this situation, efforts are needed to start 
outreach community clinics. The hospital resource should be used as imaginatively as 
possible, for example, for people with long term severe mental illness: creating half way 
houses from existing buildings on the site which may not presently be used to best 
effect. 
Functional needs, which should be met in people with severe mental illness, are food, 
housing, health care, leisure activity, occupation, family relationships and social 
networks. The structures which are put in place to satisfy those needs depend on the 
resources available. The involvement of the local community is essential, and often the 
only possible resource, but its ready availability to people with mental illness depends 
on the extent to which stigma is attached to people with mental illness and those who 
care for them. 
Some countries and regions already provide local comprehensive services, including: 
• crisis intervention services with outreach teams, telephone hot-line and crisis 
beds 
• acute beds in general hospitals for episodes of acute and severe illness, 
• 24 hour nursed long stay accommodation, in homely units, for people with 
enduring severe mental illness needing regular supervision of medication and 
daily monitoring of their mental state, but not requiring continuous presence of 
medical staff, 
• supported housing, 
• domiciliary services, 
• opportunities for daytime activities, 
• occupational rehabilitation services. 
  
De-institutionalisation and re-integration are especially important in Europe for those 
patients who have spent a long time  in large institutions. Rehabilitation programmes 
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including prevocational and vocational services, hostels, foster families and the like 
should be promoted. 
Multidisciplinary teams are needed to care for clients in hospital, residential and home 
settings. The term “community care” should therefore be taken to refer to a range of 
local services including in-patient care as well as support at home. Round the clock 
medical and nursing care will always be required for those in acute episodes of very 
severe illness, and a small group of people will need continuing nursing care for many 
years. 
Health professionals (doctors, nurses, psychologists and occupational therapists) will 
have to work closely with social workers, voluntary workers, advice and housing 
workers, probation officers, the police, and other relevant agencies to ensure proper co-
ordination of care. Police officers, for example, should know how to deal with a deluded 
psychotic patient and how to connect with the community psychiatric service. 
All efforts should have the basic aim of providing a decent quality of life – including as 
extensive autonomy as possible - to all patients, including the severely disordered, and 
their families. Patients should occupy the least restrictive slot in the system, which is 
often the most cost effective. 
Advocacy and self-help groups should be encouraged and supported. “Empowerment” 
and “participation” of patients and their families, both in planning services and in 
managing psychiatric disorders on a daily routine basis, should become a guiding 
principle.   
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J. Czeslaw Czabala, Institute of Psychiatry and Neurology, Poland 
 
Response 1: Implementation of National Mental Health Promotion 
Programme; the Case of Poland 
 
 
Professor Heinz Katschnig  presented an excellent overview of the current state of art on 
mental health promotion and prevention of mental disorders. It is quite clear from his 
presentation and from the literature that we know a lot about the concepts, mental health 
indicators, the good practices in the field, and about the policy. What we need now is 
the implementation of the policies into the practice in the European countries. In some 
of the countries such an implementation has already been started. Let me give you an 
example from Poland. 
 
RECOMMENDATION ON MENTAL HEALTH PROMOTION 
The Polish Government in 1996 adopted the recommendation on mental health 
promotion which is based on the Mental Health Act, issued by the Polish Parliament in 
1994. The main goals of  mental health promotion have been specified as: 
• Promotion of knowledge on the importance and conditions of mental health 
development and its maintenance; 
• Development of the institutions facilitating consultation, counselling, and early 
interventions; 
• Building of the environmental conditions, supporting development and maintenance 
of mental health. 
The main activities aimed on the achievement of these goals should include the 
following strategies: 
1. Development of appropriate knowledge and skills in the society, needed for self-
development and self-actualisation, coping with stress and environmental 
demands. 
2. Development of and introducing educational curricula in schools, aimed at 
enhancement of  problem solving problem skills and coping with stress. 
3. Development of educational programs on mental health promotion and their 
introduction into the curricula of under- and postgraduate training of 
professionals involved in teaching and upbringing, treatment and care provision, 
re-socialisation and rehabilitation, management and organisation. 
4. Introduction of educational programs in work places, enabling the development 
of healthy relationships. 
5. Providing different forms of psychological, educational, marital and family 
counselling, vocational guidance, etc., as well as improvement of such services 
provision in the hitherto existing facilities, such as for e.g. child guidance clinics 
or social welfare units. 
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6. Providing psychosocial support for children and adolescents who are at risk of 
mental ill-health. 
7. Organising and promoting the development of various forms of social support, 
especially self-help groups, for people with mental disorders. 
8. Establishing of crisis intervention centres for people suffering from emotional 
crises and for families experiencing difficult life situations. 
9. Establishing of provincial and communal centres providing counselling, 
guidance and psychosocial support to people at risk for mental health. 
10. Providing professional training for those professionals who are involved in 
mental health promotion, counselling and other psychosocial support. 
11. Support for research on psychosocial factors promoting enhancement and 
maintenance of mental health, and on factors detrimental to mental health. 
The National Council on Mental Health Promotion was appointed by the Ministry of 
Health in 1998 to supervise and monitor the mental health promotion policy, mental 
health program development and its implementation. Members of the Council 
represents different governmental agencies (Ministry of Health, Ministry of Social 
Welfare, Ministry of Education, Ministry of Defence, Ministry of Internal Affairs) and 
different professions: psychiatrists, psychologists, pedagogues, sociologists, academics 
and clinicians. Council has started with the development of the National Mental Health 
Promotion Program. Unfortunately, in 2001 its activities have been stopped due to the 
lack of support from the new government. 
 
IMPLEMENTATION AND MONITORING OF THE NATIONAL MENTAL 
HEALTH PROGRAM 
The first draft of the National Program on Mental Health Promotion was prepared. It 
was focused on three themes, proposed in the Report on the “Promotion of Mental 
Health on the European Agenda (Lehtinen et al., 1997):  
1. The development of the person’s ability to deal with thoughts and feelings - 
management of life and emotional resilience, 
2. The development of the person’s ability to deal with the social world, 
3. The development and maintenance of healthy communities. 
The implementation of the Program means the activities and indicators which we have 
seen as the most important are shortly described below.  
To develop person’s ability to deal with thoughts and feelings 
The methods are: 
1. Education: 
- parents 
- at schools 
- society (mass-media) 
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- professionals involved in upbringing, teaching, treatment and care, re-
 socialisation and rehabilitation, management and organisation.  
2. Counselling: 
- psychological 
- educational 
- marital and family 
- vocational guidance 
The feasible indicators could be the following: 
1. For education: 
- No. of publications for parents 
- No. of educational programs 
- No. of parents attending the educational programs 
- Quality of schools’ educational curricula with regards of being aimed on 
 enhancement solving problem skills and coping with stress 
- No. and quality of learning programs focused on development of children’s 
 abilities to deal with thoughts and feelings 
- No. and topics of mass-media programs related to mental health promotion 
- Educational campaigns  
- No. of subjects related to mental health in the training of professionals. 
2. For counselling: 
- No. of existing counselling centers in the regions 
- No. of counselling interventions for children, adolescents, parents, people at 
 risk, etc. 
To develop the person’s ability to deal with the  social world 
The methods are: 
1. Education 
2. Counselling 
3. Familiar and social support 
4. Crisis intervention 
Feasible indicators could be the following: 
Familiar support: 
- No. of single parenting families 
- No. of divorces 
- No. of siblings 
- Subjective feeling of belonging. 
 
 114 
 
Social support: 
- No. of friends 
- No. of meetings with friends 
Institutional support:  
- access to  financial support  
- access to the institutional support in the case of temporal or long lasting 
 disability. 
Crisis intervention: 
- No. of crisis intervention centers 
- No. of clients 
- Availability of different crisis interventions 
Development and maintenance of healthy communities 
The methods are: 
1. Raising awareness about the importance of community conditions for mental 
 health. 
 
2. Building local policy on: 
- safety environment 
- poverty prevention 
- support for disabled children and adults 
- living conditions and social support for elderly persons 
- prevention of unemployment 
 
3. Self-help activities 
Feasible indicators could be the following: 
1. For awareness raising:   
- No. of local experts, representatives of communities and decision makers, 
 involved in building mental health promotion policy 
- Quality of the local programs on mental health protection 
- No. of local mass-media programs related to mental health promotion and 
 mental health policy 
2. For policy development:  
- No. of  leisure time facilities for children and young people 
- No. of crime and violence incidents 
- No. of people living in poverty 
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- No. and quality of social assistance programs for disabled, elderly and other 
 groups at risk 
- Activities on unemployment prevention. 
3. For self-help activities: 
- No. of self-help groups on the local level  
- No. of volunteers involved into programs of mental health promotion 
- No. and kinds of NGOs involved in the development of the local policy on 
 mental health. 
We are aware that we need to work more on the National Program and find the way 
how to be much more precise when going for implementation and looking for networks 
which could get involved in the process. We would like to use the expertise of the 
European networks, which have been dealing with these problems for many years and 
are much more experienced in the field. It would also seem that building a European 
Strategy as it had been proposed by the Consortium working on project “Mental Health 
Promotion and Prevention Strategies for Coping with Anxiety, Depression and Stress 
Related Disorders in Europe (2001-2003)” would be an utmost importance for further 
developments, especially in new EU member countries. 
 
 
Leo De Graaf, Mental Health Europe, The Netherlands 
 
Response 2: Challenges in Mental Health Promotion and Prevention 
 
 
INTRODUCTION 
Elaborating on the theme of the Bilbao Conference “Mental Health in Europe: New 
Challenges, New Opportunities” and responding to the presentation given by Prof. H. 
Katschnig, this presentation aims to take stock of the present situation and future 
opportunities in the field of Promotion and Prevention. This approach was inspired by 
an awareness of the overwhelming task that promoters and preventers of mental health 
have set themselves, comparable to the missions of Hercules to kill one monster after 
the other or that of Sisyphus endlessly rolling uphill a large rock, loosing grip just 
before the top of the hill was reached. However, the situation is not that gloomy, 
because, on the other hand, there are also some very encouraging developments that can 
be mentioned. 
Before going into this balance of aggravating and facilitating factors, first a few words 
will be said about definitions. The presentation will continue with some comments 
about the role of NGOs and users and end with conclusions and needed actions. As the 
terms “Promotion of Mental Health and Prevention of Mental Disorders" will be 
mentioned frequently, in the rest of this paper a shorthand term will be used: 
“Promovention”. 
DEFINITIONS 
In the literature about promovention it is striking how many different definitions are 
used. In many papers Mental Health is equated with mental well-being. And well-being 
itself is sometimes, e.g. by Seligman, equated with happiness. If increasing happiness in 
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the population would be the aim of promovention the ambition or pretension would 
indeed be very high and the risk of failure correspondingly large. 
In other papers the term (promotion of) quality of life is preferred, which again is a very 
ambitious objective, and at the same time very general and unspecific. Other authors 
prefer to stress the importance of increasing the resilience of people to cope with the 
vicissitudes of life. This objective is better delineated, but it has the disadvantage that it 
can only be checked under certain circumstances, i.e. after something unfortunate has 
happened. 
Generally, disagreement about the definition of a phenomenon points to a disagreement 
on the meaning and content of that phenomenon. If that is the case with promovention, 
it would mean that there are different sorts of promoters and preventers, although they 
share the same name. This lack of consensus on the definition (and probably on the 
basic idea) of promovention is hampering progress in the field of promovention and 
deserves critical attention. 
 
FACTORS THAT LIMIT THE IMPACT OF PROMOVENTIVE 
INTERVENTIONS (AGGRAVATING FACTORS) 
Very large target group 
In recent years much attention has been paid to the large numbers of people that are 
suffering from mental health problems: Katschnig reports a 12 month prevalence of 
29.5% and a lifetime prevalence of 48.0% of mental health problems. However, the 
number of people who carry an increased vulnerability could be even higher, maybe 
even substantially higher, so that, even if promovention of Mental Health limits its 
interventions to those people that are at a higher risk (and not choose to consider the 
whole population as the target group as some promoventers propose), at least a majority 
of the population belongs to the target group. Taking into account the limited resources, 
both human and financial, that are available for the promovention of Mental Health, the 
tasks are tremendous. 
Heredity 
After a few decades in which the influence of heredity on mental disorders was treated 
as if of little importance or, by some people, flatly denied, it is clear that in recent years 
the importance of heredity is much more widely accepted and the balance in the ever 
recurring nature-nurture debate is tipping to the nature-side of the scale. The most 
prevalent opinion nowadays is that for most mental disorders some hereditary 
vulnerability is a prerequisite for the appearance of the disorder, if external 
circumstances are favourable for such actualisation. The degree of vulnerability varies 
enormously: from 1% for schizophrenia in the general population to 100% for 
individuals carrying the allele for Huntington’s disease.  
Promovention is possible and worthwhile because of the important role of specific 
circumstances that are a prerequisite for the outbreak of the disorder, also for 
individuals with a hereditary risk. That gives possibilities for intervention by preventing 
these circumstances from taking place. That is the good news. The bad news is that the 
hereditary risk as such is left untouched, so that again and again new generations with 
the hereditary risk are born.  
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Zero-sum developments 
Some developments that are propagated by promovention because of their beneficial 
effect on the decrease of risk factors or the increase of protective factors are in many 
cases found to also lead simultaneously to the increase of other risk factors or the 
decrease of other protective factors. For instance: economic improvements which 
decrease the risk factor of deprivation can increase other risk factors like stress, and 
sedentariness. 
Cultural changes like emancipation can increase the protective factor of autonomy, but 
at the same time also increase the risk factor of loss of support. On balance the gains on 
the one hand can be undone by the losses on the other. This is what I call a zero-sum 
development. In setting up promovention-programs, attention should be paid to this 
phenomenon. 
Disasters 
Many promovention-programs are strenuous and prolonged. Clear examples are 
programs for people that are exposed to traumatic situations in order to prevent the 
development of post-traumatic disorders. These traumatic situations can be caused by 
natural or by man-made disasters.  
It is very frustrating to see that, whilst teams are working for years to prevent or 
mitigate the consequences of, for example, a civil war in a certain country, some 
generals in a neighbouring country start a new civil war, causing a vast amount of risk 
factors for the population. In the Dutch language there is a saying “Mopping the floor, 
whilst the tap is still running”, which means that it is useless to combat an undesirable 
situation if one can not stop it at source, but treating only the final consequences. 
Therefore it is important to develop strategies to forestall the massive “production” of 
risk factors, because otherwise promovention will never catch up with the overload of 
situations that threaten our mental health. 
Long-term and widespread developments that massively increase the number of 
risk factors 
Several developments that are beyond the control of promovention are taking place in 
the world or some parts of the world that, because of their widespread character, 
influence the lives of many people in a fundamental way and can cause a large increase 
of risk factors or decrease of protective factors. 
Examples are: 
• Individualisation: the process that an increasing number of people are planning and 
executing their life independent from the lives of other people. This means a large 
increase in autonomy and a better internal locus of control, which is considered 
beneficial for good mental health. At the same time it can lead to a loss of social 
support, a weakening of being embedded in a reliable, intimate social structure and a 
higher risk of becoming lonely. Some people can handle such situations much better 
than other people. So some people will benefit from individualisation and 
experience it as a relief, but other people will suffer from it. These people will form 
a new high risk group. 
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• Modernisation: the process that people, due to outside influences (media, education, 
political programmes) drop their traditional opinions and way of life and adopt 
opinions and lifestyles of a different culture, in most cases the western culture. 
Usually this shift from one culture to another is partial, so that a mix of “traditional” 
and “modern” ways of life is formed which can be very stressful. One example: 
eating disorders, like anorexia nervosa and bulimia until recently were limited to 
western countries. Recently cases have shown up in Eastern Europe, South Africa 
and other parts of the world outside the USA and Western Europe. 
• Globalisation: the process in which the network of economic, financial, technical 
and cultural relationships between all parts of the world is intensifying. This process 
has several consequences. One was mentioned before: modernisation. Another 
consequence is the increase of international migration, leading to the settlement of 
many migrants in countries that are foreign and sometimes hostile to them. It is 
found that a higher percentage of migrants are admitted to psychiatric hospitals than 
was admitted in their country of origin. Many explanations are brought forward, but 
it is not unreasonable to suppose that this increased prevalence of psychiatric 
morbidity is at least partly due to the stress of living in a foreign and hostile country. 
The summing up of all these disadvantageous factors and developments might sound 
discouraging. And I must admit that I have great admiration for all those workers in the 
field of promovention who enthusiastically and energetically continue with their 
programmes, unshaken by the vastness of their tasks. But the picture is not that gloomy, 
because a number of favourable developments and conditions can also be mentioned. 
Some of them have already been mentioned, like the increase of economic prosperity in 
some countries (like China and India), reducing the risk factor of deprivation. And 
processes like individualisation, which gives opportunities for many people who can 
cope with the sequels and benefit of increased autonomy. But on top of these already 
mentioned developments a few more favourable developments and conditions are 
discernible. They are very diverse and are sometimes seen to strengthen each other. 
INCREASING ACKNOWLEDGEMENT OF THE IMPORTANCE OF MENTAL 
HEALTH 
Health 
For many years the attention of the media, the politicians and the general public on 
mental health was marginal in comparison with the attention given to physical health. 
Gradually this is changing. Good examples are the publication of the WHO sponsored 
World Health Report 2001 “Mental Health, New Understanding, New Hope”, the 
Public Health Programme of the EU, in which Mental Health is one of the priorities, 
and Standard One of the National Service Framework of the British Government, which 
prescribes to “promote mental health for all, working with individuals and 
communities” and to “combat discrimination against individuals and groups with 
mental health problems, and promote their social inclusion”. And although a real 
appreciation of the importance of mental health is still lacking for many politicians and 
governments, it seems there has arrived a turning point that can be decisive for the 
future of promovention. 
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Scientific Progress. 
Many people executing promoventive programmes have evaluated these programmes 
and made them evidence-based. The programmes were also scrutinised and screened by 
researchers and found to be solid. Clemens Hosman, working in the Universities of 
Nijmegen and Maastricht, the Netherlands, states in 2000: “Over the past three decades, 
between 1 000 and 2 000 outcome studies have been published on prevention and 
promotion in the mental health, substance use and related fields. They differ in their 
methodological rigour, but hundreds have been carefully done”. At the moment he is 
working on an extensive database for evidence-based programmes, which can be used 
elsewhere in the world. 
Allies 
For a long time only a small group of enthusiastic idealists were committing themselves 
to the issue of promovention. Now it seems that the picture is changing. Earlier the 
endeavours of the WHO, the EU and the British Government were already mentioned. 
After publishing the World Health Report 2001 and the accompanying Atlas, the WHO 
is now working on a follow-up programme mhGAP (Mental Health Global Action 
Programme) of which promotion and prevention will be important parts. Among other 
activities, the WHO is preparing a publication in which a large number of best practices 
in the field of promotion of mental health from all over the world will be presented. 
But there are many more allies. Many people working in the reconstruction of 
dilapidated neighbourhoods or combating criminality or reducing the drop-out rates in 
schools are doing work that is very much akin to promovention or has side-effects that 
favour the decrease of risk factors. Many of these people hardly realise the important 
role they play in promovention. They should be recognised and acknowledged. 
An ally of a very different kind is academic psychology. A few years ago a new branch 
of psychology was born called Positive Psychology. One of the leading figures is 
Martin Seligman, well known for his description of depression as “learned 
helplessness”. He became dissatisfied with only studying the repair of what has gone 
wrong in the psychological life of people and wanted to know more about those factors 
that increase the well-being or happiness of people. This shift of interest can lead to the 
discovery of important protective factors and therefore become very helpful for 
promoventive programmes.  
Some social developments in regard of risk factors 
The affluent society. 
Earlier it was mentioned that the increase of prosperity leads to the decrease of 
deprivation as a risk factor. But that is not the whole story. It can also be observed that 
the more affluent a society becomes, the more prevention-minded and promotion-
minded such a society becomes. Maybe not all of us are aware of the large amount of 
attention, energy and money we already spend on prevention and promotion in our daily 
lives.  
Activities like saving money, taking out insurance, inoculating against influenza, 
building a social security system, taking measures against pollution of the environment, 
setting up agencies to control our foodstuffs etc., are all examples of preventive and 
promotion measures we take to reduce the risks of the vicissitudes of daily life. Only a 
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small part of all these activities is invested in our mental health, which is very 
surprising, taking into account the importance of the good working order of our mental 
faculties for our functioning and our pleasure in daily life. But it is to be expected that, 
alongside the acknowledgement of the extent of psychological malfunctioning, the 
further increase of our prosperity will lead to more attention for prevention and 
promotion in the field of psychological functioning and strengthen the support for 
promoventive programmes. 
Decreasing acceptance of/increasing sensitivity to  violence.  
In recent years the media have paid much attention to incidents of violence and have 
given the impression that, generally speaking, violence is on the increase. This is also 
the feeling of the public and the politicians. However, in a recent study in the 
Netherlands and Germany it was found that the supposed increase has more to do with a 
raised tendency to call some act a violent act and to register and prosecute it as such. 
This seems to point to an increased sensitivity for violence, which would be in 
accordance with the theory of civilisation of Norbert Elias. 
If this thesis is correct it could lead to a decreasing acceptance of all forms of violence 
and consequently to a decreasing impact of the consequences of violence. Other 
phenomena seem to point in the same direction, like the abolition by law of the 
smacking of children, and the combating of bullying that is being adopted in many 
countries nowadays. 
In the international context the (slowly) developing control mechanisms for 
international conflicts could have the same effect. 
THE ROLE OF NGOs AND USERS IN PROMOVENTION 
Taking into account the comprehensiveness of promovention of mental health, 
governments, politicians and professionals will never be able to organise sufficient 
impact to meet the challenge. NGOs have to be involved to make the endeavour 
successful. Promovention of mental health, being a multifarious field, NGOs of 
divergent background are needed, like NGOs in education, housing, care and law. 
Within the NGOs those representing (ex-)users of psychiatric services and other people 
with mental health problems have a special place as experts on the influence of 
protective and risk factors. 
The NGOs should : 
• participate in the formulation of a definition of Promotion and Prevention  
• advise on priorities in programmes 
• monitor the planning and execution of programmes 
• scrutinise the outcome of programmes 
• reflect on the prejudices of researchers 
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CONCLUSIONS 
1. The combination of the enormous size of the target group and the large number of 
risk factors makes it necessary to use, on top of the programmes on micro- and 
meso-levels, also interventions on the macro, i.e. political, level. So, to have a 
lasting impact, additional instruments have to be developed. 
2. A possible new instrument could be Mental Health Impact Assessments (MHIA). In 
Europe, MHIAs could be applied in the case of, for example: 
• New European legislation about migration 
• The implementation of the decision to make Europe the most 
 competitive region of the world 
• The way that cultural changes are handled in the accession countries. 
 
SOME NEEDED ACTIONS 
1. An authoritative committee of researchers and professionals in the field of 
promovention of mental health should come up with a generally accepted definition 
for promotion of mental health. 
2. Professionals and researchers should develop specific expertises that enables them 
to draft mental health impact assessments 
3. All of the present stakeholders in promovention should re-label much of the work 
that is done by other professionals and NGOs in the fields of education, justice, 
housing, care, etc. as actually being part of and belonging to promotion of mental 
health and prevention of mental disorders, so that it can be researched and valued as 
such.  
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WORKSHOP 3A REPORT: Implementation of the Policy 
Recommendations for Mental Health Promotion and Prevention of 
Depression, Anxiety and Related Disorders 
 
Coordinator: Ville Lehtinen, Finland 
Facilitator: Andres Lehmets, Estonia 
Rapporteur: Juha Lavikainen, Finland 
 
The facilitator of the workshop, Dr. Andres Lehtmets opened the workshop by 
introducing the participants to the theme, for example by presenting the priorities 
outlined in the report "Framework for Promoting Mental Health in Europe" and 
describing the central parts of the draft policy report of the EC-funded project "Mental 
Health Promotion and Prevention Strategies for Coping with Anxiety, Depression and 
Stress-related Disorders in Europe". The full version of the draft policy report had been 
disseminated to all participants of the conference as part of the general background 
material.  
As the most essential objectives of action, Dr. Lehtmets highlighted the development of 
better concepts, improved methods of evaluation, and sets of indicators for mental 
health promotion. In addition, there is a need to raise awareness concerning the best 
models of mental health promotion, and to focus mental health promotion efforts on 
children and adolescents. Moreover, development of telematic methods for supporting 
mental health promotion should be continued and equality issues need to be taken into 
account in the field of mental health.  
After the introduction, the workshop participants were invited to discuss and express 
their opinions on four different questions which had been outlined prior to the 
conference.  
The questions were:  
1. How to apply the strategies of needed actions both on national and regional levels? 
2. How to stimulate the needed interdisciplinary and intersectoral collaboration? 
3. How to cover the life-span? 
4. What kind of support is needed from different stakeholders? 
The workshop proceeded by addressing the above questions sequentially, although it 
was clear that the questions are overlapping and complementary.  
NEEDED ACTIONS 
Concerning the application of strategies of needed actions, it was mentioned that even 
the regional level can be too large to manage efficiently. Therefore, the local level, such 
as part of a city, was mentioned as an appropriate target level. Connected to this, it was 
highlighted that interdisciplinary action needs to be tailored to the needs.  
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There was also a call for operationalising the concepts in order to find out "what to do 
and how to do it". In conjunction with this argument, it was highlighted that a lot of 
information has already been collected on the so-called best practices (for example in 
the EC-funded project mentioned above).  
With regard to the next steps, the implementation of the strategies will be started with 
existing networks and the action plan will be decided together with the partners who 
will take part in the new project. A good example of concrete measures would be the 
organisation of national seminars. The need to translate the messages into political 
language was also emphasised.  
STIMULATING COLLABORATION 
As to question 2, the workshop fully agreed that promotion and prevention work cannot 
be dealt with by the health sector alone.  
The workshop constructed the following list of potential interdisciplinary collaboration 
partners in the area of mental health promotion and prevention of mental disorders:  
• The Media 
• The Public at large 
• Professionals in prevention 
• Mental health services 
• Health care services 
• Social services 
• Social insurance 
• Labour organisations and trade unions 
• School/education 
• Church 
• Police/prisons 
• Self-help groups 
• Consumers 
• Families 
• Pharmaceutical industry  
When it comes to the implementation of the strategies, it will, however, be very difficult 
to include all possible sectors. This led to a general discussion of responsibilities and 
co-ordination of promotion and prevention actions. Here, one view was that an 
accountable entity would be needed for the above purpose. On the other hand, it was 
maintained that different forums may be beneficial in formulating the action plans. 
Therefore, cooperation should be facilitated and it could be worthwhile to investigate 
the current forms of cooperation, namely where and how people work together. 
COVERING THE ENTIRE LIFE-SPAN 
The necessity of covering the entire life-span, including childhood, youth, adult life and 
later life, was more or less self-evident. It was underlined that:  
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• the main focus should be on children; 
• specific emphasis should be put on transitional periods; 
• the growing number of older people poses new challenges.  
Here, it was also noted that at each age, there are problems on both the societal and the 
economical level. It was felt that children need to be able to build skills, e.g. problem-
solving skills, for life and parents need to be supported in acquiring and improving 
parenting skills.  
The workshop also brought to the fore the challenges posed by trauma and abuse. The 
raised life expectancy also challenges us to find innovative ways to promote the mental 
health of older people.  
SUPPORT FROM DIFFERENT STAKEHOLDERS 
As to the support from the different stakeholders, this workshop started by 
complementing the list of current stakeholders in promotion and prevention. These 
were: 
• International bodies (European Union, Council of Europe, WHO, ILO, etc.) 
• State level 
• Regional governments 
• Local governments 
• Social partners 
• Different public sectors 
• NGOs, advocacy groups, users 
• Insurance companies 
• Communities 
• Individuals 
• Pharmaceutical industry 
• Research institutions and research companies 
The role and interests of the pharmaceutical industry were discussed in this context. It 
was noted that their interests are most often in the consumers rather than, say, 
prevention. A real challenge would be to guide these companies in the "right direction". 
Funding issues were connected to the above and the role of the service users, families, 
and employers are highlighted here as well. 
FINAL REMARKS  
In the reporting session, the general conclusion was that strategy development is still an 
ongoing process. Within this process, it is essential that:  
• the local level is included when discussing the different levels of necessary 
actions;  
• better concepts are developed, evaluation methods are improved and sets of 
indicators for mental health promotion are fine-tuned;  
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• the governments' awareness concerning the best practices of mental health 
promotion is raised; 
• concentrated mental health promotion efforts focus on children and adolescents. 
Finally, it needs to be noted that the implementation of policy recommendations is a 
long-term process that is of interest to a large number of different stakeholders. Further 
elaboration is required to carry out the results and recommendations that have been 
obtained and formulated. 
 
 
WORKSHOP 3B REPORT: Monitoring mental health to support its 
promotion and the prevention of mental disorders 
 
Coordinator: Ville Lehtinen, Finland 
Facilitator: Viviane Kovess, France 
Rapporteur: Peter Breier, Slovakia 
 
GENERAL ISSUES 
 
The workshop was attended by 19 participants. V. Kovess introduced the issue of 
monitoring mental health. Various organisations work on the selection of proper mental 
health indicators – the WHO, Eurostat, OECD, EC. Until now, efforts have not been 
satisfactory as the collection of data is very difficult and the data are hardly comparable 
across countries.  
Professor Kovess listed the main categories, which should be including in monitoring:  
1. Demographic and socio-economic factors 
2. Health status which includes mortality, as well as disease specific and generic 
morbidity 
3. Determinants of health  (which should include positive factors) 
4. Health systems with subcategories: a) prevention, health protection, and health 
promotion, b) health care resources, c) health care utilisation, d) social services 
and welfare, e) expenditure, f) health care quality indicators 
 
The discussion in the group revealed the obstacles faced when trying to obtain 
comparable data across Europe. The entire set of indicators is not gathered in most of 
the European countries. In addition, the data are even difficult to compare within one 
country due to the different ways in which they are gathered on different levels (e.g. on 
federal and republic levels, or even regional differences).   
 
The possible methods of gathering relevant data were also discussed. The group agreed  
that it is important to include mental health aspects in general health surveys.  It was 
stressed that even if it is difficult to harmonise surveys in all countries, it is useful to 
collect information which can be comparable not only at one time but also from the 
long-term perspective. From the dynamic point of view even imperfect data can reveal 
trends inside a country, and also serve as trend comparisons between different countries. 
However, it is necessary to be careful to in interpreting causal relationships between 
data trends. 
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There  are two types of  collected data: 1) Routinely collected data on selected 
indicators, 2) Data collected by surveys done within general health surveys, as physical 
and mental health are closely linked.   
 
One of the greatest obstacles is that many countries have already developed their own 
indicators to monitor their systems, and these are not comparable with other countries. It 
was proposed that a core set of data should be mandatory for all countries as it is e.g. 
with the data on illicit drug consumption and policies in Europe.  Each country could 
then add their own indicators according to its needs, and, thus, will be able to continue 
to evaluate its own system. It was also proposed that there should be studies to compare 
countries which are close to each other (geographically, with similar health care 
systems, or on the basis of language similarity). This could help to study the effect of 
different policies, too.  It can be expected that by working on these comparative studies 
the problems will ameliorate with time and the comparable data could be better realised. 
 
KEY RECOMMENDATIONS 
 
The key recommendations from the group were as follows: 
• There is a need to collect data on mental health that will allow monitoring and 
comparison of mental health across the EU 
• The data have to be of two types: routinely collected data by approximately 10 
selected indicators and data to be collected by a population survey  
• Countries may be compelled to gather the data: within a time-frame, following 
specifications including design and instruments 
• A centre, closely related to the network of epidemiologists and mental health 
workers, should be set up in order to properly interpret trends across time and 
their relationships with interventions. 
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THEME 4: PREVENTION OF PREMATURE MORTALITY 
AND ABUSE PROBLEMS  
 
Iveta Bluka, Health Promotion Centre, Latvia, 
 
 
Prevention of Premature Mortality and Abuse Problems 
 
INTRODUCTION 
The enlargement of the EU will increase the current population of 375 million by 170 
million, thus bringing together 545 million people within a new political and economic 
trading zone. Background information gathered over the last tree decades and current 
health data show that this new grouping will unite a population with not only a diverse 
range of health profiles, but also 28 quite different health systems. 
From infant mortality to overall life expectancy rates, countries differ quite 
substantially. These differences are to a large extent related to social stress, mental ill-
health and destructive life styles. Especially in societies and populations undergoing 
stressful change, these differences are attributable to a cluster of stress-related factors, 
including depression and suicide, addiction, violence, risk-taking behaviour and 
lifestyles, and cardiovascular and cerebrovascular morbidity and mortality. 
All candidate countries report significantly higher mortality rates than those in the EU. 
As in the EU, non-communicable diseases, namely cancer, cardiovascular diseases and 
injuries, represent the bulk of morbidity and mortality. For both heart ischemic disease 
and injuries, the death rate in the candidate countries is about double that of the EU, 
while cancer mortality is slightly above that rate. 
Cardiovascular diseases continue to be one of the leading causes of premature mortality. 
It is highest in Latvia, Estonia, and Hungary. High cardiovascular mortality in Estonia, 
Latvia and Lithuania is determined by ischemic disease (overall rate in these three 
countries is 327/100 000) 
Only Slovenia reports figures slightly above the EU average. The Czech Republic has 
gone from having one of the highest ischemic heart disease mortality rates to having 
one of the lowest levels in the region (183 compared with the average rate of 227 among 
all). 
The so called “health gap” between the east and west of Europe has been well 
documented. The gap refers to the sharp divide in mortality patterns between the two 
regions. This will be the major issue for the EU as, despite considerable diversity 
among candidate countries, there remains a substantial and clearly avoidable health gap 
between the Member States and the accession countries. In 1998, overall life expectancy 
in the EU was 78.2 years compared to 72.5 in the candidate countries.  
However, the candidate country Slovenia has mirrored, to a large extent, the EUs' 
steady progress in reducing mortality. Slovenia has shown a relatively steady increase in 
life expectancy, from just over 72 years in 1985 to a level of about 76 years at present. 
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In contrast, countries such as Slovakia, Poland and Bulgaria have generally shown 
stagnation or even some decrease in the life expectancy. 
Mental health problems are increasing significantly. Of the 10 leading causes of 
disability world-wide, five are mental disorders: unipolar major depression, alcohol 
dependence, bipolar depression, schizophrenia and obsessive-compulsive disorder. 
Depression alone accounts for 4.1% of the total, ranking fourth among the leading 
causes of disease burden. By 2020 it is expected to be the second leading cause of 
DALYs lost, second only to ischemic heart disease. In many European countries the 
mortality from suicide now exceeds that from road traffic accidents. The burden is even 
greater when taking into account the association with other conditions, such as 
depression and cardiovascular diseases.  
SUICIDE MORTALITY  
Suicide is one of the leading causes of injury worldwide with an estimated 10–20 
million attempted suicides and 1 million completed suicides each year. In the last 45 
years suicide rates have increased 60% worldwide. Suicide was estimated to represent 
1.8% of the total global burden in 1998, and 2.4% in countries with market and former 
socialist economies. 
In the European region, injuries and other external causes of death (such as accidental 
poisoning, suicide and homicide) are thought to account for a substantial proportion of 
all deaths. They also account for a large part of the overall burden of disability and ill 
health in the region. 
Europe alone sees 700 000 suicide attempts per year and approximately 45 000 
completed suicides. Although suicide rates are higher in some EU countries than in 
others, they do not reach the levels seen in Eastern Europe. The mortality rates due to 
suicide and self-inflicted injuries range from 11 to 36 per 100 000 population in 
European countries. Suicide rates in the European region vary 10-fold among young 
females but 40-fold among young males, with very different trends in different 
countries, ranging from a 40% decrease to an 80% increase over the 15 year period.  
Suicide figures have risen during the 20th century. It is easy to guess that the 
secularisation, urbanisation and increasing availability of suitable drugs have 
contributed to this. 
Suicide in the EU 
The EU has achieved significant health gains over the past three decades since the 
previous report on health status in 1992. However, there is still a significant level of 
preventable morbidity and mortality before the age of 65 years. 
Suicide is an important contributor to life-years lost in the EU. However, differences 
between various countries and nations in regard to suicide behaviour can be enormous 
(Schmidke 10). Several factors may influence this variation: socio-demographic factors, 
ethnic differences, religious beliefs and affiliations, attitudes towards suicide, legislation 
regarding suicide, coping strategies, prevention strategies, and the reliability and 
validity of death certification and reporting. The latter is particularly relevant because 
practices in recording the cause of death can be influenced by legal, moral and cultural 
factors.  
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In general males had considerably higher suicide rates than females. The literature 
review suggested that suicide rates in the northern EU countries are higher than the rates 
in the Mediterranean countries such as Spain, Portugal, Italy and Greece. The Nordic 
countries have a common pattern with relatively fewer suicides among older people and 
relatively more suicides among people below the age of 45 years when compared to the 
UK and the Catholic countries of Europe. But the total number of suicides differs rather 
a lot between the Nordic countries, with Finland and Denmark sitting at the top of the 
European rankings, while Norway and Iceland report only half as many suicides, and 
Sweden lies somewhere in-between.  
Age-standardised suicide rates for the individual countries showed that Finland had the 
highest suicide rate for the latest available year, while Greece had the lowest. 
Significant downward trends over time occurred in Austria, Denmark, France, 
Germany, Greece, the Netherlands, Portugal, Sweden and the UK while significant 
upward trends were observed in Ireland and Spain. No significant trend was observed 
for suicide rates in Belgium, Finland, Italy and Luxembourg. 
A decline in male suicide rates was observed for 10 of the 15 EU countries while 13 
countries reported a decline in female rates over the study period. A significant 
downward linear trend in male mortality was observed for Austria, Denmark, France, 
Germany, Netherlands, Portugal and Sweden. Significant upward linear trends in male 
suicide mortality were observed in Ireland and Spain while no significant trend was 
observed for Belgium, Finland, Greece, Italy, Luxembourg and the UK. 
Suicide mortality is higher over- rather than under-65 years of age. Under the age of 65 
the lowest mortality cluster of countries includes Greece, Ireland, Italy, Portugal, Spain 
and the UK, and the highest mortality clusters includes Belgium, Finland and 
Luxembourg. For males and females under or over the age of 65 years the overall EU 
trend is currently downwards. Although the trends vary from country to country, in both 
sexes under 65, the trend is still upwards for Ireland and Luxembourg.  
While a decrease in suicide rates in general has been reported from most EU countries, 
rates in young adults (15–24 year olds) have been on the increase for almost half the EU 
countries. Although a decline was also observed in suicide rates in the older age groups, 
suicide mortality was highest in the age bracket of the over 65's. 
Depressive illness is thought to be the most important predictor of suicide among the 
elderly, and social isolation has also been highlighted as an important contributor. The 
treatment gap is still considerable. In primary health care settings, 50% of depressions 
are unrecognised, despite the fact that 30% of the consultations with general 
practitioners are for mental health problems.  
PREMATURE MORTALITY IN THE CANDIDATE COUNTRIES 
The accession of up to 13 new members in the next decade is the most important 
development now facing the EU. The total population for the candidate countries was 
nearly 105 million people in 2000 – about 28% of the current population of the EU. The 
average birth rate has consistently been below the death rate, leading to a natural decline 
in total population. Fertility has been below replacement level for a number of years. 
Health status in the candidate countries improved generally until the early 1970s, but 
then stagnated. Death rates overall, and those due to the major causes, began to fall in 
the 1990s, and life expectancy increased. 
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Dramatic economic and social changes through the 1990s were associated with low 
birth rates, net emigration and falling populations, particularly those of working age 
persons. Demographic change has increased the proportion of older people, though not 
yet as dramatically as in the EU. This particularly affects Bulgaria, Estonia and Latvia. 
Populations in the EU, in contrast, are generally rising slowly. 
The experience of the CEE applicant countries in the 1990s has been very different, 
with marked falls in national income during the process of transition away from 
socialist systems. The economies in almost all cases have now been growing for several 
years (Bulgaria and Romania are exceptions with a rocky recent period) but there is 
clearly enormous catch-up growth to be made if typical levels of EU income are to be 
reached. Only Slovenia had income per head in 1997 as high as the bottom limit of the 
EU-15 range – and only in Poland had the GDP grown to exceed its 1989 level (several 
other Central European countries were nearly there but Bulgaria and the Baltic states 
were still 25-45% down) In Romania, Lithuania, Latvia and Bulgaria, national income 
per head in 1997 was less than a third of the EU-15 average. The differences within the 
CEE group are much larger than those among the EU members. 
Life expectancy in older age groups (45 and 65 years) is also below the EU level. Only 
Slovenia and the Czech Republic are approaching the life expectancy of some EU 
countries. Estonia, Latvia and Lithuania experienced particular mortality problems 
during the social transition of the late 1980s and early 1990s, and now have the lowest 
life expectancy in the group, followed by Romania, Hungary and Bulgaria. The gender 
difference in life expectancy is larger in this group of countries than in the EU, but in 
both the gap has narrowed in recent years. 
Deaths due to external causes are particularly common in Estonia, Latvia and Lithuania, 
with high levels of road traffic deaths, homicides and suicides. Mortality from suicide is 
relatively high in Latvia, Hungary and Slovenia. All the candidate countries have high 
rates of accidental and violent deaths. Estonia, Latvia and Lithuania have the highest 
rates, with trends that mirror both overall and cardiovascular mortality. This particular 
pattern of mortality seems to be associated with high alcohol consumption in these 
countries. 
Road traffic deaths in Estonia, Latvia and Lithuania are among the highest in the entire 
region. These were over twice as high in Latvia as in the EU in 1998, at 27 against 10.7 
standardised death rate per 100 000 respectively. Trends in these countries are 
associated with alcohol consumption. In contrast, rates in Bulgaria are lower than in 
many countries in the EU. 
Homicide rates are generally also higher than in the EU, particularly for women. 
Homicides are particularly common in Estonia, Latvia and Lithuania. Several other 
candidate countries (Slovenia, Czech Republic, Poland, Slovakia and Hungary) have 
homicide rates lower than those in Finland (the highest EU country). 
Suicide rates are high in Estonia, Hungary, Latvia, Lithuania and Slovenia, while they 
are similar to the EU average in the other candidate countries. Suicide rates for men are 
consistently higher than the EU average, with much less uniform pattern for women. In 
the Baltic States during the 1980s and early 1990s, the trend for male suicide followed 
the trend in overall mortality and the mortality rates for cardiovascular diseases and 
external causes, reflecting the social disruption and the trends in other alcohol-related 
deaths. Though this trend was not seen among women, it dominated the overall trend, as 
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male suicide rates are significantly higher than female. Romanian, Polish and Slovak 
women have relatively low suicide rates, below several EU countries. 
SITUATION ON DATA COLLECTION ON SUICIDES 
Suicide mortality rates varied markedly between countries for reasons that remain 
unclear. Deficiencies in routine data need to be addressed. These include different  
methods of data collection, the lack of suicide method-specific data, inconsistencies in 
recording standard demographic variables and the paucity of data on risk factors. The 
main deficiency in parasuicide data was the virtual non-existence of data on a national 
level. Possible remedial measures include the standardisation of recording and reporting 
suicide events and suicide methods in all member states, and the establishment of 
national parasuicide registers following Ireland’s example. In the absence of adequate 
EU-wide data on suicide epidemiology, effective prevention of suicide is likely to 
remain elusive.  
In all EU countries, mortality data are collected as part of routine vital statistics. The 
main sources identified for these data were the WHO-Euro, European Statistical Office 
of the EC (EUROSTAT), the European Public Health Information Network (EUPHIN) 
and the national statistical agencies of each member state.  
Comparing rates between countries is difficult because of concerns arising from a 
variety of definitions, and methods for recording, coding and reporting. Some countries 
investigate deaths that may possibly be due to suicide thoroughly while others tend to 
classify such deaths routinely as accidents. The reasons for such differences between 
countries are largely unknown although one hypothesis is that suicide is less socially 
stigmatised in some countries than in others. A study investigating religious influences 
on the rates of suicide worldwide reported that religious differences between countries 
influenced the accuracy of suicide data returned to the WHO ( Kelleher, Chambers et al 
1998). A comprehensive analysis suggested that the average reporting rates for 
countries with “religious sanctions” against suicide tended to be lower than those 
without.  
Some countries require a suicide note, while others require a decision on intent made by 
the coroner. An investigation into the reliability and sensitivity of suicide certification 
(Rocket & Thomas, 1999) revealed that some countries (Austria and the Netherlands) 
generate suicide data of excellent quality for all age groups and gender. However, others 
such as Finland, Greece, Ireland and the UK reveal potential misclassification within 
certain subpopulations, especially the 15-24 and 75 and older age groups. 
The Netherlands, Belgium, France and Portugal have at some stage incorporated 
parasuicide as part of the data collected by sentinel practice networks. Suicide and 
parasuicide were included in morbidity surveillance via sentinel general practitioners in 
Belgium. 
The conclusion is that the most urgent priority is to develop a standardised approach 
across the EU to the defining, recording, coding, classification and reporting of suicide 
and parasuicide. The means of committing suicide should be specified in routine 
national data. Risk and exposure variables should be included in routine suicide data. 
Notwithstanding the current deficiencies in data, continued monitoring of 
epidemiological trends in place and time in the EU is necessary to inform the 
development of preventive policies and activities. In this regard, the establishment of 
 132 
 
parasuicide databases in each member state is particularly important. Research of an 
analytical and evaluative nature is especially urgent to help improve the evidence base 
for the clearer identification of high-risk groups and environments, and the 
implementation of effective suicide and parasuicide prevention. 
Networking between organisations in the field of suicidology is difficult to achieve 
without an adequate infrastructure. Therefore, we would urge the EC to support the 
creation of such an infrastructure. 
ALCOHOL CONSUMPTION 
Each year over 55 000 young Europeans die from the effects of alcohol abuse: one in 
four deaths in European men aged 15-29 years is related to alcohol. In addition, between 
40% and 60% of all deaths from injuries are attributable to alcohol. Alcohol is directly 
and indirectly implicated in various types of assault, criminal behaviour, unintentional 
injury, violence, homicide and suicide. The European Region has the highest rate of 
alcohol consumption in the world, but the average recorded consumption of 7.3 litres of 
pure alcohol per person in 1998 hides considerable differences between countries, from 
a low of 0.9 litres to a high of 13.3 litres per person. Nordic countries show stable levels 
of alcohol consumption, except Sweden, which is experiencing a decrease. 
Consumption is increasing in Latvia and Lithuania, while Estonia shows a slight 
decrease. Among 15 EU countries, Ireland is the only country where consumption is 
increasing considerably, although it is increasing to a lesser extent in Greece, 
Luxembourg and Portugal. In the CEE countries consumption is increasing in the Czech 
Republic, Romania and the former Yugoslav Republic of Macedonia.  
The Czech Republic, Slovakia, Slovenia and Hungary report the highest levels of 
alcohol consumption, associated with the high levels of cirrhosis also found in these 
countries. The highest mortality associated with chronic liver disease and cirrhosis is 
currently reported in Hungary, Romania and Slovenia, all significantly higher than the 
EU average. 
Motor vehicle deaths, seemingly associated with high alcohol consumption, increased 
quickly in most candidate countries, particularly in Latvia and Lithuania. 
Today, it is well known from individual-level studies that the percentage of suicides 
connected to alcohol abuse is high. According to a recent review of research findings by 
Russow (1996) it was shown that a history of alcohol abuse and heavy drinking was 
present in between 10 to 54 percent of suicides. Moreover, in the majority of studies 
reviewed, an excess mortality from suicide of 5 to 10 percent was estimated for samples 
of alcoholics. The absolute number of yearly deaths associated with alcohol abuse is in 
excess of 8659 for men and 2248 for women. 
Available data suggest that the highest levels of alcohol-related deaths are observed in 
Danish males and the lowest in Luxembourgean males. The highest levels among 
females are observed in Greece and the lowest in Spain. In some Member States there is 
a significant alcohol effect on the suicide rates of males (Finland, Sweden, Austria, 
Belgium and Portugal) and females (Sweden, Austria, Belgium, The Netherlands and 
Germany). Per capita consumption is a key factor in explaining changes in cirrhosis 
mortality for men and women and for different age groups. Alcohol also contributes to 
cancer of the mouth and of the oesophagus. Sustained drinking progressively increases 
the risk of raised blood pressure and stroke and the possibility of ischeamic heart 
disease.  
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However, the strength of this connection may differ between countries, or more 
specifically, between drinking cultures with different characteristics. By comparing 
individual level studies from different countries one cannot explore this question since 
such studies are seldom similar enough for any meaningful comparisons in this respect. 
Moreover, although the individual-level findings certainly suggest that the alcohol-
suicide link can be found in most countries, these kinds of study are particularly 
vulnerable to selection effects, i.e. the possibility of an underlying factor that increases 
the risk for both alcoholism and suicide. (Norstrom 1988) 
Any associations between the age-standardised suicide rates and annual alcohol 
consumption (litres per person) for each country were investigated by computing the 
relevant correlation coefficients. A significant positive correlation was observed 
between the two variables for Austria, France, Germany and Ireland. In fact Irish 
suicide rates and annual alcohol consumption showed the strongest association. When 
the trend of alcohol consumption in Ireland was observed it was apparent that the 
consumption of alcohol had increased dramatically over time compared to the other EU 
countries. On the other hand, Swedish suicide rates correlated negatively with the 
annual alcohol consumption suggesting that as the suicide rate decreased an increase 
was observed in the consumption of alcohol. 
SUICIDE PREVENTION 
Suicide has been referred to in the context of improved detection of depression. Any 
preventive measure that reduces the incidence of depression should also reduce suicide 
rates as approximately 1 in 6 of all depressed patients end their life by suicide. 
Suicidality can be treated. There is evidence that lithium treatment of bipolar disorder 
significantly reduces suicide rates. In fact, lithium may have specific anti-suicidal 
effects on people with this disorder since these effects may be separate from its 
antidepressant and anti-manic effects. Rates are reduced only while the patients take 
lithium; after discontinuation of treatment, the rates begin to rise to levels similar to 
those seen prior to lithium treatment.  
Medication alone is not sufficient for treating mental disorders or suicidality, nor are 
treatments equally effective across individuals and diagnoses. Psychotherapy provides a 
necessary therapeutic relationship that reduces the risk of suicide. Cognitive-
behavioural approaches that include problem-solving training seem to reduce suicide 
attempts and suicidal ideation more effectively than treatment with typical or non-
directive therapy.  
Patients are at much greater risk of suicide in the weeks immediately following 
discharge from the hospital. Patients who continued care either through community 
services or with pharmacotherapy had lower suicide rates. 
Psychological autopsy studies reveal that only 6-14% of depressed suicide victims were 
adequately treated and only 8-17% of all suicides were under treatment with the 
prescription of psychiatric medication. There are significant barriers to receiving 
effective mental health treatment. About two thirds of people with diagnosable mental 
disorders do not receive treatment. The stigma of mental illness deters people who need 
treatment from seeking it. The fragmented organisation of mental health services and 
the cost of care are among the most frequently cited barriers to mental health treatment.  
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Physicians are reticent to talk to their patients about suicide; they often do not ask about 
intent or ideation, and patients do not often report it by themselves. The goal of suicide 
treatment in specialty care is to develop and implement a treatment plan, which includes 
monitoring of medication efficacy and safety, as well as discharge planning. Primary 
care has become a critical setting for detection of the two most common risk factors for 
suicide: depression and alcoholism. Currently, only about 30-50% of adults with 
diagnosable depression are accurately diagnosed by primary care physicians.  
Recommendations for suicide reduction: 
1. The National Institute of Mental Health (or other responsible organisation) in 
collaboration with other institutions should develop and support a national 
network of suicide research and suicide prevention across the life cycle. 
2. National monitoring of suicide and suicidality should be improved (long-term 
studies of health behaviour, mental health interventions, genetic studies of 
mental disorder) 
3. Tools for recognition and screening of suicidal patients should be developed and 
disseminated. 
4. Programs for suicide prevention should be developed, tested, expanded and 
implemented through funding from appropriate agencies. (11) 
5. Prevention programs that have shown success within selected populations 
should be expanded. 
6. Pilot programs for coping and resilience training as part of the curriculum for 
school-aged children should be implemented, evaluated, and scaled up when 
feasible. 
7. Long-term public education campaigns and media training should be evaluated. 
A reduction of alcohol use would also likely reduce the suicide rate, as around a quarter 
of all those who successfully complete suicide are dependent on alcohol. Secondary 
prevention–reduction of alcohol availability is a political and legal decision that affects 
alcohol consumption in the whole population, but making those who are at special risk a 
target for more intensive intervention is more cost-effective and in most cases preferred 
to general health promotion. Intervention of an educational nature has helped to reduce 
subsequent alcohol consumption. A combination of patient education and counselling 
can also help change people’s behaviour and prevent dependency. Primary care has a 
potential role to promote alcohol screening programs and train staff to provide advice 
and counselling.  
DRUG RELATED MORTALITY WITH IN EU 
Drug related deaths also create serious social concern. Problem drug users suffer a high 
overall mortality rate mainly due to overdoses, but also due to AIDS, accidents, 
suicides, violence etc. The impact of acute drug-related deaths becomes evident when it 
is considered that each year between 7 000 and 8 000 such deaths are reported by EU 
countries. The real number of cases is probably higher. Opiates are present in most 
overdose deaths, although the presence of additional substances is frequent. The 
mortality of opiate users, in particular injectors, is up to 20 times higher than the general 
population of the same age. The mortality of injectors is 2 to 4 times higher than non-
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injectors and (until recently) the mortality of drug users infected by HIV was 2 to 6 
times higher than non-infected users. With recent improvements in HIV treatment, this 
difference might be decreasing. 
From a long-term perspective of trends in EU countries (15-20 years), a marked 
increase of drug-related deaths was observed during the 1980s and early 1990s. During 
recent years the number of acute deaths has stabilised at this higher level. However, it is 
worrying that some EU countries report recent increases after a period of stabilisation 
and decrease. These overall trends may be explained by the expansion of heroin 
injection in many European countries during the 1980s and 1990s. 
DRUG RELATED MORTALITY IN THE CANDIDATE COUNTRIES 
Even if data quality and availability differ a lot between candidate countries and the 
resulting picture is rather patchy, we can hypothesise that, in the last decade, candidate 
countries have experienced accelerated growth in problem drug use and treatment 
responses similar to that experienced by the EU Member States over the last 35 years. 
Since the illicit drug market is clearly part of the “global’” market, a process of 
'westernisation' of the previously closed national scenes of all candidate countries is 
occurring, with local specifics increasingly being eroded. 
The treatment response in most candidate countries is also beginning to mirror the EU 
model, with substantial involvement of recognised non-governmental organisations 
(NGOs) and other bodies. 
Problem drug users represent a very small minority of the whole population, compared 
with people who have never used any illicit drug in their lifetime or with people who 
currently use illicit drugs. 
EU enlargement could create a new – even if not totally unknown – situation, as drug 
users differ significantly between the Member States and Accession Countries, whereas 
the general trend in problem drug use in the EU is stable and the population of problem 
drug users is ageing (especially users of opiates, the majority of accession countries are 
still situated in the rising part of the curve and problem drug users are younger, on 
average). 
Heroin, which is generally perceived as the most dangerous and the most harmful illicit 
drug, together with other opiates, is the prevailing drug for problem drug users in almost 
all candidate countries. The only exception is the Czech Republic, where the traditional 
domestic amphetamine still plays a major role; however heroin use is increasing rapidly. 
This heroin trend is common for all the Candidate Countries. 
ATD abuse is also present to a lesser extent (5-10%) in problem drug users seeking 
treatment in Slovakia, Hungary, Latvia, Lithuania and Estonia. The use of cocaine is 
insignificant in the candidate countries. Solvent abuse represents a challenge for most of 
the candidate countries. Quantitative data generally fails to provide a reliable picture of 
the phenomenon, because the affected population is mostly extremely young, socially 
marginalised and consequently hidden. The treatment facilities and services have not 
succeeded in reaching the population at risk. 
Last but not least, it is important to stress the need to improve data gathering and 
monitoring systems in all candidate countries. Compared to the EU Member States, the 
average level of data quality and availability is substantially lower, though with a few 
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exceptions. The political support of each government is a priority, as, without quality 
data, it is impossible to evaluate interventions and policies – the priority target of the 
EU Action Plan on Drugs. 
SUBSTANCE ABUSE PREVENTION AND MENTAL HEALTH PROMOTION 
The health promotion approach dominates prevention, integrating prevention measures: 
community-wide projects in schools, youth clubs, workplaces etc., and public 
information campaigns, following WHO principles on health promotion. The focus of 
all promotional work should be on healthy lifestyle promotion and life-skills 
development, implemented in compulsory school curricula with its vision of a healthy 
and confident society, free from alcohol and drug-related harm. 
Prevention strategies apply a two-pronged complementary preventive strategy: the 
broad (population-targeted interventions and the life-skills approach), and the narrower 
(specific action targeting high-risk groups). The broad strategy aims to identify and 
strengthen factors that promote healthy lifestyles and facilitate the development of 
autonomy, responsibility and critical sense. High-risk group interventions focus on a 
framework offering alternatives to drug use. Specific interventions also provide 
solutions for youths engaged in risk behaviours, and may include accessing drug 
services. 
Local initiatives and face-to-face communications are essential, accompanied by a 
holistic approach to co-ordinating programs and services at local level, involving 
communities in the development and delivery of local strategies, and focusing action 
where it is most needed. 
There are evidence-based studies on programs for young people, on alcohol and 
pregnancy and on the effectiveness of community and workplace policies. There is a 
special need to reach young people, low income and vulnerable groups, black and 
minority ethnic groups and older people. Harm reduction should be an integral part of 
drug policy in every country. It considers the legal frameworks for substitution and 
maintenance programs. It is essential that the countries concerned continue to reinforce 
their policies, institutions and co-ordination mechanisms and allocate additional 
resources to this end. 
It should also be underlined that the efforts of the candidate countries to align their 
actions in the drug field with those of the EU and its Member States are worth not only 
recognition, but continued support. 
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Response 1: Mental Health Can Be Improved and Suicide Prevented 
 
 
RELIABILITY AND VALIDITY OF THE DATA 
 
According to WHO estimates for the year 2020 approximately 1.53 million people will 
die from suicide and approximately 10-20 times that number will attempt suicide. 
Suicide is among the foremost single causes of death in Europe, and the one involving 
the most years of life lost. Therefore it is not advisable to use only suicide and 
attempted suicide rates, but there is also a need to calculate Disability Adjusted Life 
Years (DALY’s) and Potential Years of Life Lost (PYLL). In the age group 15-44, 
suicide is the most common cause of death in Sweden, more common than death due to 
traffic accidents, as well as in many other European countries. The reliability and 
validity of data on suicide and attempted suicide is however questionable. For many 
reasons suicide as a cause of death can be hidden behind a) traffic accidents; b) violent 
deaths; c) alcohol and drug intoxication; d) mental disorders; e) drowning accidents etc. 
 
All of the above-mentioned causes of death can include suicide, and misclassification 
depends on local traditions, rules, attitudes, religion, and knowledge. The suicides can 
also be misclassified and hidden in the diagnosis of uncertain causes of the death. This 
diagnostic category varies between different European countries, within different 
regions in the same country, between different ages and between different sexes. This 
only reinforces the gravity of the global picture of suicide, because many suicides are 
underreported due to improper diagnosis. The same applies to attempted suicide. There 
is however, reliable data from the MONSUE project. 
 
MONSUE – The Monitoring of Attempted Suicide and Suicide has been carried out 
since 1989. In 2003, the following European countries are invovled in this project: 
Austria, Belgium, Denmark, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, 
Latvia, the Netherlands, Norway, Poland, Slovenia, Spain, Sweden, Turkey, and the 
United Kingdom.  
 
The goals of the MONSUE project are: 
• Assessment of frequency and risk factors in suicidal behaviour and its repetition 
• Developing proposals for the implementation of strategies to reduce this 
behaviour  
• Determination of groups at risk, methods, “hot spots” and individual and social 
causal factors and their changes over time  
• Determination of protective factors 
• Testing the effect of specific measures  
 
Due to the magnitude of the problem among young people, the WHO / EURO Network 
on Suicide Research and Prevention initiated the SAYLES’s project in 2003. The goals 
of the SAYLE (Saving Young Lives in Europe) project are to compile: 
• Evidence based EU/WHO guidelines of recommended care for young suicide 
attempters in Europe  
• Evidence based EU/WHO guidelines for school personnel on how to prevent 
mental ill-health and suicidal behaviour among school children  
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• Information material to parents and significant others about how to support 
young suicidal persons and how to prevent suicidal behaviour  
• Implementation and scientific evaluation measurements  
 
STRESS-VULNERABILITY MODEL IN SUICIDE PREVENTION 
 
Below, I will only briefly summarise some thoughts about suicide prevention, thoughts 
that are fully developed in the book Suicide, an unnecessary death, (ref.1). According to 
the stress-vulnerability model, genetic makeup as well as acquired susceptibility 
contributes to a person’s constitutional predisposition. This constitutional predisposition 
is called diathesis, which is thought to be the crucial determinant of whether suicidality 
is manifested under the influence of stress as a result of for example acute psychiatric or 
somatic illness, severe abuse of alcohol and drugs, pressing social problems, or family 
crisis. The stress-vulnerability model can be supplemented by the broader model of 
development of the suicidal process in order to provide a better understanding of the 
interaction between suicidal people and the people around them, as well as the role of 
environmental factors that contribute to the person’s vulnerability being held back 
(protective factors) or in some negative circumstances (risk factors) expressed in suicide 
or attempted suicide (ref. 2). 
 
STRATEGIES IN SUICIDE PREVENTION  
Suicide, attempted suicide, and suicidal thoughts have been subject to powerful 
sanctions, both religious and legal. Questions of suicide are surrounded by taboo and 
feelings of shame and guilt. There is ambivalence towards suicide and suicide 
prevention among politicians and policy makers. Suicide is often seen as a very specific 
problem or as such a complex matter that nothing can be done about it. This is all in 
sharp contrast to existing evidence, which shows that suicide, and attempted suicide can 
be prevented.  
 
In suicide prevention, work strategies can be pursued through health-care services 
(health care perspective) directed at the general population (public health perspective). 
The health care strategy includes identification, diagnostics, treatment, access to health 
services etc. The public health strategy involves: policies, knowledge, attitudes, 
controlling access to means of suicide, and responsible media reporting etc. (ref. 3)  
 
EXAMPLES OF SUCCESSFUL SUICIDE PREVENTION 
1. There is evidence that effective treatment of major psychiatric disorders 
(depression, bipolar disorder, schizophrenia) can bring about a reduction in the rate 
of suicide and attempted suicide. However, it is important to closely and carefully 
follow up side effects of medication and especially anxiety and acathisia. 
Monitoring the blood for concentrations of medicines as well as simultaneous 
psycho-social and rehabilitation measures should be used routinely in suicide 
prevention. There are a great deal of obstacles, such as poorly functioning health 
care systems, constant reorganisation, economic restrictions, poor knowledge, and 
negative attitudes towards suicidal patients and suicide prevention. However, 
training of staff in psychiatric clinical work can improve knowledge, change 
negative attitudes towards suicidal patients, improve the climate in the work and 
give co-workers better self-esteem (ref. 4.). 
 
2. Cognitive Behavioural Psychotherapy (CBT) and Dialectical Behavioural 
Therapy (DBT) have been effective in reducing the repetition of suicide attempts. 
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There are also reports that show that regular follow-up after a suicide attempt can 
reduce the repetition of suicide attempts. Hawton et al (ref. 5) showed, while 
scrutinising several randomised control trials, that repetition of attempted suicides 
could be decreased when emergency help was easily accessible.  
 
3. Reduction of alcohol consumption during perestroika in the former USSR has 
been shown to be a very effective suicide preventive programme for men (ref. 6). 
Suicide for men decreased by 40% in the years 1984-1986, especially for men in the 
workforce. All 15 republics of the USSR showed a decline of suicide, while in 
Europe during the same time period the decrease in suicide was as small as only 
3.0%. Alcohol restriction also influenced decreased mortality from undetermined 
causes, either accidental or intentional. Death due to accidental alcohol poisoning, 
violent death, external injuries, and homicide also decreased. Other researchers have 
shown that during perestroika the decrease in mortality due to cardiovascular and 
respiratory diseases could be assigned to alcohol restriction (ref. 7).  
 
4. Controlling the environment through gun possession regulations, detoxification of 
car emissions or domestic gas, control of the availability of toxic substances 
including drugs and medication, as well as responsible media reporting about 
suicide have clear suicide preventive effects (ref. 8). There is also some evidence 
that suicide preventive programmes in schools can decrease suicide and attempted 
suicide (ref. 9). The WHO has published a document, “Preventing Suicide: A 
Resource for Teachers and other School Staff”(ref. 10), which has been translated 
into several languages and can be ordered from the WHO office in Geneva.  
  
CONCLUSIONS  
 
In suicide preventive work it is important to: 
 
• Continuously disseminate knowledge  
• Combine psychosocial, cultural, and biological (genetic) factors in research 
• Create national institutes 
 
The national suicide preventive programmes exist in several countries, and details are 
available in the European monitoring survey on suicide preventive programmes and 
strategies carried out by NASP on behalf of the WHO Regional Office in Copenhagen 
(ref. 11).  
 
It is important to remember in suicide preventive work that many obstacles stem from 
the strong taboo on suicide that still exists and the distress it arouses and has aroused 
throughout history. The silence, ambivalence and negligence encountered make it 
difficult to approach the problem of suicide in an open and scientific way. Suicide is 
still associated with shame, uneasiness and guilt. As a result, suicides are not only 
concealed in the statistics as other causes of death or recorded only as injuries without 
mentioning even the word self-inflicted, but also due to the taboo. This reinforces the 
view that suicide is predestined or impossible to prevent or treat, which is not true. Of 
course still more evidence and better studies are needed, but the evidence from suicide 
preventive studies both from the health care and from the public health perspectives, 
gives encouragement and hope.  
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Lubomir Okruhlica, Center for Treatment of Drug Dependencies, Slovakia 
 
Response 2: Prevention of Abuse Problems 
 
 
SITUATION 
 
The prevention of abuse problems is an important part of the European Commission 
Public Health Action Programme 2003-2008. One of the aims of this Conference is to 
start dialogue on the issues of mental health between the existing and forthcoming 
Member States. Important issues are the new mental health threats encountered in the 
Central and Eastern European Countries, many of them being in the accession process 
to the EU. Drug abuse deserves special attention in this respect. In the course of the 
European Commission's consultations it has clearly emerged that young people's 
welfare and autonomy are influenced primarily by factors like health and drugs. 
Empirical studies show that the spectrum of ill-health is starting to change even among 
young people, and that a trend towards the spectrum of illnesses for adulthood can be 
anticipated. Today, the major health problems affecting young people are no longer the 
typical infectious diseases but, instead, chronic illnesses, psychosomatic illnesses and 
emotional disturbances. Besides the "modern-day" risks in the shape of consumption of 
"hard" and "soft" drugs, careless sexual behaviour and the associated risks of infection, 
the "conventional" risks, including alcohol consumption, tobacco consumption and 
risky behaviour in sporting and leisure-time activities, also have a significant impact on 
the physical and psycho-social health of young people. 
 
Nonmedical use of psychoactive substances is a significant factor contributing to ill-
health in Europe. Poly-substance use was an important trend in the last decade. It also 
means that a combination of licit and illicit drugs as a cause of health damage is 
occurring frequently. When analysing the "health gap" mortality between EU and 
candidate countries, then high tobacco consumption is playing a significant role, too, 
besides illicit drugs and alcohol. The (lifetime) prevalence of legal drug consumption 
(tobacco and alcohol) in the candidate countries is extremely high and the age of onset 
both of alcohol use and first drunkenness is very low when compared with the EU 
Member States. 
  
Europe, and especially Central and Eastern Europe, has the highest consumption of 
alcohol in the world. Alcohol abuse often leads to a deterioration of social and family 
ties and, at the same time, reduces individual self-control and provokes depression, 
which is the primary cause of suicide. However, the scale of harm caused by alcohol is 
much wider. It contributes to a whole range of social, psychological and physical 
problems. Let me mention a few very severe harms such as RTAs, family disruption, 
aggressive behaviour, insomnia, depression, anxiety, amnesia, attempted suicides, 
suicides, hepatitis, pancreatitis, cirrhosis, liver cancer, gastritis, diabetes. These are 
related to heavy drinking with or without dependency, as well as to excessive drinking 
(e.g. binge drinking). Overall, the WHO estimates that in developed countries alcohol 
accounts for 10-11% of all illnesses and deaths each year. Between 40% and 60% of all 
deaths in the European Region from intentional and unintentional injury are attributable 
to alcohol consumption. The link between the trend in alcohol consumption and the 
three mortality indicators (standardised death rate for liver cirrhosis, injuries and 
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poisoning, and RTAs) was demonstrated by regional overview of the countries in the 
WHO report (2001).  
 
Among the 15 EU countries, Austria, France and the Netherlands were experiencing a 
decrease in alcohol consumption, which was consistent with a decrease in all the 
mortality indicators, whilst Denmark and Finland had stable levels. In central and 
Eastern Europe: Latvia shows a consistent increase in both alcohol consumption and all 
of the mortality indicators. In Lithuania, considerable increase in cirrhosis and external 
causes suggest increasing alcohol consumption. In Hungary and Poland there is an 
increase in liver cirrhosis, but consumption is decreasing. Alcohol consumption is 
increasing in the Czech Republic, while the mortality indicators are stable or decreasing.  
 
Serious depression is frequently associated with heavy drinking. Victims are not 
necessarily people with alcohol dependency. Depressed mood is present in most people 
with alcohol dependency, particularly in the immediate post-intoxication period. Part of 
it is undoubtedly the result of some of the life consequences of drinking, including 
isolation from family and friends who will no longer accept the drinking behaviour. 
This leads to a spiral of loneliness and dysphoria. In addition, the neuro-chemical 
disturbances induced by “heavy” bouts of drinking lead to a depressed mood (“alcoholic 
sadness”), which is temporary and will clear after two or three weeks of abstinence. 
However, some alcoholics have a primary depression which is present even in periods 
of prolonged abstinence. Studies of inpatients with alcohol dependency have shown that 
about 15% of women and 5% of men who met criteria for alcohol dependency have 
affective disorder as a second diagnosis. Suicide is a particularly common problem 
associated with alcohol dependence and has been estimated to be as high as 32 times the 
risk of the general population (Sexias, 1982). Next to advancing age, alcohol (and other 
drug) dependence is among the greatest risk factors for suicide. Men are more likely to 
commit suicide than women. The lifetime risk for completed suicide among people with 
alcohol dependency is between 5% and 15%.  
 
Substance-related depression is particularly high among users of psychoactive 
substances with depressant effects such as opiates, alcohol and benzodiazepines. The 
results of studies among patients entering drug treatment show that more than half of 
them had scores indicating depression on depression rating scales. Substance-induced 
(“secondary”) depression may dissipate rapidly, however it is as dangerous as, or more 
so than, major depressive disorder in terms of the risk of suicide and self-injurious 
behaviour. 
 
The rate of comorbidity is high when completed suicides are investigated. Patients with 
medically more severe suicide attempts had a statistically higher prevalence of 
substance-induced mood disorder than the patients who had less severe suicidal 
attempts. Moreover, the majority of the patients with substance-induced mood disorder 
do not meet the criteria for substance dependence, because alcohol can dysregulate the 
mood independently of use, which suggests that some individuals are at risk for 
depression regardless of the chronicity of use. Studies show a conservatively estimated 
rate of about 30% lifetime prevalence of substance-induced depression among cocaine 
users with dependence. 
 
The impact of acute drug-related deaths becomes evident when you consider that each 
year between 7 000 and 8 000 deaths are reported in the EU countries. It is worrying 
that some EU countries recently reported an increase after a period of stabilisation or 
decrease. Most countries consider that there is some level of under-notification, which 
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in some cases is significant. This is the case of the candidate countries as a whole, 
where reporting systems on this specific cause of death are just in the phase of 
preparation and early implementation. A European standard protocol has been 
developed by EMCDDA to report cases from general mortality registries. Basically, it is 
possible to differentiate between acute drug-related deaths and overall mortality among 
problem drug users. Suicides are part of acute drug-related deaths.  
 
Most victims of overdoses are young males, in their 20s or 30s, who have been using 
opiates for several years. Injection represents a major risk factor. A clear ageing trend 
among victims is observed in most countries. The mortality of injectors is two to four 
times higher than non-injectors and (until recently) mortality of drug users infected by 
HIV was two to six times higher than that of non-infected drug users. It is difficult to 
distinguish unintentional overdose from suicidal activity. For the time being, deaths due 
to intoxication by cocaine, amphetamine or ecstasy without the presence of opiates are 
infrequent in Europe. However several countries (Spain, France, Italy, the Netherlands 
and the United Kingdom) have reported a national or local increase of cases where 
cocaine is found.  
 
Since methadone maintenance has become quite widespread in recent years, 
circumstantial toxicological findings of methadone are more frequent among drug users 
who die due to accidents, AIDS and suicides. A few local studies suggest that some 
acute deaths may be caused by methadone diverted to criminal markets. Despite these 
problems research shows that substitution treatment reduces the risks of drug-related 
death among programme participants. The combined use of opiates with other 
depressant substances such as alcohol or benzodiazepines may increase the risk of 
overdose. The problem of widespread misuse of benzodiazepines and their IDU in 
combination with heroin was a typical problem of central European countries in the 
1990s. High availability of these sedatives on criminal markets was one of the reasons.  
 
RESPONSES TO THE QUESTIONS WHICH HAVE EMERGED 
 
How do we apply the strategies for necessary actions on regional, national and 
European levels? The Commission of the EU, the Directorate General responsible for 
the administration of the Public Health Action Programme, has shown interest and 
attention in mental health issues. The EU has foreseen the far-reaching impact and 
consequences of the enlargement process in its recent documents, e.g. the Programme of 
the Community Action in the Field of Public Health 2003-2008. A good example of the  
increasing collaboration between the EU and the WHO is the European Alcohol Action 
Plan (EAAP) 2000-2005 (WHO Regional Office for Europe); the European Union 
drugs strategy (2000-2004) drawn up by EMCDDA and Europol with six main targets 
in the EU action plan on drugs (2000-2004). One of the six main targets of the EU 
action plan on drugs is: “to reduce substantially over five years the incidence of drug-
related health damage (HIV, hepatitis, TBC etc.) and the number of drug-related 
deaths.” These are the main frameworks indicating responses to the problem at a 
European level.   
 
The EAAP aims to reduce the harm caused by alcohol 
Nevertheless, alcohol use by individuals and in the community cannot and should not be 
isolated from other factors, not least the use of other psychoactive substances. The 
opportunities for EAAP implementation depend largely on economic, social and 
cultural factors in the communities. It is useful for a group of countries with similar 
geographical and cultural traditions and economic conditions to work together. There 
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are five overall objectives and ten strategies and actions on how to achieve them: (a) 
generate greater awareness of, provide education in, and build up support for public 
health policies that address the task of preventing the harm that can be done by alcohol; 
(b) reduce the risk of alcohol-related problems that may occur in a variety of settings 
such as the home, workplace, community or drinking environment; (c) reduce both the 
breadth and depth of alcohol-related harm such as fatalities, accidents, violence, child 
abuse and neglect, and family crisis; (d) provide accessible and effective treatment for 
people with hazardous and harmful alcohol consumption and those with alcohol 
dependence; (e) provide greater protection from pressures that encourage drinking for 
children, young people and those who choose not to drink. 
 
All these principles are interconnected. More specific for the public health field, the 
prevention of premature mortality and abuses problems is following selected strategies: 
so that by the year 2005, all countries of the European Region should:  
• Develop public awareness of the harm that can be done by alcohol and the 
consequences on the health and well-being of individuals, families and 
communities;  
• Create support for public health policies;  
• Provide children and young people with effective skills to make healthy choices and 
to be confident in their ability to withstand the pressure of under-aged drinking.  
 
By the year 2005, all countries should have a comprehensive broad-based alcohol 
policy; a system of reporting on alcohol consumption and for monitoring and evaluating 
the implementation of alcohol policy and the harm that can be done by alcohol.  
 
The EU Drug Strategy 
The EU Drug Strategy made it clear that prevention of drug abuse should address both 
licit and illicit drugs. More attention should be paid to the connection between an early 
start with smoking tobacco, an early introduction to alcohol and initial use of illegal 
drugs. The European Council meeting in Helsinki on 10-11 December 1999 endorsed 
the European Union Drug Strategy 2000-2004 that covers all European Union drug-
related activities and sets the main targets. These targets include substantial reduction 
over five years of the incidence of drug-related health damage (such as HIV, hepatitis B 
and C and tuberculosis) and the number of drug related deaths. The European Union 
Action Plan on drugs 2000-2004, endorsed in June 2000 at the European Council 
meeting in Santa Maria da Feira, transposes the strategy into concrete actions. The 
Member States, according to technical tools and guidelines provided by the European 
Monitoring Centre on Drugs and Drug Addiction (EMCDDA), should give reliable 
information on the five key epidemiological indicators, one of which is "drug related 
deaths and mortality of drug users". Similarly, very important from the perspective of 
Public Health Action Programme is also another harmonised epidemiological indicator: 
"drug-related infectious diseases (HIV, hepatitis)". 
  
The EMCDDA annual report on the state of drug problems in the EU and Norway 2002 
stated that scientific evidence indicates that methadone maintenance has substantial 
protective effect on mortality from opioid overdose and mortality from all causes. 
Innovative approaches to prevent and manage cases of overdoses were reported from 
Belgium, Germany, Finland, Norway and the United Kingdom.  They include such 
things as the training of drug users to protect themselves against overdosing and to 
better manage overdoses they witness; training in naloxone administration as well as 
basic resuscitation techniques; and the development of specific prevention information 
materials. In the latter, the government launched an action plan to prevent drug-related 
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deaths in November 2001. Similar activities have been launched in candidate countries, 
especially in the Czech Republic, Slovakia, Slovenia and some Baltic countries, where 
NGOs and their street workers have predominantly been involved. 
 
Preventing the spread of infectious diseases has a significant impact on prevention of 
premature mortality among users of psychoactive substances. Major evidence-based 
responses to prevent the spread of infectious diseases among drug users are community-
based out-reach schemes, drug treatment - in particular the prescription of methadone or 
other substitution drugs (which has considerably expanded in the EU and candidate 
countries over recent years), - hepatitis immunisation, access to sterile injection 
equipment and the use of information and training. Some outreach services are available 
in all EU and candidate countries, but the degree to which the staff of drug agencies set 
off and bring their services to where the clients are varies considerably between and 
within countries. Candidate countries, in general, have to catch up with the EU 
countries in these efforts. A positive exception is Slovenia.  
 
Special programmes that provide access to sterile needles are of major importance for 
minimising the rate of HIV and other blood-borne viral infections in drug users, and 
syringe exchange programmes, through drug agencies and pharmacies or vending 
machines exist, in all EU countries and, after some delay, now also exist in all candidate 
countries. Systematic efforts are under way in Germany, Ireland, the Netherlands, 
Portugal, Austria, Finland, the United Kingdom and Norway, as well as Slovakia and 
the Czech Republic; to make the hepatitis B vaccination more accessible and to achieve 
full immunisation among a higher percentage of drug users. Vaccination against 
hepatitis A is also recommended. Harm preventing and reducing programmes, which 
are vital for public health, are still facing serious obstacles in many communities in the 
candidate countries 
 
Treatment as a response to the problem of drug use is stressed in the EU Action Plan. It 
can significantly reduce morbidity and mortality also due to reduction of suicides as it 
was mentioned above. The comprehensive offer of treatment modalities, their 
availability and accessibility is crucial. Therapeutic psycho-education, substitution 
treatment, drug-free programmes, specialised medical facilities for users with double 
diagnosis, treatment programmes for dependencies (also substitution) in prisons, and 
aftercare are the major treatment modalities, which should be developed and provided. 
The past five years have seen a considerable increase in the availability of treatment 
facilities in the EU and candidate countries. On the whole, medically assisted treatment 
appears to have grown more rapidly than drug-free treatment. However, there are still 
reports from Greece and Portugal, for example, that the treatment supply does not meet 
the client demand. The candidate countries have in common the later onset of the drug 
epidemic (compared to the EU countries), as well as a lag in the development of 
specialised treatment programmes both in quantity and also in the spectrum of provided 
treatment services. In this respect they have a lot in common with Greece and Finland 
where opiate use started about the same time as in majority of Central and Eastern 
European countries. Another specific feature is the close to zero prevalence of HIV 
among intravenous drug users in central European countries and Slovenia. Poland is an 
exception; it has a relatively high proportion of infected persons among drug users. 
 
There is no candidate country, which can comply with demand of fully developed 
prevention and treatment system for drug using population. Neither the availability nor 
accessibility of treatment services is sufficient. For instance, there is generally a smaller 
number of patients with opiate dependence in substitution programmes in comparison 
 147 
 
with the EU average. Maintenance treatment with methadone in prisons started only 
recently as a pilot programme in Slovenia, and may be soon in the Czech Republic, but 
not in the other countries. Late introduction and insufficient development of substitution 
and other harm reduction programmes is associated with a higher prevalence of HIV 
among drug users in Poland and Estonia. Slovakia has one large methadone 
maintenance programme but only in the capital city. Similar problems with accessibility 
are typical for most of the candidate countries. The availability of existing treatment and 
harm reduction programmes is threatened by cuttings on public service expenditures. 
People with alcohol and drug related problems are becoming an easy target.  In 
Slovakia, for example, there have surfaced suggestions to radically reduce the provision 
of these health insurance funded services as a possible means of imposing fiscal 
restrictions. 
 
Future plans for implementation  
The importance of co-ordinated action was acknowledged in an international agreement 
in 1987 by the United Nations comprehensive multidisciplinary outline of future 
activities in drug abuse control. Subsequent international agreements by the United 
Nations and the European Union have identified co-ordination as a cornerstone of 
a balanced and comprehensive drug policy, most recently in the 198 United Nations 
Declaration on the Guiding Principles of Drug Demand Reduction (UNGASS). Within 
the EU, the need for both national and international co-ordination is widely accepted. 
The European Union drug strategy 2000-2004 reaffirms the importance of co-ordination 
and provides a mandate for improvement.  
 
An EMCCDA report published in 2001 defined co-ordination within the field of drugs 
as the task of organising or integrating the diverse elements comprising the national 
response to drugs with the objective of harmonising the work and, at least implicitly, 
increasing effectiveness. In October 2001, the Council's Horizontal Working Party on 
Drugs examined the ´Report on identification of criteria for evaluation of the European 
Union Strategy on drugs (2000-2004)´, drawn up by the EMCDDA and Europol. It 
offers an analysis of each of six targets of the EU action plan and underlines monitoring 
and evaluation constrains. Article 1.1.3 calls on the Council to provide regular 
opportunities for those responsible for drugs at a national level to meet and exchange 
information on national developments and to increase cooperation. So far as national 
strategies are concerned, the trend established over the past few years to translate drug 
policy frameworks into an action plan, drug strategy or policy document has continued, 
although a gap between the written strategy and its implementation still remains. The 
PHARE Technical Assistance programme (2001/2002), and its twinning with the EU 
and candidate countries in the field of drugs and drug policy, has proved an effective 
programme. 
  
The European Convention, a meeting to draft a new treaty and overarching constitution 
for the EU, offers an excellent opportunity to strengthen co-ordination on drug policy at 
a European level. The principle that action on drugs should be comprehensive, balanced 
and co-ordinated is already recognised at the EU level and implemented in many 
countries, but it lacks a legal basis. There remains considerable scope for further 
approximation of national drugs policies and strategies, and for greater co-ordination 
between countries.  
 
The prospect of the enlargement of the EU, embracing up to 10 new countries and 75 
million more inhabitants presents new challenges. Drug abuse in these candidate 
countries, including opiate injection, is now approaching similar levels to those seen in 
the EU Member States. Whilst recreational drug use gives rise to some concerns, the 
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increase in opiate and meta-amphetamine injection is a much more serious problem, 
because of the associated spread of infectious diseases, overdoses, suicides and social 
deprivation. The existing co-ordination between the EU Member States and its bodies 
such as EMCDDA and the candidate countries, and future member states, should 
continue and be further strengthened. 
  
In this way, it is possible to accelerate the introduction of effective harm preventing and 
reducing programmes into the candidate countries, where for instance “the window of 
the opportunity” is still open, e.g. concerning HIV/AIDS infection among intravenous 
drug users, but where the introduction of methadone substitution is slow. The 
implementation of new treatment approaches/substitution in prison environments is 
another possible example of positive measures.  
 
All EU countries have endorsed the principle that co-ordination is an essential element 
in national drug policy. In every state there is a cross-departmental ministerial 
committee that acts as the forum for co-ordinating top-level policy. At the next tier 
down many countries have established central co-ordinating units to implement policy 
and provide technical advice to ministers. The candidate countries are creating similar 
organisational structures. These units should operate and make the gap between 
documents and praxis narrower. It is possible that horizontal intersectoral "action 
groups" (bodies, which are known from the other types of epidemics) constituted from 
administrators and experts from different sectors, could complete this structure and act 
as a more flexile and dynamic instrument in the transfer of strategic objectives into real 
life. 
 
The transfer of good practices is an important objective, which is congruent with the 
European drug strategy and with the European Alcohol Action Plan, and it applies not 
only to candidate countries, but also to different communities across the whole of 
Europe. Emphasis should be given to the need for an evaluation of the experiences 
gained, and identifying the best practices with a view to ensuring the consistency and 
continuity of the Community's action in this field. An active promotion of evidence-
based interventions can make important contributions despite the scarcity of the 
resources. 
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WORKSHOP 4A REPORT: The Prevention of Premature Mortality 
 
Co-ordinator: Andrej Marusic, Slovenia 
Facilitator: Lars Mehlum, Norway 
Rapporteur: Maja Zorko, Slovenia 
 
The following questions were put to the workshop beforehand: 
A Recent changes in premature mortality statistics (focusing on suicide): how to apply 
the strategies of necessary actions at a regional, national and European level? 
B Different parts of society need to be involved: how to stimulate the needed inter-
disciplinary and intersectoral collaboration, and how to cover the entire life-span? 
C What goals should the emerging European Union have for suicide prevention for the 
next five-year period?  
HOW TO APPLY THE STRATEGIES ON DIFFERENT LEVELS? 
The experiences from several pioneering, ongoing6 and developing7 national strategies 
for suicide prevention indicate the importance of: 
• defining responsibilities for national co-ordination; 
• terms of reference given by federal authorities; 
• interdisciplinary basis and ownership; 
• multisectoral involvement; 
• creation of suicide prevention networks; 
• specific goals and practical measures; 
• evidence-based strategy; 
• including actions that are open to monitoring and continual evaluation; 
• continual revisions and updates of the strategy; 
• establishing resource centres. 
 
The Suicide Prevention Strategy for England (2002) is a good example, demonstrating 
the main goals and objectives for action that should be met by every suicide prevention 
programme. The programme activities of the suicide prevention strategy are based on 
six goals:  
1. To reduce suicide risk in key high risk groups 
- the group must have a documented statistical increase in the risk of suicide; 
- the actual numbers of suicide in the group must be known; 
                                                          
6 Finland (1992-), Norway (1994-), Sweden (1995-), ,Greenland (1997-), Denmark (1999-), Australia 
(1999-), Canada, USA (1999), England (2002), Scotland (2002) 
7 Slovenia, Germany, Belgium, China 
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- evidence exists on which to base preventive measures; 
- there must be ways of monitoring the impact of preventive measures that have 
been implemented. 
 
2. To promote mental well-being in the wider population by targeting: 
- socially excluded and deprived groups; 
- ethnic minority groups; 
- alcohol and drug misusers; 
- victims of violence and sexual abuse; 
- children and young persons under 18 years of age; 
- women during and after pregnancy; 
- older people; 
- those bereaved by suicide. 
 
3. To reduce the availability and lethalness of suicide methods such as: 
- firearms; 
- pharmaceutical drugs; 
- poisonous substances; 
- car exhaust; 
- bridges and high places. 
 
4. To improve the reporting of suicidal behaviour in the mass media. 
5. To promote research on suicide and suicide prevention. 
6. To improve epidemiological monitoring of suicides to track the progress of suicide 
prevention actions. 
Past experiences show that developing an infrastructure is of high importance. The 
provision of high quality epidemiological data on suicide and nonfatal deliberate self-
harm is crucial and can be provided only through standardised approaches to defining, 
reporting, recording, classifying and coding. An establishment of resource centres in 
charge of research, monitoring trends, supervision and education is needed. National 
centres now exist in many countries with some countries also having regional centres. 
Furthermore the establishment of a European Centre was discussed.  
It was concluded that national suicide prevention strategies should be supported by: 
a) establishment of national resource centres for suicide research and prevention; 
b) networks on national, regional and local levels: 
- International: IASP, IASR, WPA (WFMH, MHE and more); 
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- European: EUR/WHO Network for suicide research and prevention, 
European biennial suicide research conferences; 
- National networks - various dimensions; 
- Regional networks (examples: Sweden, Norway); 
- Local networks.  
c) international collaboration. 
INVOLVING DIFFERENT PARTS OF SOCIETY 
The continuum of different phases and risk factors of the suicidal process is 
accompanied by the continuum of responsibility, - from the generalised to the 
specialised, and from the public to the experts (Figure 1). Thus, suicide prevention 
cannot only be the responsibility of the health care system or experts, but requires a 
much wider approach, which includes different parts of society (Figure 2).  
 
The public, users, families
Volunteers, NGOs
Primary health care
Mental health
Experts/suicidologists
The basis is the public, users and primary health care
 
 
Figure 1. Suicide prevention in different phases of the suicidal process (Mehlum, 2000).  
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Figure 2. Different parts of societies that are involved in suicide prevention (Mehlum, 
1999).  
 
CONCLUSIONS AND RECOMMENDATIONS  
C1 For the European Union to require of each member state that national health 
plans must address the need for suicide preventive measures. 
C2 For the European Union to recommend the establishment of national suicide 
prevention strategies for:  
a) increasing public awareness about suicide: 
- that suicide is a major public health problem; 
- that suicide prevention is a responsibility of the whole society, not only of 
experts, mobilising interdisciplinary and intersectoral collaboration; 
- mobilising/empowering the public and users through: 
- IASP/WHO World Suicide Prevention Day (celebrated for the first time on the 
10th September 2003); 
- National/regional suicide awareness days; 
- First-aid/Band-aid concept (Living Works, VIVAT, Other); 
- mobilising/empowering NGOs suicide prevention in partnerships with 
professional agencies for suicide prevention through:  
- crisis support/intervention: Crisis centres/telephone services (Samaritans and 
numerous similiar organisations); 
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- bereavement support: Survivor associations (SPES, LEVE etc.); 
- suicide prevention advocacy (SPAN, IASP); 
- fundraising for research and development (AFSP). 
b) reducing suicide rates in key high risk groups through 
- treatment of depressive disorder and bipolar disorder; 
- more targeted preventive treatment for patients with schizophrenia and risk of 
suicide; 
- improved follow-up treatment of suicide attempters; 
- improved treatment for patients with double diagnoses of substance abuse and 
mental disorder; 
- establishing support/treatment for suicide survivors. 
d) limiting the access of and lethalness of suicide methods. 
e) improving the reporting of suicidal behaviour in the mass media. 
C3 Establishment and maintenance of a European database of good practices/ 
methods in suicide prevention across sectors of society and national borders 
C4 Establishment of a resource centre for:  
- epidemiological surveillance and evaluation of trends; 
- improvements in the quality of epidemiological data; 
- evaluation of suicide preventive strategies and measures. 
C5 The European strategy should be regarded as an evolving strategy regularly 
updated with the emergence of new challenges and new evidence based methods. 
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WORKSHOP 4 B REPORT: Prevention of Alcohol and Drug Abuse 
Problems 
 
Co-ordinator: Andrej Marusic, Slovenia 
Facilitator: Pier Paolo Pani, Italy 
Rapporteur: Marianne Sipilä, Finland 
 
The specific questions to be answered: 
1. What priorities in intervention should be used for the general population? 
2. What priorities in intervention should be used for high risk groups? 
3. Different parts of society need to be involved: how do we stimulate the much 
needed inter-disciplinary and intersectoral collaboration? 
The prevention of abuse problems is an important part of European Commission Public 
Health Action Programme 2003-2008. Europe, and especially Central and Eastern 
Europe, has the highest consumption of alcohol in the world. Alcohol and drug abuse 
often leads to a deterioration of social and family ties and, at the same time reduces 
individual self-control, and provokes depression, which is the primary cause of suicide. 
The scale of harm caused by alcohol and drugs is wide. It contributes to a whole range 
of social, psychological and physical problems. 
GENERAL POPULATION 
The focus of all promotional work should be on healthy lifestyle promotion and life-
skills development. More knowledge and education about alcohol and drugs should be 
given on: the use, abuse, consequences, dependence, effects on brain, etc. The 
information should be conveyed frankly and seriously.  
The development of psycho-educational preventive interventions and programmes are 
needed: e.g. having different public information campaigns, following the WHO 
principles on health promotion. The health promotion approach should dominate 
prevention and different prevention measures should be integrated. In the community, 
extensive projects in schools, youth clubs, workplaces, the army etc. are needed. 
Examples of these could be: ‘Have a View on a Healthy and Confident Society', 'Be 
Free from Alcohol and Drug Related Harm!’; or, ‘It’s Your Choice and Decision – 
Have a Free Urine Test!’ It would also be a good strategy to have well-known people 
like movie stars or other famous people tell openly about their experiences of using 
drugs or alcohol. 
The collection of good quality data at a general and local level is needed. Even though 
much has been done, further development in this direction would help to assess the 
national and regional needs, and to monitor interventions and their impact in an 
evidence-based context. There is also a need for the standardisation of data across 
countries and for co-ordination both at a local and general level.  
Stigmatisation and discrimination connected with substance use should be overcome. 
This is essential for increasing information and knowledge about substance abuse, 
predisposing factors and concomitant illnesses. It is important to use available and 
 155 
 
effective treatments in order to enhance social participation, to prevent abuse, to break 
through the existing barriers to available interventions, and to involve societal resources 
in prevention and treatment. 
HIGH RISK GROUPS 
Who are in the high-risk groups? Perhaps there should be some kind of general test to 
evaluate high risk groups? A lot of research has been done and many reports published 
on the risks involved in alcohol and drug use. Specific interventions and treatments 
have been developed, and they provide solutions for people with risky behaviour. Still, 
more has to be done. 
More attention should be paid to the connection between an early introduction to 
smoking, alcohol, and the use of illegal drugs. More attention should be made to the 
monitoring of experimental drug use at sports events, other public events, and beer or 
wine festivals. Parents who use alcohol or drugs are increased the health risks to their 
children. There is a need to minimise alcohol- and drug-related problems in a variety of 
settings such as the home, workplace, community or drinking environment, in order to 
reduce accidents, family crises, violence, child abuse and neglect. 
Effective methods to prevent substance abuse should be included in alcohol and drug 
strategies:  
• Increasing knowledge and resistance of users and abusers by providing information 
on the prevention and treatment of drug related harm.  
• Information, education and provision of psycho-educational programmes can be a 
helpful step before treatment for high risk groups.  
• Effective treatments for substance abusers should be implemented. The treatments 
should be flexible enough to fit to different settings and to the use of different drugs. 
Preventing and treating related morbidity and mortality (overdose, infectious 
diseases, psychiatric disorders etc.) is important. By adding some psychosocial 
intervention, the outcome can be still more favourable. Non-pharmacological 
psychosocial interventions have still to show their efficacy.  
• Special programmes that, for example, provide access to sterile needles are 
important.  
• Offering rehabilitation for drug users is part of an optimum comprehensive 
programme. 
All countries should have a comprehensive broad-based alcohol policy, including a 
system of reporting on alcohol and drug consumption for the monitoring and evaluation 
of alcohol policy implementation and the harm that can follow alcohol or drug use. 
Special focus should be on adolescents, the ageing population, prisoners, minorities, 
immigrates, recreational drug users, motor vehicle drivers etc. 
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INTERDISCIPLINARY AND INTERSECTORAL COLLABORATION 
Local initiatives and face-to-face communication are essential, accompanied by a 
holistic approach in co-ordinating programs and services at local level. It is important to 
involve communities in the development and delivery of local strategies, and in 
focusing the action where it is most needed. Harm reduction should be an integral part 
of drug policy in every country. It includes the legal framework for substitution and 
maintenance programs.  
All EU countries have a intersectoral ministerial committee that acts as the forum for 
co-ordinating national policy. The candidate countries are creating the same 
organisational structures. These units should operate and make the gap between 
documents and praxis narrower. 
Administrators and experts from different sectors should cooperate and work in 
intersectoral collaboration. They should share responsibilities via mechanisms of shared 
project budgeting. It should include all actors and stakeholders, like NGOs, university 
departments and public health facilities owned by the local community. 
The principle that action on drugs and alcohol should be comprehensive, balanced and 
co-ordinated is already recognised at the EU level, and is implemented in many 
countries, but it still lacks a legal basis. Thus, there remains considerable scope for 
further approximation of national drug policies and strategies and for greater cross-
national co-ordination. The prospect of the enlargement the EU, embracing up to 10 
new countries and 75 million more inhabitants presents new challenges for the future. 
The mechanisms for co-ordination between the EU Member States and its bodies, such 
as the EMCDDA, and the candidate countries (and any new member states that may 
later join) should continue and even be strengthened further. 
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CONCLUDING PRESENTATIONS 
 
Eero Lahtinen, Ministry of Social Affairs and Health, Helsinki, Finland 
 
 
Future Prospects of the European Mental Health Agenda 
The future depends on whether we will be able to keep mental health on the agenda; our 
own, the national, the EU25 and the global agenda. I think that I have been asked to talk 
about the future because I have had some connection with the mental health agenda 
since the mid-1990s. Therefore, I will present a few quite personal reflections on the 
issue.   
First, I would like to emphasise the importance of the continuous development of an 
understandable conceptual and operational framework, and the importance of using that 
framework to systematically fill in the gaps in data information we need to get decision- 
makers to be supportive of mental heath work and to deal with mental health issues as 
effectively as possible. My personal view is that following the public health path will be 
the most effective strategy here. We should focus on issues that make the work of 
mental health so unique, especially prevention and promotion. The themes I would like 
to suggest are resilience, concepts, monitoring and interventions. In addition, we should 
work more and more on mental health economics, where - I think - we have already 
made immense progress in a very short time. But we need more in order to convince 
decision-makers all over the world.  
Second, I think we should try to avoid an unnecessary polarisation between the different 
stakeholders at different levels: 
• Between international organisations such as the WHO and the EU: they both have 
their own roles, but their efforts should be complementary as far as possible. 
• Between continents:  Europe - North America or Australia: a lot is done currently on 
the other side of the world  - with Australia being especially advanced. We do not 
need to independently reinvent the wheel on every continent.  
• Between countries, regions, organisations and people: There will be enough to do 
for everybody in this domain, wherever they are. In order to make progress we need, 
naturally, to have our own agendas, but making efforts together makes 1 + 1 to be 
more than just 2.   
• Between the policy and administration level vs. NGOs and users and carers. If we 
want to have sustainable development, the process must be participatory and 
empowering, not an activity imposed from the top down. This is not always easy, 
but it is absolutely necessary.  
• Between promotion, prevention, treatment and rehabilitation. Mental health work 
needs all these components, and they are complementary. This is perhaps the most 
important lesson we should learn from general health promotion. 
Third, we need to keep the political momentum that we have already achieved going. 
Ministers come and go, but we stay. We need to repeatedly educate new ministers on 
the basics about mental health work to get them committed. I am happy, for instance, to 
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tell you that the new Finnish Government and its Health Minister are still committed to 
this issue. A particular challenge is that we will have a new Commission and a new 
European Parliament next year. We all need to do everything in our power to sensitise 
the new Commissioner and the new MEPs on mental health issues. There, I would say, 
we are very much in the hands of, not only the coming presidencies of the EU, but 
increasingly also the positions of the accession countries. We might not yet be ready to 
debate on a Council and European Parliament recommendation on mental health with 
the aim of further raising its importance by providing a concrete tool for country level 
lobbying, but we are not far away. 
I do not know any other example in the field of public health and especially health 
promotion where so much progress has been possible in such a short time, while having 
such a continuous and close link with the political sphere. We have seen conclusions 
and resolutions at the top political level, but we have also seen a growing evidence- and 
knowledge base and more and more information on good practices. And that is because 
you have made this possible, your work, your innovations and your commitment. 
In terms of mental health promotion, coming from the field of general health promotion, 
I must say that we might even be able in a few years to show the way to general health 
promotion, because we seem to be getting a very solid, multidimensional and balanced 
basis for future progress in our work. But that requires that we: 
• respect different science domains as providers of evidence, another lesson to be 
learned from the mistakes of general health promotion;  
• avoid a conscious medicalisation of mental health promotion; and  
• in the first place, keep alive the unique togetherness and collaboration of those who 
have been, and will be, active in this field. 
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Andrej Marušič, Institute of Public Health of the Republic of Slovenia 
 
There is No Public Health without Public Mental Health 
 
 
When Tyrer and his colleagues tried to locate the early foundations of public mental 
health they had to look back to the middle of the nineteenth century. Since both public 
and mental health medicine became identified as a discipline within medicine the major 
concerns facing public health doctors were those relating to epidemics of disease such 
as the cholera epidemics. Accordingly, the first role of public health became one of 
social reform. The only mental health component of these reforms was an indirect one, 
as improvements in the productivity and spending of money for the relief of the poor led 
to improvements in moral and mental behaviour. In the early twentieth century public 
health was preoccupied with prevention, hygiene, the surveillance of communicable 
diseases and the administration of health facilities. One of the reasons why mental 
health did not figure highly on public health agendas was the absence of mental health 
indicators, broadly in line with the popularity of psychoanalysis. Most recently, mental 
health indicators have been developed, which in turn has presented an important 
opportunity for the public mental health to develop further. 
 
As Kendell (1997) has pointed out, public health has traditionally been concerned with 
the primary prevention of disease, either by eliminating its causes or by enhancing host 
resistance. Unfortunately, the majority of mental disorders have not yet proved 
susceptible to this approach. Measures like introducing dietary intervention to eliminate 
pellagra, the widespread use of penicillin to eliminate general paralysis of the insane, 
and neonatal screening programs to detect phenylketonuria and congenital 
hypothyroidism also prevent the related mental disorder. Amniocentesis and 
contemporary ultrasound diagnostics have the potential to reduce the incidence of 
Down’s syndrome. In the same way, a wide range of safety measures and legislation 
intended to minimise the risk of accidents have effectively reduced the incidence of 
post-traumatic stress disorder. Evidence might show that improvements in obstetric care 
will lead to a lower incidence of schizophrenia!? There are several other opportunities 
for prevention which are not yet properly exploited, for example, the detection of 
postnatal depressions by a questionnaire followed by counselling; the prevention of 
puerperal psychoses in high-risk pregnant women; the prevention of pathological 
bereavement reactions, and possibly of post-traumatic stress disorders, by early 
interventions. 
 
Of course, prevention is not the only aspect of public (mental) health. Another 
important aspect of public (mental) health has been covered by Kleinman and Becker 
(1998), when they presented the concept of sociosomatics as opposed to 
psychosomatics. According to this concept, social contexts are integrated into mind and 
body understandings. Mind and body interactions are reframed as mind and body in a 
social context. A direct impact of the social context upon bodily or illness experience is 
therefore expected: psychophysiologic processes are shaped by social forces, and 
patterns of symptoms are identified as local idioms of distress and cultural syndromes. 
This concept is also relevant to the cross-cultural understanding of mental health, which 
is becoming increasingly important with the ongoing enlargement of the European 
Union. 
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With the potential for such a wide spectrum of activities, we first need to agree about 
the name of a public health discipline covering mental health issues. It is true that public 
health medicine consists of what used to be called social medicine, epidemiology and 
hygiene. Nevertheless, we should not use any of the following names: social psychiatry, 
psychiatric epidemiology or mental hygiene as none of these would cover the whole 
spectrum of public health responses to mental health needs. On the other hand, the name 
public mental health will do! 
 
At the moment, we have already recognised that mental health problems are of major 
importance to all societies and to all age groups. We have agreed that mental health 
problems are a significant contributor to the burden of disease and that the related loss 
of quality of life can cause human suffering and disability and increase social exclusion 
and mortality. Furthermore, the stigma attached to mental health contributes negatively 
to equality and societal inclusion. Hence, we need to: collect good quality data on 
mental health (valid and reliable across time and across Europe); support the analysis of 
the mental health situation based on research and an assessment of needs; develop, 
implement and evaluate actions to prevent mental disorders and to promote mental 
health; allow access to treatment, the labour market, education and other public services 
for (re)integration of people with mental disorders into society; and  to enhance the 
visibility of mental health and to raise awareness of the real burden of mental disorders. 
 
One wonders if the European Union's Community Action in the Field of Public Health 
is good enough to effectively cover all the above presented tasks! It probably does not 
treat public mental health globally enough as it only provides compartments for mental 
health under the health determinants section. Furthermore, division into compartments 
is neither evidence- nor value- based; e.g. depression comes under mental health and 
suicide under injury prevention. 
 
In terms of health information, mental health information should also be covered by 
the development, co-ordination and the dissemination of mental health information and 
monitoring systems, by reporting and analysing mental health issues and producing 
public mental health reports, and by improving access to and transfer of data at an EU 
level. Whereas health determinants have already covered some mental health 
determinants, health threats have been almost mental health free. These should also 
cover at least the following areas affecting mental health threats: 
• the surveillance development and integration (e.g. the rights of people with 
mental disorder continue to be violated in the EU, e.g. exemplary actions by the 
associations like Geneva Initiative); 
• the safety of new illicit drugs; 
• the building of targeted capacity is also relevant to mental health (e.g. for those 
events that adversely affect large numbers of people, like September  11th 2001). 
 
As a great degree of support and co-ordination will be needed, the European Union 
should start thinking about agencies to cover public mental health. We have already 
seen the effectiveness of EMCDDA (European Monitoring Centre for Drugs and Drug 
Addiction) in Lisbon. A similar agency could cover other relevant public mental health 
concerns, e.g. suicidal behaviour. About 70% of deaths due to suicide occur in the age 
group 25 to 64, which are, from a socio-economic point of view, the most productive 
years. They impose great economic burdens on society due to lost future productivity. 
Suicides claim substantially more life-years and more personal income loss during the 
age interval from 20 to 64 years than any of the two “major killers”, i.e. cardiovascular 
diseases and cancer. The average number of years of lost productivity due to suicide is 
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twice the number due to cerebrovascular disease and ischemic heart diseases. For 
example in Slovenia, which has one of the highest suicide rates in the world, around 
30/100.000/year, deaths from suicide in 2001 accounted for the greatest loss of future 
income (Šešok et al, 2004): 
• the first leading cause of Future Lifetime Income Lost; 
• the first leading cause of Valued Years of Potential Life Lost (VYPLL); 
• the second leading cause of Working Years of Potential Life Lost (WYPLL) 
with an average number of 21.7 years per person who died prematurely; 
• the second leading cause of Premature Years of Potential Life Lost (PYPLL) 
(29.7 years per person who died prematurely); 
• the third leading cause of Premature Death (rate 15.9 per 100.000 inhabitants 0-
64). 
Would it be too daring to think of agencies like EMCSAS - the European Monitoring 
Centre for Suicide and Attempted Suicide? 
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